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OSTEOARTHRITIS
Osteoarthritis (OA) is the most common musculoskeletal disease and the second largest 
contributor to disability within the musculoskeletal disorders.1 Recently, new definitions 
to address OA have been developed.2 The OsteoArthritis Research Society International 
defined OA as “a disorder involving movable joints characterized by cell stress and ex-
tracellular matrix degradation initiated by micro- and macro-injury that activates mala-
daptive repair responses including pro-inflammatory pathways of innate immunity. The 
disease manifests first as a molecular derangement (abnormal joint tissue metabolism) 
followed by anatomic, or physiologic derangements (characterized by cartilage degra-
dation, bone remodeling, osteophyte formation, joint inflammation and loss of normal 
joint function), that can culminate in illness”.3 The hands and knees are among the most 
frequently affected joints.4,5
Classification criteria
Clinical characteristics of OA are pain, stiffness and disability. During physical examina-
tion a decreased range of motion, bony enlargements and deformities of the joint can 
be observed. Radiographic examination reveals structural abnormalities of the joint as 
osteophytes, joint space narrowing and sclerosis of the subchondral bone (Figure 1). 
Magnetic resonance imaging can also visualize soft tissue abnormalities as synovitis, and 
subchondral bone lesions (Figure 1). 
OA can be measured and defined according to different sets of classification criteria, 
focusing on either clinical or radiographic characteristics of OA, or on both. The most 
commonly used classification criteria are listed in Table 1.6-8 Recently, preliminary criteria 
for OA assessment based on magnetic resonance imaging have been proposed.9
Figure 1. Radiographic examination of the knee by X-ray (left) and T1-weighted magnetic resonance image (right).
502331-L-bw-Visser
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Table 1. Classification criteria for osteoarthritis (OA)
Hand OA Knee OA
Clinical criteria# Clinical criteria#
Pain, aching or stiffness Pain 
≥ 3 of the 4 following: ≥ 3 of the 6 following:
- Bony swelling in ≥ 2 of 10 selected joints* - Age > 50 years
- Bony swelling of ≥ 2 DIP joints - Stiffness < 30 minutes
- < 3 swollen MCP joints - Crepitus on active motion
- Deformity of ≥ 1 of 10 selected joints* - Bony tenderness
- Bony enlargement
- No palpable warmth
Clinical and radiographic criteria#
Pain 
Osteophytes
≥ 1 of the 3 following:
- Age > 50 years
- Stiffness < 30 minutes
- Crepitus 
Radiographic criteria§ Radiographic criteria§
Doubtful OA: possible osteophytes, doubtful JSN Doubtful OA: possible osteophytes, doubtful JSN
Minimal OA: definite osteophytes, possible JSN Minimal OA: definite osteophytes, possible  JSN
Moderate OA: moderate osteophytes, definite JSN, 
some sclerosis and bone deformity 
Moderate OA: moderate osteophytes, definite JSN, 
some sclerosis and bone deformity
Severe OA: large osteophytes, severe JSN, severe 
sclerosis and bone deformity
Severe OA: large osteophytes, marked JSN, severe 
sclerosis and bone deformity
# American College of Rheumatology criteria
§ Kellgren and Lawrence grading system
* Selected joints: bilateral DIP II and III, PIP II and III, and first CMC joints
CMC, carpometacarpal; DIP, distal interphalangeal; JSN, joint space narrowing; MCP, metacarpaphalangeal; OA, 
osteoarthritis; PIP, proximal interphalangeal.
1
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Prevalence
The prevalence of OA depends on the classification criteria that are used, and increases 
with age.4,5 A national survey among adult Dutch men and women aged from 18 years to 
over 80 years assessing self-reported diagnosis of OA showed an overall prevalence of 
knee OA of 5% and a prevalence of hand OA of 3%. When assessing the OA prevalence in 
different age categories, individuals aged 65 years or older had a 10-fold higher preva-
lence than individuals aged up to 64 years. From all individuals reporting to be diagnosed 
as having knee or hand OA, 75% reported severe complaints due to their OA.10,11 These 
numbers illustrate the clinical burden of OA, especially in increasing age categories. In a 
recent survey of a population study in Rotterdam, the Netherlands, comprising 5650 men 
and women aged 55 years and older, the prevalence of OA of the different hand joints 
was 5-33%, according to the radiographic ACR criteria. The prevalence of radiographic 
knee OA was 15%.12 
Incidence
The incidence of OA also depends on the applied classification criteria and is difficult to 
assess due to the gradual onset of the disease. Since the prevalence of a disease is equal 
to its incidence multiplied by the disease duration (lifelong in case of OA), the overall 
incidence of self-reported knee OA is estimated to be 81 per 100,000 person-years (5 per 
100 persons per 62 assessed years) based on the 5% prevalence reported by the above 
described survey among Dutch men and women aged 18 to over 80 years (mean life ex-
pectancy 80 years). The overall incidence of self-reported hand OA is estimated to be 48 
per 100,000 person-years (3 per 100 persons per 62 assessed years).11 
As shown in a large-scale incidence study of symptomatic and radiographic knee and 
hand OA, the incidence of OA increases with age. This increasing incidence however was 
found only until the age of 80, above this age the incidence of OA decreased. Further-
more, a higher incidence of OA was found in women than men, especially after the age 
of 50.  The calculated age- and sex-standardized incidence rates were 100 per 100,000 
person-years for hand OA and 240 per 100,000 person-years for knee OA.5 
Risk factors
Although the pathogenesis of OA is not completely understood, several risk factors are 
known to contribute to the development of the disease and its clinical features (Figure 
2). Risk factors can be estimated both from incident and prevalent disease cases. In OA 
estimation of risk factors is mostly done based on prevalent cases, since this is most time 
efficient and the incidence-prevalence bias is low.
OA is a multifactorial disease affecting all joint tissues; degenerative changes of cartilage 
and subchondral bone but also inflammation of the synovial tissue occur. Both systemic 
factors and local biomechanical factors are thought to play a role in OA development.13,14 
Age and female sex are well-known risk factors. Obesity is another prominent risk factor, 




Figure 2. Systemic and local risk factors for OA development and clinical features (Dieppe, 2005)
Obesity
The association between obesity and OA of both weight-bearing and non-weight-bear-
ing joints suggests involvement of biomechanical as well as systemic processes. Several 
mechanisms are thought to explain the association between obesity and OA (Figure 3). 
Besides increased mechanical stress, resulting in damaged joint tissue due to overload,17 
multiple systemic processes seem to play a role. Adipose tissue is known as a source 
of pro-inflammatory and anti-inflammatory adipokines, which have been suggested to 
be involved in OA pathogenesis.18 Obesity-associated hyperglycemia and diabetes have 
been related to OA,19-21 possibly acting through different pathways: via insulin-like growth 
factor I resistance of chondrocytes,22 via changes in striated muscles due to insulin resist-
ance,23 or via formation of advanced glycation end (AGE) products.24,25 The association of 
OA with measures of atherosclerosis suggests involvement of systemic inflammation or 
pathology of subchondral bone vasculature.12,26,27
The relative importance of different processes in the relationship between obesity and 
OA remains unclear. Obesity is usually defined by a body mass index (BMI) of ≥30 kg/m2. 
Since BMI is defined based on height and weight only, it provides little information about 
body composition. More insight into the underlying mechanisms of the relation between 
obesity and OA can be obtained by studying different compounds of body composition 
separately. For example studying the amount and distribution of fat (visceral and sub-
cutaneous adipose tissue) or fat free mass may provide valuable information regarding 
involvement of these body compositions in OA. 
Biomechanical pathways
(cytokines, preteoases, and so on)
Site and severity of osteoarthritis



















12   
Figure 3. Mechanisms explaining the association between obesity and OA (EULAR textbook on Rheumatic 
Diseases, 2012)
Treatment of OA
Although the clinical burden of OA is high, treatment modalities are limited to symptom 
alleviation.28,29 The lack of structure-modifying treatment is partly caused by the incom-
plete understanding of underlying disease processes. Furthermore, development of ef-
fective treatments is difficult because of the lack of high-quality studies on OA treatment. 
Especially in hand OA, few high-quality studies have been performed due to the use of 
many different and poor outcome measures, preventing adequate assessment of the 
disease and possible treatment effects.30 
Outcome measures in OA research
The Outcome Measures in Rheumatology (OMERACT)  is an initiative of international pro-
fessionals interested in outcome measures in rheumatology, aiming to improve outcome 
measures through a data driven, iterative consensus process.31 Core sets with a minimum 
number of domains and instruments are described for outcome description in clinical 
trials.32 For phase III clinical trials in OA of the knee, hip and hand, four core domains have 
been identified depending on the setting: pain, (physical) function and patient global as-
sessment for symptom modifying trials, and in addition imaging for structure modifying 
trials.33 However, the existing set of core domains for hand OA is not hand OA specific and 
has several shortcomings.
The OMERACT Hand OA working group comprised health professionals and researchers 
with interest and experience in hand OA, whose goal is to identify a preliminary set of 
core domains using the OMERACT framework for four different settings: clinical trials 
aimed at symptom modification, clinical trials targetted at structure modification, obser-

















This thesis contains two parts; part I covers the first objective, focusing on the underlying 
mechanisms of the association between known risk factors and OA, and especially on 
obesity. For this part of the thesis, data of the Netherlands Epidemiology of Obesity (NEO) 
study have been used.
The NEO study is a population-based prospective cohort study, set up to investigate the 
underlying mechanisms of the relationship between obesity and  related diseases, such as 
OA. The study population includes 6,673 individuals of the general population, aged 45 to 
65 years, with an oversampling of persons with overweight or obesity. Due to the double 
counting of two individuals, the population was reduced to 6,671 individuals.  Patients 
were included for baseline assessment between September 2008 and September 2012 
and are followed for the incidence of obesity-related diseases and mortality. At baseline, 
data regarding presence of hand and knee OA were collected through questionnaires and 
physical examination of the hand and knee joints. In addition, in 1,285 participants mag-
netic resonance imaging of the knee was performed to assess structural abnormalities 
within the joint. Furthermore, all participants completed questionnaires on demographic 
and clinical data and underwent extensive physical examination including anthropometry 
and blood sampling.35 
Using data of the NEO study, we took advantage of the unique opportunity that extensive 
data have been collected on metabolic factors associated with obesity simultaneously to 
extensive sampling of OA in both weight-bearing and non-weight-bearing joints. In chap-
ter 2 we investigated the relative contribution of mechanical stress and systemic process-
es in OA of weight-bearing and non-weight-bearing joints, by examining the association 
of surrogates for both mechanisms with OA of knees, hands or both. Chapter 3 reports on 
the association between adiposity and OA. We investigated the association of adipose tis-
sue and its abdominal distribution with the presence of OA in non-weight-bearing joints: 
the hands. To enhance our understanding of the role of obesity in knee OA, we investigat-
ed the association of fat mass and skeletal muscle mass with OA of the knees in chapter 4.
OA is characterized by degenerative changes of joint structures; however, these structural 
abnormalities are not specific for OA since they have also been observed in persons with-
out OA.36-39 To increase the understanding of the disease processes leading to sympto-
matic OA, in chapter 5 we investigated which specific structural abnormalities on specific 
locations within the knee joint could best discriminate presence of symptomatic OA in the 
same knee.
To gain more insight into the mechanisms underlying the association of known 
risk factors with OA, focusing especially on obesity in association to OA of both 
weight-bearing and non-weight-bearing joints. 
To contribute to the identification of appropriate outcome measures that can be ap-
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Symptomatic OA has been associated with decreased health-related quality of life 
(HRQOL).40-42 In order to gain insight into possible targets for improvement or prevention 
of possible decline in HRQOL in knee OA patients, in chapter 6 we evaluated the impact 
of knee OA and its modifiable or preventable risk factors obesity, fat free mass (as proxy 
for muscle mass) and comorbidities. In addition, the interaction between knee OA and 
these risk factors in relation to HRQOL was examined.
Part II comprises the second objective, focusing on the identification of appropriate out-
come measures that can be applied in OA research. In the framework of the OMERACT 
Hand OA working group  we performed two systematic reviews to assess available in-
struments measuring the previously identified domains pain, physical function, patient 
global assessment and imaging in more detail. 
Chapter 7 evaluates the use of instruments measuring pain, physical function or patient 
global assessment in studies on hand OA, as well as the metric properties of these in-
struments. Chapter 8 focuses on the imaging results, evaluating the use of conventional 
radiography in studies on hand OA, and to assess the metric properties of the different 
available radiographic scoring methods.
Finally, chapter 9 provides a summary and general discussion of the thesis, as well as the 
future perspectives that result from our conclusions.
502331-L-bw-Visser
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  PART I




  CHAPTER 2
 The relative contribution of mechanical stress and systemic processes in  
 different types of osteoarthritis: the NEO study
 A.W. Visser, R. de Mutsert, C. le Cessie, M. den Heijer, F.R. Rosendaal, 
 M. Kloppenburg, for the NEO Study Group
 Annals of the Rheumatic Diseases 2015;74(10):1842-7.
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ABSTRACT
Objective 
To study the relative contribution of surrogates for mechanical stress and systemic pro-
cesses with osteoarthritis (OA) in weight-bearing and non-weight-bearing joints. 
Methods 
The Netherlands Epidemiology of Obesity (NEO) study is a population-based cohort in-
cluding 6,673 participants (range 45 to 65 years, 56% women, median BMI 26 kg/m2). 
Weight (kg) and fat mass (FM) (kg) were measured, fat-free mass (FFM) (kg) was calculat-
ed. The metabolic syndrome was defined following the Adult Treatment Panel III criteria. 
Knee and hand OA were defined according to the American College of Rheumatology 
clinical criteria.
Logistic regression analyses were performed to associate surrogates for mechanical 
stress (such as weight, FFM) and systemic processes (such as metabolic syndrome) with 
OA in knees alone, knees and hands or hands alone, adjusted for age, sex, height, smok-
ing, education and ethnicity, and when appropriate for metabolic factors and weight.
Results 
Knee, knee and hand, and hand OA were present in 10%, 4% and 8% of the participants, 
respectively. Knee OA was associated with weight and FFM, adjusted for metabolic fac-
tors (OR 1.49 (95% CI 1.32 to 1.68) and 2.05 (1.60 to 2.62) respectively). Similar results were 
found for OA in knees and hands (OR 1.51 (95% CI 1.29 to 1.78) and 2.17 (1.52 to 3.10) 
respectively). Hand OA was associated with the metabolic syndrome, adjusted for weight 
(OR 1.46 (95% CI 1.06 to 2.02)). 
Conclusion 
In knee OA, whether or not in co-occurrence with hand OA, surrogates for mechanical 
stress are suggested to be the most important risk factors, whereas in hand OA alone, 




Overweight and obesity are well-known risk factors for osteoarthritis (OA) in weight-bear-
ing and non-weight-bearing joints.1,2 Several mechanisms are thought to explain the as-
sociation between obesity and OA. First, increased mechanical stress can result in dam-
aged joint tissue.3 Second, systemic processes seem to be involved. Adipose tissue is 
known as a source of proinflammatory and anti-inflammatory adipokines, which have 
been suggested to play a role in OA pathogenesis.4-7 Furthermore, hyperglycaemia and 
diabetes have been related to OA,8-12 possibly via insulin-like growth factor I resistance 
of chondrocytes,13 via changes in striated muscles due to insulin resistance,14 or via for-
mation of advanced glycation end products.15,16 The association of OA with measures of 
atherosclerosis suggests another systemic link with OA,17,18 possibly via systemic inflam-
mation or pathology of subchondral bone vasculature.19 
The relative contribution of mechanical stress and systemic processes to different types 
of OA remains unclear. In OA of weight-bearing joints as the knees, the concept of ex-
cessive mechanical stress leading to OA is supported by previous reported associations 
of weight or lean body mass with knee OA.20-23 The role of systemic processes in OA of 
weight-bearing joints is questionable, and difficult to identify since in obese individuals 
increased mechanical stress and systemic processes frequently occur together. Two re-
cent studies on the metabolic syndrome, as surrogate for systemic processes, in relation 
to knee OA reported conflicting results. One observed an association between the met-
abolic syndrome and increased OA incidence even after adjustment for BMI, whereas 
the other did not.24,25 So far, no studies examined knee OA in the presence of OA of non-
weight-bearing joints as the hands, while this type of polyarticular OA might be particu-
larly driven by systemic processes.
In hand OA, being non-weight-bearing joints, systemic processes may be most impor-
tant in the association between obesity and OA. Although a number of studies assessed 
individual metabolic factors in relation to hand OA,8,17,18 the association between the met-
abolic syndrome and presence of hand OA has not been investigated. 
To gain more insight into the relative contribution of mechanical stress and systemic 
processes to OA of both weight-bearing and non-weight-bearing joints, we examined 
the association of surrogates for both mechanisms with OA of knees, hands or both. We 
hypothesized that surrogates for mechanical stress associate predominantly with knee 
OA, whereas surrogates for systemic processes associate predominantly with presence of 
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METHODS
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based prospective 
cohort study with an oversampling of persons with overweight or obesity, aiming to in-
vestigate pathways leading to obesity-related diseases. The present study is a cross-sec-
tional analysis of baseline measurements of the NEO study. Detailed information about 
the study design and data collection has been described previously.26 In short, men and 
women between 45 years to 65 years of age with a self-reported BMI ≥27 kg/m2 living in 
the greater area of Leiden (in the West of The Netherlands) were eligible to participate in 
the NEO study, resulting in 5,002 participants. In addition, all inhabitants aged 45 to 65 
years from one municipality (Leiderdorp) were invited irrespective of their BMI, resulting 
in 1,671 participants (including 605 with BMI ≥27 kg/m2) allowing for a reference distri-
bution of BMI. 
All participants completed questionnaires on demographic and clinical data and visited 
the NEO study center for several baseline measurements including extensive physical 
examination and blood sampling. The study was approved by the medical ethics com-
mittee of the Leiden University Medical Center and all participants gave written informed 
consent. 
Measures of body composition
Measured weight (kg) and height (cm) were used to calculate the BMI (kg/m2). Fat mass 
(FM) (kg) was measured by bioelectrical impedance analysis (BIA) using the Tanita foot-
to-foot BIA system TBF-300A Body Composition Analyzer.27 Fat-free mass (FFM) (kg) was 
calculated on weight and FM. Waist circumference (cm) was measured midway between 
the lower costal margin and iliac crest with a precision of 0.1 cm. 
Measurement of metabolic factors
Blood pressure was measured three times, the average was used as diastolic and systolic 
pressures. Serum concentrations of triglycerides (mmol/L), high density lipoprotein (HDL) 
cholesterol (mmol/L) and glucose (mmol/L) were measured after an overnight fast.
The metabolic syndrome was defined according to the Adult Treatment Panel III criteria, 
based on presence of at least three of the following: (1) elevated waist circumference 
(men ≥102 cm, women ≥88 cm), (2) elevated triglycerides (≥1.7 mmol/L or drug treatment 
for elevated triglycerides), (3) reduced HDL cholesterol (men <1.03 mmol/L, women <1.3 
mmol/L or drug treatment for reduced HDL cholesterol), (4) elevated blood pressure 
(systolic ≥130 mm Hg, diastolic ≥85 mm Hg or antihypertensive medication), (5) elevated 
fasting glucose (≥5.6 mmol/L or glucose lowering medication).28 
Clinical assessment and OA diagnosis
Self-reported pain on most days of the prior month and presence of morning stiffness 
with ≤30 minutes duration were measured using standardized questions. Physical exam-
ination of knees and hands was performed by trained research nurses, using a stand-
ardized scoring form. Bony swelling, palpable pain and warmth, crepitus and movement 
restriction of both knees were assessed. Regarding the hands, bony and soft swellings 
as well as deformities of the distal interphalangeal, proximal interphalangeal, metacar-
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pophalangeal, carpometacarpal and wrist joints were assessed. Clinical OA was defined 
according to the American College of Rheumatology clinical criteria.29,30 Presence of a 
knee prosthesis was considered as knee OA.
Statistical analysis
Data were analyzed using SPSS V.20 and STATA V.12. 
In the NEO study there is an oversampling of persons with a BMI ≥27 kg/m2. To correctly 
represent associations in the general population,31 adjustments for this oversampling 
were made by weighting individuals towards the BMI distribution of participants from 
the Leiderdorp municipality (n = 1,671),32 whose BMI distribution was similar to the BMI 
distribution in the general Dutch population.33 All results were based on weighted anal-
yses. Consequently, results apply to a population-based study without oversampling of 
BMI ≥27 kg/m2. 
Based on OA diagnosis, four groups were defined: (1) individuals without knee or hand 
OA, (2) individuals with only knee OA, (3) individuals with knee and hand OA, and (4) 
individuals with only hand OA. We performed logistic regression analyses to examine 
cross-sectional associations of each of the surrogates for mechanical stress (weight, FFM, 
FM) and systemic processes (FM, metabolic syndrome) with each of the three OA types, 
using individuals without knee or hand OA as reference group. FM probably is a surro-
gate for mechanical stress and systemic processes. To approximate FM as surrogate for 
mechanical stress, adjustment for metabolic factors was performed, and adjustment for 
weight was performed to approximate FM as surrogate for systemic processes. Associa-
tions were expressed as odds ratios (OR) with 95% confidence intervals (CI). 
All continuous variables were standardized by dividing individual values by the standard 
deviation (SD) to be able to compare ORs. Consequently, all ORs describe the risk of 
OA associated with an increase of 1 SD of the studied variable. All analyses have been 
adjusted for age, sex, height, smoking, education and ethnicity. Analyses on surrogates 
for mechanical stress were additionally adjusted for metabolic factors (presence of meta-
bolic syndrome, hypertension, hyperglycaemia, hypertriglyceridaemia and reduced HDL 
cholesterol) and analyses on surrogates for systemic processes were adjusted for weight. 
Finally, to illustrate the relative importance of mechanical stress and systemic processes, 
age, sex, height, smoking, education and ethnicity adjusted ORs were calculated for pres-
ence of each OA type in three weight categories (based on tertiles of weight of the total 
study population: <75 kg, 75-90 kg, >90 kg), stratified by the metabolic syndrome. Par-
ticipants in the lowest weight category without metabolic syndrome served as reference. 
RESULTS
Population characteristics
After exclusion of individuals with missing data of BIA (n = 31) or physical examination (n 
= 14), data from 6,628 participants were analyzed. Unweighted baseline characteristics, 
that is, without taking the oversampling into account, are shown in the online supple-
mentary table. Table 1 shows the weighted baseline characteristics stratified by OA; these 
characteristics represent the population on which all subsequent results apply. Median 
(25th to 75th centiles) age of the total study population was 56 years (50 to 61 years), BMI 
26 kg/m2 (23 to 28 kg/m2), 56% women.
2
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The prevalence of knee OA alone was 10% (95% CI 9% to 11%), knee and hand OA 4% 
(95% CI 4% to 5%) and hand OA alone 8% (95% CI 7% to 8%). The prevalence of a knee 
prosthesis was 1% (95% CI 1% to 1%). 
The percentage of women and median age were higher in individuals with knee, knee 
and hand, or hand OA as compared with individuals without OA. Furthermore, individuals 
with knee, hand or knee and hand OA had a higher median FM and metabolic syndrome 
prevalence than individuals without OA. 
Surrogates for mechanical stress and different OA types
First, we investigated associations of surrogates for mechanical stress with the OA types 
(Table 2). 
Weight, FFM and FM were positively associated with all OA types. The ORs were highest 
for presence of knee OA and OA in knee and hand. The ORs per SD weight for example, 
were 1.55 (95% CI 1.39 to 1.73) for knee OA and 1.52 (1.31 to 1.76) for knee and hand OA, 
meaning that 1 SD of weight (15.95 kg) was associated with a 55% higher odds of having 
knee OA and a 52% higher odds of having knee and hand OA. The OR for hand OA was 
1.25 (1.09 to 1.42). 
After additional adjustment for metabolic factors, weight, FFM and FM remained associ-
ated with knee OA and with OA in knee and hand. The associations with hand OA on the 
contrary decreased. 
In addition, we assessed if associations between surrogates for mechanical stress and 
knee OA were stronger for bilateral than for unilateral knee OA. Fully adjusted ORs of 
weight, FFM and FM were higher for bilateral OA (OR 1.68 (1.44 to 1.97), 2.29 (1.58 to 3.34) 
and 1.54 (1.36 to 1.75), respectively), than for unilateral OA (OR 1.38 (1.19 to 1.59), 1.92 
(1.44 to 2.57) and 1.27 (1.12 to 1.44), respectively).










Age (year) 55 (49-61) 58 (53-61) 59 (55-62) 59 (55-63)
Sex (% women) 52 63 86 76
Smoking (% current) 12 11 9 8
Education (% high) 39 28 25 32
Ethnicity (% Caucasian) 95 96 92 95
BMI (kg/m2) 25.5 (23.2-28.0) 26.9 (24.6-30.3) 26.7 (24.6-29.8) 25.9 (23.0-28.8)
Height (m) 1.74 (1.67-1.81) 1.71 (1.66-1.79) 1.68 (1.63-1.73) 1.68 (1.63-1.75)
Weight (kg) 77.8 (67.6-88.8) 80.4 (70.8-92.8) 75.6 (66.8-86.8) 73.4 (63.8-85.6)
Fat-free mass (kg) 51.8 (44.0-64.6) 49.2 (44.2-64.0) 45.9 (43.2-50.3) 45.1 (41.8-54.4)
Fat mass (kg) 22.7 (18.2-29.0) 27.5 (21.0-34.7) 27.5 (22.4-35.0) 24.4 (19.8-31.9)
Metabolic syndrome (%) 28 39 36 38
Results are based on weighted analyses of the study population (n = 6,628).
Numbers represent medians (25th-75th centiles) or percentages. 
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Surrogates for systemic processes and different OA types 
Next, we assessed associations of surrogates for systemic processes with OA (Table 3). 
Although the OR of FM for hand OA was higher (1.17 (0.74 to 1.86)) than for knee OA or 
OA in knee and hand (OR 0.88 (0.61 to 1.26) and OR 1.03 (0.51 to 2.11), respectively), the 
associations were not statistically significant after adjustment for weight. 
The metabolic syndrome, surrogate for systemic processes particularly, was associated 
with all OA types. However, after additional adjustment for weight the associations with 
knee OA and knee and hand OA disappeared whereas the metabolic syndrome remained 
associated with hand OA  (OR 1.46 (1.06 to 2.02).
Relative contribution of weight and metabolic syndrome to different OA types
Figure 1 illustrates the relative contribution of weight as surrogate for mechanical stress 
and metabolic syndrome as surrogate for systemic processes to the OA types.
The ORs for knee OA were stronger in higher weight categories as compared with the 
lowest weight category. In addition to the depicted OR representing the highest weight 
category compared with the lowest in individuals without metabolic syndrome 2.62 (1.77 
to 3.88), we calculated the OR of highest versus lowest weight category in individuals with 
metabolic syndrome (2.30 (1.29 to 4.12)). Presence of metabolic syndrome, adjusted for 
the weight categories, did not result in a higher OR for knee OA (OR 1.16 (0.91 to 1.47). 
The same was observed in relation to OA in knee and hand. 
In hand OA on the contrary, ORs did not increase with increasing weight (highest vs. 
lowest weight category: OR 1.40 (0.89 to 2.21) in individuals without metabolic syndrome 
(Figure 1) and 0.77 (0.39 to 1.51) in individuals with metabolic syndrome. The metabolic 
syndrome on the other hand was associated with presence of hand OA, adjusted for the 
weight categories; individuals with metabolic syndrome had a higher OR for hand OA as 
compared with individuals without metabolic syndrome (OR 1.52 (1.10 to 2.09)). 
Table 3. Associations of surrogates for systemic processes with different types of OA (individuals without OA 
served as reference) 
OR (95% CI)
Knee OA Knee and hand OA Hand OA
SD Adjusted* Adjusted incl. 
weight#
Adjusted* Adjusted incl. 
weight#






























Results are based on weighted analyses of the study population.
The OR of fat mass expresses the risk of OA per SD.
* Adjusted for age, sex, smoking, education, ethnicity, height.
# Adjusted for age, sex, smoking, education, ethnicity, height, weight.  
CI, confidence interval; OA, osteoarthritis; OR, odds ratio; SD, standard deviation.
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Figure 1. The adjusted ORs and corresponding 95% CIs for osteoarthritis (OA) stratified by weight and meta-
bolic syndrome. Participants in the lowest weight category without metabolic syndrome served as reference. 
Gray connected lines represent individuals with metabolic syndrome, black connected lines represent individuals 
without metabolic syndrome. Results are based on weighted analyses of the study population, adjusted for age, 
sex, smoking, education, ethnicity and height. MetS, metabolic syndrome, representing the odds ratio of the 
metabolic syndrome for OA, adjusted for the weight catagorie
DISCUSSION
This study aimed to increase insight into the relative contribution of mechanical stress 
and systemic processes in the relation between overweight or obesity and OA of 
weight-bearing and non-weight-bearing joints. Knee OA was associated with surrogates 
for mechanical stress, adjusted for metabolic factors. Similar results were found for OA 
in knees and hands. Hand OA was associated with the metabolic syndrome, adjusted for 
weight. 
A growing body of literature exists on mechanical stress and systemic processes in OA 
pathogenesis, however innovative in this study is the investigation of the relative contri-
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The association of surrogates for mechanical stress with knee OA has been described 
previously,20-23,34 supporting the concept of excessive mechanical stress on the joint sur-
face of obese individuals resulting in damaged joint tissue. Compression of cartilage 
might activate mechanoreceptors on chondrocytes, inducing signaling cascades leading 
to synthesis of inflammatory mediators and tissue remodeling.35,36 It is unclear which bi-
omechanical factors are involved in the relation between weight and OA, since a recent 
study showed that neither a decrease nor increase in knee peak compression force was 
associated with OA progression.37 
Our finding regarding the metabolic syndrome in relation to knee OA is in accordance 
with a recent study of Han et al.,24 reporting no association between metabolic syndrome 
and knee OA. Another recent study, by Monira Hussain et al.,25  did report an association 
between metabolic syndrome and knee OA, adjusted for BMI. This discrepancy might 
be due to differences in OA definition. Where in this study clinical knee OA was assessed 
following the ACR criteria, Monira Hussain et al. defined severe knee OA requiring total 
knee replacement as OA. Han et al. defined knee OA by self-reported physician-made 
diagnosis. The strength of our study is that knee OA was assessed in all 6628 patients by 
physical examination. Consequently, OA was diagnosed following the ACR criteria, pro-
viding an objective and well validated definition.
Presence of knee and hand OA has not been investigated before. Our hypothesis was 
that this type of polyarticular OA might be driven by systemic processes, however we ob-
served no association with surrogates for systemic processes after adjustment for weight. 
Presence of knee and hand OA was associated with surrogates for mechanical stress, even 
after adjustment for metabolic factors, like presence of knee OA alone. This observation 
suggests that co-occurrence of knee and hand OA may not be based on a common un-
derlying pathogenic mechanism, but may represent presence of two different types of 
OA. Since the association between mechanical stress and knee OA was relatively strong, 
this association could dominate the association with OA at both sites. 
The association between metabolic syndrome and hand OA, adjusted for weight, has 
not been reported before. A number of studies assessed individual metabolic factors in 
relation to OA, however the metabolic syndrome, as composition of different metabolic 
processes, might act as risk factor beyond the risk of its individual components.38 
The association between metabolic syndrome and hand OA might be explained by sys-
temic inflammation, a main characteristic of the metabolic syndrome. Adipose tissue is 
known as source of proinflammatory and anti-inflammatory cytokines, which have been 
related to the metabolic syndrome39 and have been suggested to affect joint tissues.4,6,7 
Visceral fat has been described as the most actively secreting type of adipose tissue,40 
and has been associated with the metabolic syndrome.41-45 In addition, in a recently per-
formed study we associated visceral fat with hand OA in men.46
Strengths of this study are the large study population, extensive characterization of par-
ticipants and availability of information of both weight-bearing and non-weight-bearing 
joints.
However, there are a number of potential limitations. The observed associations were 
not very strong, however since this study aimed to assess the relative contribution of 




Increased mechanical stress and systemic processes are highly correlated in overweight 
or obese individuals. Therefore, we adjusted for surrogates for mechanical stress in our 
analyses on systemic processes and vice versa. Although these analyses identified the rel-
ative contribution of both mechanisms for OA, residual confounding may still be present 
in this observational study. We further minimized residual confounding by adjusting for 
possible confounders as age, sex and surrogates for socioeconomic status (education, 
smoking, ethnicity). Unfortunately we did not have information on previous knee injury, 
which may be a confounder in the associations with knee OA.
Furthermore, since this is a cross-sectional study, causality is difficult to identify. Since the 
direction of associations cannot be determined, reverse causation may be present. Lon-
gitudinal studies are needed to confirm and further explore associations of mechanical 
stress and systemic processes with OA. 
Knee and hand OA were diagnosed based on clinical criteria, no X-rays were available. 
However, the ACR clinical criteria are well validated and have high sensitivity and specific-
ity in diagnosing OA.29,30 This criteria include findings at physical examination and pres-
ence of symptoms as pain. Since it is known that obese individuals are more likely to 
report pain,47 they could be more prone to be diagnosed as having OA than non-obese 
individuals. However, the OA prevalence observed in this study is comparable with the 
prevalence observed in other population-based studies.18,48
Furthermore, FM was measured using foot-to-foot BIA. Although this method has been 
suggested to overestimate FM,49 studies comparing foot-to-foot BIA with hand-to-foot 
BIA, underwater weighing and dual-energy X-ray absorptiometry reported strong corre-
lations.27,50
We assessed all body composition measures in relation to OA per SD to be able to com-
pare strength of associations observed in this study. It must be noted that the OR of the 
metabolic syndrome, analysed dichotomously, cannot be directly compared to the ORs 
of the body composition measures.
This study suggests that in knee OA, whether or not co-occurring with hand OA, mechan-
ical stress is the most important underlying mechanism, whereas in hand OA alone, sys-
temic processes might contribute most. To gain more insight into the underlying mech-
anisms, longitudinal research could help to understand how excessive mechanical stress 
leads to degeneration of joint tissue. In hand OA, the role of the metabolic syndrome 
might be explored by studying the contribution of the different components of the met-
abolic syndrome to OA development. Furthermore, future research should focus on the 
role of systemic inflammation.
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Supplementary table. Unweighted baseline characteristics of 6,628 participants of the NEO study with an over-
sampling of BMI ≥ 27 kg/m2, stratified by OA status








Age (year) 55 (50-61) 57 (53-61) 59 (55-62) 58 (54-62)
Sex (% women) 47 62 84 70
Smoking (% current) 12 12 8 8
Education (% high) 32 25 20 24
Ethnicity (% Caucasian) 95 94 94 95
BMI (kg/m2) 29.3 (27.1-32.0) 30.8 (28.2-34.1) 30.5 (27.9-34.0) 29.8 (27.6-33.2)
Height (m) 1.74 (1.67-1.81) 1.71 (1.65-1.79) 1.68 (1.63-1.73) 1.69 (1.63-1.76)
Weight (kg) 89.6 (79.4-99.8) 91.6 (81.4-102.4) 87.6 (78.2-96.4) 86.2 (76.6-98.0)
Fat free mass (kg) 58.6 (47.5-68.3) 52.9 (47.0-66.5) 48.6 (45.4-54.3) 49.8 (45.0-61.5)
Fat mass (kg) 30.2 (24.0-37.8) 35.0 (28.2-42.5) 36.1 (29.9-43.8) 33.4 (26.9-40.8)
Metabolic syndrome 
(%)
48 57 55 56
Numbers represent medians (25th to 75th percentiles) or percentages. 
BMI, body mass index; NEO, Netherlands Epidemiology of Obesity; OA, osteoarthritis.
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 Adiposity and hand osteoarthritis: the NEO study
 A.W. Visser, A. Ioan-Facsinay, R. de Mutsert, R.L. Widya, M. Loef, A. de   
 Roos, S. le Cessie, M. den Heijer, F.R. Rosendaal, M. Kloppenburg, for the   
 NEO Study Group
 Arthritis Research & Therapy 2014;16(1):R19.
502331-L-bw-Visser
38   
ABSTRACT 
Introduction 
Obesity, usually characterized by the body mass index (BMI), is a risk factor for hand os-
teoarthritis (OA). We investigated whether adipose tissue and abdominal fat distribution 
are associated with hand OA.
Methods 
The Netherlands Epidemiology of Obesity (NEO) study is a population-based cohort aged 
45 to 65 years, including 5,315 participants (53% women, median BMI 29.9 kg/m2). Fat 
percentage and fat mass (FM) (kg) were estimated using bioelectrical impedance analysis. 
The waist-to-hip ratio (WHR) was calculated. In 1,721 participants, visceral adipose tissue 
(VAT) and subcutaneous adipose tissue (SAT) (cm2) were assessed using abdominal MR 
imaging. Hand OA was defined according to the ACR criteria.
Odds ratios (OR) with 95% confidence intervals (CI) were calculated for the association of 
fat percentage, FM, WHR, VAT and SAT with hand OA using logistic regression analyses 
per standard deviation, stratified by sex and adjusted for age.
Results 
Hand OA was present in 8% of men and 20% of women. Fat percentage was associated 
with hand OA in men (OR 1.34 (95% CI 1.11 to 1.61)) and women (OR 1.26 (1.05 to 1.51)), 
as was FM. WHR was associated with hand OA in men (OR 1.45 (1.13 to 1.85)), and to a 
lesser extent in women (OR 1.17 (1.00 to 1.36)). Subgroup analysis revealed that VAT was 
associated with hand OA in men (OR 1.33 (1.01 to 1.75)). This association increased after 
additional adjustment for FM (OR 1.51 (1.13 to 2.03)).
Conclusion 
Fat percentage, FM and WHR were associated with hand OA. VAT was associated with 





Osteoarthritis (OA) is the most common musculoskeletal disorder. Although the patho-
genesis of OA remains largely unknown, several risk factors are known to contribute to 
disease development. One of the most prominent risk factors is overweight or obesi-
ty, usually defined by a body mass index (BMI) of 25 to 30 or ≥30 kg/m2, respectively.1 
Obesity acts as a risk factor of both weight-bearing and non-weight-bearing joints, sug-
gesting that obesity-associated systemic factors could play an important role in OA.2,3 
The relative contribution of systemic factors and excessive biomechanical stress in the 
association between obesity and OA remains to be elucidated and could be different for 
different subtypes of OA, such as hand OA versus knee OA. 
Although the systemic effects of obesity are most probably dependent on the amount 
and distribution of adipose tissue, most studies on OA performed until now used BMI 
as marker for obesity. However, since BMI is defined based only on height and weight, it 
provides little information about body composition and the amount and distribution of 
adipose tissue. More insight into the relation between adiposity and OA can be obtained 
when alternative measures of body composition are investigated, such as the fat percent-
age, fat mass (FM) and waist-to-hip ratio (WHR). Previous research assessing these body 
composition measures mostly studied knee OA and showed inconclusive results regard-
ing FM,4-9 whereas WHR was not associated with OA.4,7,10 Only a few studies focused on 
OA in non-weight-bearing joints like the hands, showing no association with fat percent-
age and waist circumference and conflicting results regarding the WHR.8,11-13
Adipose tissue is a source of several cytokines that could influence whole-body metabo-
lism. Secretion of these bioactive mediators depends on the type of adipose tissue; they 
are secreted more actively by visceral fat than by subcutaneous fat.14 In addition, visceral 
fat has been shown to be associated more strongly with obesity-related co-morbidities, 
such as diabetes mellitus and the metabolic syndrome, and with markers of inflammation 
as compared with subcutaneous fat.15,16 Cytokines have the potential to affect joint tis-
sues,17-19 and therefore visceral fat could also be involved in the pathogenesis of OA. No 
research has so far been performed regarding different body fat depots in relation to OA.
The aim of the present study was to gain more insight into the mechanisms underlying 
the association of adiposity and OA. To this end, we investigated the association of adi-
pose tissue and its abdominal distribution with the presence of OA in non-weight-bear-
ing joints, the hands.
METHODS
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based prospective 
cohort study in lean, overweight and obese individuals aged between 45 and 65 years. The 
present study is a cross-sectional analysis of the baseline measurements of the 5,313 partici-
pants included in the NEO study between September 2008 and January 2012. Detailed infor-
mation about the study design and data collection has been described previously.20 Men and 
women with self-reported BMI ≥27 kg/m2 living in the greater area of Leiden (in the West of 
The Netherlands) were eligible to participate in the NEO study. In addition, in one municipality 
(Leiderdorp) all inhabitants aged 45 to 65 years were invited, irrespective of their BMI. 
3
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All participants completed questionnaires on demographic and clinical data and visited 
the NEO study center for several baseline measurements. The study was approved by the 
medical ethics committee of the Leiden University Medical Center and all participants 
gave written informed consent.
Body composition measures
Measured body weight (kg) and height (cm) were used to calculate the BMI (kg/m2). Waist 
and hip circumference (cm) were used to calculate the WHR. The percentage of body fat 
and amount of FM (kg) were measured by bioelectrical impedance analysis (BIA) using 
the Tanita foot-to-foot BIA system TBF-300A Body Composition Analyzer (Tanita Cor-
poration of America, Inc, Arlington Heights, IL, USA).21 To test the reliability, repeated 
measurements were performed after approximately 3 months in a random sample of 72 
participants; the calculated intraclass correlation coefficient was 0.98.
Abdominal adipose tissue
A random sample (about 30%) of the study participants without contraindications (me-
tallic devices, claustrophobia and a body circumference ≥170 cm) underwent magnetic 
resonance imaging (MRI) of the abdomen. Abdominal visceral adipose tissue (VAT) and 
subcutaneous adipose tissue (SAT) (cm2) were measured by a turbo spin echo imaging 
protocol, performed on a 1.5 T system (Philips, Medical Systems, Best, the Netherlands): 
echo time 11 milliseconds; repetition time, 168 milliseconds; flip angle, 90o; slice thickness, 
10 mm. The total acquisition time, including the initial survey sequence, was 3 minutes. At 
the level of the fifth lumbar vertebra, three transverse images with a slice thickness of 10 
mm were obtained during a breath-hold. The MASS software package (Medis, Leiden, the 
Netherlands) was used to quantify VAT and SAT, allowing a semi-automated detection of 
the VAT and SAT area. The mean values of VAT and SAT (cm2) were calculated. 
Osteoarthritis definition
Self-reported pain was measured using standardized questionnaires. Physical examina-
tion of the hand joints was performed by trained research nurses, using a standardized 
scoring form. Bony and soft swellings of the distal interphalangeal (DIP), proximal inter-
phalangeal (PIP), metacarpophalangeal (MCP), carpometacarpal (CMC) and wrist joints 
were scored, as well as deformities of the DIP, PIP, first MCP, CMC and wrist joints. OA 
was defined according to the criteria of the American College of Rheumatology as pain 
or stiffness on most days of the prior month in addition to three of the following criteria: 
bony swelling of ≥2 of the 10 selected joints (bilateral DIP II and III, PIP II and III, and first 
CMC joints), bony swelling of ≥2 DIP joints, <3 swollen MCP joints, and deformity of ≥1 
of the 10 selected joints.22
Statistical analysis
Data were analyzed using SPSS version 20 (SPPS, Chicago, IL, USA) and STATA version 12 
(StataCorp LP, College Station, TX, USA). 
In the NEO study there is an oversampling of persons with BMI ≥27 kg/m2. To correct-
ly represent associations in the general population,23 adjustments were made for the 
oversampling of individuals with BMI ≥27 kg/m2. This was done by weighting individuals 
towards the BMI distribution of participants from the Leiderdorp municipality,24 whose 
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BMI distribution was similar to the BMI distribution in the general Dutch population.25 
Consequently, results apply to a population-based study without oversampling of BMI 
≥27 kg/m2. 
Pearson correlation coefficients between all body composition measures were calculated. 
A correlation below 0.4 was considered weak, between 0.4 and 0.7 moderate, and above 
0.7 strong. Logistic regression analyses were used to calculate cross-sectional associa-
tions of all body compositions measures with hand OA, and were expressed as odds ra-
tios (ORs) with 95% confidence intervals (CIs). All continuous variables were standardized 
by dividing individual values by the standard deviation to be able to compare the ORs, 
because in this way all ORs describe the effect on the odds of OA of an increase of one 
standard deviation of the corresponding variable. All analyses have been stratified by sex 
and adjusted for age. To minimize variation in FM due to differences in body height, addi-
tional adjustment for height was performed in the analysis on FM. Furthermore, addition-
al adjustment for FM has been performed in the analyses on visceral and subcutaneous 
fat in relation to hand OA.
RESULTS
Population characteristics
After exclusion of subjects with missing data of the BIA (n = 25) or physical examination 
(n = 4), data from 5,284 subjects were analyzed. Table 1 presents the baseline character-
istics. Median age was 56 years, and 53% were women. Women had a lower median body 
weight and WHR but a higher fat percentage and FM than men. Hand OA was present in 
8% of men and 20% of women. 
Abdominal fat was measured in a random subset of 1,721 participants (46% women). Ex-
cept for a clinically nonrelevant difference in WHR in men (0.980 vs. 0.982), this subgroup 
did not differ from the total group (data not shown). 
The median amount of VAT was lower than the median amount of SAT, and this difference 
was most apparent in women (Table 1). 
Table 1. Baseline characteristics of the total Netherlands Epidemiology of Obesity study population and stratified 
by sex 
 Total population Men Women
 (n= 5,284) (n= 2,490) (n= 2,794)
Age (years) 56 (51 to 61) 57 (51 to 61) 56 (51 to 61)
BMI (kg/m2) 29.9 (27.8 to 32.8) 29.6 (27.9 to 32.0)) 30.3 (27.8 to 33.5)
Weight (kg) 90.6 (80.6 to 100.8) 96.6 (89.2 to 106.0) 84.0 (75.8 to 94.2)
Fat percentage (%) 37.5 (29.0 to 43.7) 29.0 (25.9 to 32.7) 43.3 (39.9 to 46.4)
Fat mass (kg) 32.4 (26.1 to 40.0) 28.1 (23.6 to 34.0) 36.4 (30.4 to 43.1)
WHR 0.93 (0.87 to 0.99) 0.98 (0.94 to 1.03) 0.88 (0.84 to 0.92)
VAT (cm2)* 122.1 (85.4 to 166.3) 142.1 (108.1 to 185.5) 97.2 (67.8 to 138.2)
SAT (cm2)* 308.3 (242.3 to 388.4) 262.4 (210.3 to 324.2) 359.4 (298.7 to 434.0)
Hand osteoarthritis 746 (14.1) 188 (7.6) 558 (20.0)
 Numbers represent medians (interquartile ranges) or number (percentage).
*n = 923 men, n = 798 women.
BMI, body mass index; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue; WHR, waist-to-hip ratio.
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Correlations between body composition measures
First, we calculated Pearson’s correlation coefficients between all measures of body com-
position (Table 2). Besides body weight, BMI was strongly correlated with fat percentage 
and FM in both men and women. BMI, body weight, fat percentage an FM were strongly 
correlated with SAT in both sexes. The correlations of these body composition measures 
with VAT were somewhat lower, and were slightly stronger in women as compared with 
men. Moreover, WHR correlated more strongly with VAT than with SAT in both sexes. The 
WHR showed a stronger correlation with all measurements of fat (FM, SAT and VAT) in 
men as compared with women. 
The differences between men and women underscored the need for stratified analyses 
in the sexes. 
Associations of body composition measures with hand osteoarthritis
We next investigated the associations of all body composition measures with hand OA 
(Table 3). 
The fat percentage was associated with hand OA in both men (OR 1.34 (95% CI 1.11 to 
1.61)) and women (OR 1.26 (1.05 to 1.51)), meaning that one standard deviation increase in 
fat percentage (men 6.22%, women 6.88%) is associated with a 34% higher risk of having 
hand OA in men and a 26% higher risk in women. FM was also associated with hand OA 
in both sexes (men: OR 1.24 (1.05 to 1.47); women: OR 1.22 (1.07 to 1.39)). Additional ad-
justment for height in the analysis on FM resulted in comparable ORs (men: OR 1.29 (1.10 
to 1.51); women: OR 1.25 (1.10 to 1.42)).
When focusing on the distribution of adipose tissue, we observed the WHR to be asso-
ciated with hand OA in men (OR 1.45 (1.13 to 1.85)) and to a lesser extent in women (OR 
1.17 (1.00 to 1.36)).
Table 2. Correlations between body composition measures in 2,490 men (right upper corner) and 2,794 women 













BMI (kg/m2) 0.864 0.859 0.920 0.608 0.667 0.802
Weight (kg) 0.919 0.727 0.893 0.480 0.564 0.787
Fat percentage (%) 0.871 0.890 0.949 0.656 0.696 0.753
Fat mass (kg) 0.927 0.981 0.951 0.612 0.679 0.825
WHR 0.490 0.462 0.526 0.493 0.683 0.512
VAT* (cm2) 0.738 0.691 0.720 0.727 0.595 0.479
SAT* (cm2) 0.873 0.849 0.846 0.878 0.448 0.623
 All correlations were statistically significant. Numbers represent Pearson correlation coefficients. 
*n = 923 men, n = 798 women.




Since both the amount of adipose tissue and its distribution are of importance, we inves-
tigated the associations of VAT and SAT with hand OA in a subgroup who underwent MRI 
of the abdomen (Table 4). No association was observed between SAT and hand OA. VAT, 
on the other hand, showed a statistically significant association with hand OA in men (OR 
1.33 (1.01 to 1.75)) but was not associated with hand OA in women.
Since VAT and SAT are associated with the total amount of body fat, we also assessed 
their association with hand OA independent of total body fat by additional adjustment 
for FM. As a result, the association of VAT with hand OA in men increased (OR 1.51 (1.13 
to 2.03)). In women, again no association between VAT and hand OA was observed (OR 
0.91 (0.69 to 1.20)). 
DISCUSSION
In this study we aimed to gain insight into the association between adiposity and hand 
OA. Since both the fat percentage and FM were associated with hand OA in men and 
women, the amount of adipose tissue seems to be important. The association between 
WHR and hand OA indicates that the fat distribution is also of importance. When assess-
ing the abdominal distribution of adipose tissue, VAT was shown to be associated with 
hand OA in men, suggesting involvement of visceral fat in hand OA. 
To our knowledge, this study is the first to show an association between the amount 
of fat and its abdominal distribution with hand OA. Other studies showed associations 
between OA of the hands and obesity-related co-morbidities: Jonsson and colleagues 
demonstrated that hand OA and atherosclerosis were associated in older women; both 
carotid plaques and coronary calcifications showed a linear association with hand OA 
Table 3. Associations of body composition measures and hand osteoarthritis
SD Adjusted OR (95% CI)
Men Women Men (n= 2,490) Women (n= 2,794)
Fat percentage (%) 6.22 6.88 1.34 (1.11 to 1.61) 1.26 (1.05 to 1.51)
Fat mass (kg) 9.39 10.76 1.24 (1.05 to 1.47) 1.22 (1.07 to 1.39)
WHR 0.07 0.07            1.45 (1.13 to 1.85) 1.17 (1.00 to 1.36)
BMI  (kg/m2) 4.01 5.19 1.29 (1.08 to 1.55) 1.25 (1.11 to 1.41)
Weight (kg) 14.49 14.73 1.15 (0.92 to 1.45) 1.20 (1.06 to 1.36)
 All ORs express the increase in odds of osteoarthritis per standard deviation and are adjusted for age.
BMI, body mass index; CI, confidence interval; SD, standard deviation; OR, odds ratio; WHR, waist-to-hip ratio.
Table 4. Associations of abdominal adipose tissue and hand osteoarthritis
SD Adjusted OR (95% CI)
Men Women Men (n = 923) Women (n = 798)
VAT (cm2) 61.3 50.0 1.33 (1.01 to 1.75) 1.10 (0.85 to 1.44)
SAT (cm2) 91.7 117.6      1.05 (0.74 to 1.50) 1.22 (0.92 to 1.63)
 All ORs express the increase in odds of osteoarthritis per standard deviation and are adjusted for age.
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severity.26 Hoeven and colleagues confirmed this observation in a population aged 55 
years and older; they showed an association of atherosclerosis and OA of the DIP and 
MCP joints in women, independent of cardiovascular risk factors.27 Finally, Haara and 
colleagues showed that symmetrical DIP OA predicted mortality in women and that OA 
in any finger joint predicted cardiovascular mortality in men, suggesting an underlying 
common metabolic factor.28
A possible common underlying explanation could be an effect of adipose tissue, espe-
cially the visceral component. Visceral fat has been shown previously to be associated 
with coronary calcifications and carotid atherosclerosis.29,30 The amount of visceral fat has 
also been associated with other obesity-related co-morbidities such as diabetes mellitus 
and metabolic risk factors such as elevated blood pressure, impaired fasting glucose and 
elevated triglycerides.15,31,32 Our study shows that visceral fat is also associated with hand 
OA, implying that adipose tissue and its products can be involved in hand OA. 
Visceral fat has been suggested to secrete bioactive cytokines, acting as a unique path-
ogenic fat depot.14 The involvement of visceral fat in the pathogenesis of hand OA might 
thus be explained by its secretion of cytokines, which have been suggested to act locally 
in joint tissues.17 Leptin, known especially for its proinflammatory effect, has been shown 
to affect human cartilage.17-19 Adiponectin appears to counteract the effect of leptin by 
anti-inflammatory actions.17 In vitro studies suggest that adiponectin affects chondrocyte 
function and modulates cartilage destruction, which might indicate a protective role for 
adiponectin in OA.33 This suggestion has been confirmed in an observational follow-up 
study in patients with hand OA, showing that a higher level of adiponectin is associated 
with a lower risk for hand OA progression.34 Knowledge on other adipose-derived cy-
tokines in relation to OA is scarce. 
Differences between both sexes regarding body compositions are well known and were 
also observed in this study. Women had a lower WHR, more subcutaneous fat and less 
visceral fat than men. The WHR was more strongly correlated to all measurements of fat 
in men than in women. This is in accordance with previous studies describing sex differ-
ences in body composition measures.35,36 Because of these differences between men and 
women regarding most body composition measures, all analyses were stratified by sex. 
The greater amount of overall fat and lower susceptibility to accumulate visceral fat in 
women as compared with men might explain the lower ORs of WHR and VAT for hand 
OA in women. A similar gender difference regarding VAT has been described previously 
in a study on cardiometabolic risk; VAT was observed to be of greater relevance in men, 
whereas total FM was of most importance in women.37 In addition, VAT was observed 
to be associated with insulin resistance and inflammatory markers primarily in men.38,39 
Another explanation for the lower ORs of WHR and VAT in women might be the impor-
tance of unmeasured or unknown risk factors such as hormonal status or genetic effects, 
overshadowing a possible relatively minor effect of visceral fat. 
There are some potential limitations of this study. Hand OA could only be diagnosed 
based on clinical criteria since no imaging data of the hands were available. However, 
the ACR clinical criteria are well validated and have a high sensitivity and specificity in 
diagnosing hand OA.22
Furthermore, the fat percentage and FM were measured using a foot-to-foot BIA system, 
and not with a hand-to-foot BIA. Although it has been suggested that foot-to-foot BIA 
might overestimate the amount of FM,40 a study comparing body fat percentages pro-
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vided by foot-to-foot BIA with those obtained by hand-to-foot BIA observed a strong 
correlation between the two methods (r = 0.84).21 In a study comparing resistance meas-
urements obtained from foot-to-foot BIA with those from underwater weighing and du-
al-energy X-ray absorptiometry, a strong correlation (r = 0.89) with both methods was 
also reported.41  
We investigated all body composition measures in relation to hand OA per standard de-
viation to be able to compare the different ORs observed in this study. However, whereas 
the fat percentage and FM involve whole body fat, the amounts of VAT and SAT apply to 
a small region of the abdominal fat depot. The ORs for fat percentage and FM therefore 
cannot be compared directly with the ORs for VAT and SAT. 
The amount of VAT and SAT were measured in a random 30% of the total study pop-
ulation. Although individuals with a body circumference of 170 cm or higher were not 
eligible for MRI, body composition measures of the MRI subgroup were not significantly 
different as compared with the total study population. However, since individuals with 
extremely high body circumference could not be assessed, the described association 
between VAT and hand OA might be underestimated.
CONCLUSION
This study showed that both the amount of adipose tissue and its distribution are of im-
portance in hand OA. Assessment of abdominal distribution of adipose tissue showed an 
association between VAT and hand OA in men, suggesting involvement of visceral fat in 
hand OA. More research is necessary to gain more insight into the role of adipose tissue 
in OA, aiming at abdominal fat distribution and secretion of cytokines in relation to OA. 
Longitudinal studies could help to better understand how visceral fat plays a role in OA 
development. Furthermore, research towards treatment aiming at the inflammatory ef-
fect of adipose tissue may lead to potential new treatment targets in OA.
3
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ABSTRACT
Objective 
To investigate if the amount of fat mass (FM) or skeletal muscle mass (SMM) is more 
strongly associated with knee osteoarthritis (OA), in both men and women.
Methods 
The Netherlands Epidemiology of Obesity (NEO) study is a population-based cohort aged 
45 to 65 years, including 5,313 participants (53% female, median body mass index (BMI) 
29.9 kg/m2). FM (kg), fat percentage, SMM (kg) and skeletal muscle (SM) percentage were 
estimated using bioelectrical impedance analysis (BIA). Clinical OA was defined following 
the ACR criteria. Structural OA was defined based on magnetic resonance imaging (MRI) 
in 1,142 participants. Logistic regression analyses were used to examine the associations 
of all body composition measures with clinical and structural knee OA per standard devi-
ation (SD), stratified by sex and adjusted for age and height. 
Results 
Clinical or structural OA was present in 25% and 14% of women and 12% and 13% of men, 
respectively. FM and fat percentage were positively associated with clinical knee OA in 
men and women. SMM was positively associated, while the SM percentage was negative-
ly associated with clinical OA in both men and women. The FM/SMM ratio was positively 
associated with clinical OA. All determinants showed even stronger ORs for structural 
knee OA. In men, SMM was more strongly associated with knee OA as compared to FM 
whereas in women, FM was most strongly associated. 
Conclusion 
Especially a high FM/SMM ratio seems to be unfavorable in knee OA. In men, SMM is 






Knee osteoarthritis (OA) is a common musculoskeletal disorder and a major cause of 
disability, especially in the elderly.1 Overweight or obesity, usually characterized by body 
mass index (BMI), is an important risk factor for knee OA.2 However, BMI does not distin-
guish between fat mass (FM) and lean body mass. Therefore it remains unclear whether 
FM or skeletal muscle mass (SMM) is more important in knee OA. 
In knee OA biomechanical pathways are thought to play an important role; excessive 
mechanical stress due to either a decrease in the load-bearing area on the joint surface 
or an increase in loading leads to a failed repair of damaged joint tissue.3 Earlier studies 
showed that body weight is associated with knee OA and that especially persons with a 
high FM are at risk for knee OA.4,5 However, inconsistent results have been described re-
garding FM in relation to knee OA. Where some studies reported a negative association 
between FM or fat percentage and knee OA or knee cartilage as well,6-8 other studies did 
not find an association.9,10
Besides FM the body consists of lean body mass, consisting partially of SMM. SMM is 
important in the distribution of mechanical loading across the joint surface. Decreased 
muscle forces can alter the mechanical loading and ultimately result in degeneration of 
the joint. For example, quadriceps weakness has been shown to be associated with knee 
OA.11,12 Conroy et al. confirmed this negative association between quadriceps weakness 
and OA, however they reported a positive association between SMM and knee OA.7 This 
is remarkably since muscle mass and strength have been shown to be highly correlated.13 
Other studies on the association of SMM and knee OA show conflicting results; some 
observed a negative association,6,12 where others reported a positive association.5
The present study investigates whether the amount of FM or SMM is more strongly asso-
ciated with knee OA in both men and women. To this end we used two OA definitions: the 
partly subjective clinical criteria of the American College of Rheumatology (depending on 
the presence of pain) as well as an objective measure of structural OA, assessed by mag-
netic resonance imaging (MRI).14,15 We examined the associations of the relative amounts 
of FM and SMM with both clinical and structural knee OA. 
PATIENTS AND METHODS
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based prospective 
cohort study in lean, overweight and obese individuals aged between 45 and 65 years. 
The present study is a cross-sectional analysis of the baseline measurements of the 5,313 
participants included in the NEO study between September 2008 and January 2012. De-
tailed information about the study design and data collection has been described previ-
ously.16 Men and women with a self-reported BMI ≥27 kg/m2 living in the greater area of 
Leiden (in the West of The Netherlands) were eligible to participate in the NEO study. In 
addition, in one municipality (Leiderdorp), all inhabitants aged 45 to 65 years were invit-
ed, irrespective of their BMI (n = 874). 
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All participants completed questionnaires on demographic and clinical data and visited 
the NEO study center for several baseline measurements. The study was approved by the 
medical ethics committee of the Leiden University Medical Center and all participants 
gave written informed consent.
Clinical assessment and clinical OA diagnosis
Self-reported pain and morning stiffness were measured using standardized question-
naires. Physical examination of both knee joints was performed by trained research nurs-
es, using a standardized scoring form. Bony enlargement, tenderness of the bony margins 
of the joint, palpable warmth, crepitus and movement restriction were scored. Clinical OA 
was defined according to the clinical criteria of the American College of Rheumatology.14
Body composition measures
Measured body weight (kg) and height (cm) were used to calculate the BMI (kg/m2). The 
percentage of body fat and amount of FM (kg) were measured by bioelectrical imped-
ance analysis (BIA) using the Tanita foot-to-foot (FF) BIA system TBF-300A Body Compo-
sition Analyzer.17 The percentage of skeletal muscle (SM) and amount of SMM (kg) were 
calculated based on height, gender, age and resistance measured by the BIA.18 To test the 
reliability, repeated measurements were performed in a random sample of the partici-
pants (n = 72); the calculated intraclass correlation coefficient was 0.98. 
Since FM and SMM are positively correlated, we also calculated the FM/SMM ratio.
MRI
A random sample (about 20%) of the study participants without contraindications (me-
tallic devices, claustrophobia, body circumference ≥170 cm) underwent MRI of the right 
knee. Imaging was performed using a dedicated knee coil in a 1.5T system (Philips, Med-
ical Systems, Best, the Netherlands). A standardized scanning protocol was used.  
The following parameters were identical for the TSE images; a 150-160 mm field of view 
and a 304 x 512 matrix. Sequences performed were:
(1) coronal proton density (PD) (repetition time (TR)/echo time (TE) 2335/35 ms); (2) 
fat-suppressed PD TSE images (TR/TE 2334/35 ms; 3 mm slice thickness; 0.6 mm interslice 
gap); (3) sagittal PD TSE images (TR/TE 2338/35; echo train length 6; 3.5 mm slice thick-
ness; 0.7 mm interslice gap); (4) sagittal frequency selective fat-suppressed T1-weighted 
3D gradient echo (GE) sequence (TR/TE 11/5.5; 25o flip angle; 150 mm field of view, 272 x 
512 matrix, 2 mm slice thickness with a 1 mm overlap between images; no gap); (5) axial 
fat-suppressed PD (TSE) images (TR/TE 3225/15; echo train length 6, 4 mm slice thickness; 
0.8 mm interslice gap). Total acquisition time, including the initial survey sequence, was 
30 min.
MRI scoring and structural knee OA diagnosis
All MR images were analyzed using the validated semi-quantitative knee OA scoring sys-
tem (KOSS),19 by a trained reader (AWV), blinded to clinical data. The presence or absence 
of osteophytes, cartilage loss, subchondral bone marrow lesions (BMLs) and cysts were 
scored at four anatomic locations: the medial and lateral femoral condyle and medial and 
lateral tibial plateau. 
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Osteophytes were defined as focal bony excrescences extending from a cortical surface 
and measured from base to tip; ≥3 mm was considered a definite osteophyte. 
Based on their depth, cartilage defects were classified as full- or partial thickness.
BMLs were defined as ill-defined areas of increased signal intensity in the subchondral 
bone extending away from the articular surface; cysts as well-defined foci of high signal 
intensity in the subchondral bone. Both were required not to be associated with meniscal 
or ligamentous attachments. 
The medial and lateral menisci were reviewed for the presence of subluxation, maceration 
and degenarative tears. Subluxation was defined as protrusion over the egde of the tibial 
plateau, maceration as an intrameniscal focus of intermediate signal intensity and tears 
as regions of intermediate signal intensity within the meniscus, communicating with the 
surface or inner margin on more than one section.
A random ten percent of the MR images (n = 120) were scored twice to test the repro-
ducibility; the calculated intraclass correlation coefficient was 0.61 to 0.97 for the different 
features (meniscal maceration 0.61, meniscal tear 0.87, meniscal subluxation 0.93, cyst 
0.64, BML 0.93, cartilage loss 0.90, osteophyte 0.97).
Structural OA was defined based on the MRI features following the criteria recently sug-
gested by Hunter et al.15 Structural OA was defined on the presence of a definite osteo-
phyte and full thickness cartilage loss, or one of these features in addition to at least two 
of the following features: (1) subchondral BML, (2) cyst, (3) meniscal subluxation, macer-
ation or degenerative tear, or (4) partial thickness cartilage loss. In the recommendation 
by Hunter et al. bone attrition was described as a fifth feature, since this was not scored 
in the KOSS it was left out of the definition.
Statistical analysis
Data were analyzed using SPSS version 20 and STATA version 12. In the NEO study there 
is an oversampling of persons with a BMI of 27 kg/m2 or higher. To correctly represent 
associations in the general population,20 adjustments for the oversampling of individuals 
with a BMI ≥27 kg/m2 were made. This was done by weighting individuals towards the 
BMI distribution of participants from the Leiderdorp municipality,21 whose BMI distribu-
tion was similar to the BMI distribution in the general Dutch population.22 Consequently, 
results apply to a population-based study without oversampling of BMI ≥27 kg/m2. 
Body composition measures were compared between men and women using a t-test, 
further analyses were stratified by sex because of the observed significant differences for 
all measures of body composition. Logistic regression analyses were used to calculate 
cross-sectional associations of BMI and body compositions with clinical and structural 
knee OA, and were expressed as odds ratios (OR) with 95% confidence intervals (CI). 
Furthermore, multivariate logistic regression analysis including both FM and SMM was 
performed to investigate their independent association with knee OA. All continuous 
variables were standardized by dividing individual values by the standard deviation (SD) 
to be able to compare ORs, because in this way all ORs describe the effect on the odds 
of OA of an increase of one SD of the corresponding variable. All analyses have been 
stratified by sex and adjusted for age and height. Analyses on SMM and SM percentage 
in relation to OA were additionally adjusted for the total level of physical activity during 
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RESULTS
Population characteristics
After exclusion of individuals with missing data of the BIA (n = 25) or physical examination 
(n = 4) data from 5,284 participants were analyzed. Table 1 shows the baseline charac-
teristics of the total population and stratified by sex. Women had a lower median weight, 
SMM and SM percentage, but a higher FM, fat percentage and FM/SMM ratio than men 
(P < 0.001). Clinical OA was present in 25% of women and 12% of men. 
MRI of the right knee was performed in a subset of 1,142 participants. Except for a higher 
median weight in women (86.0 kg (IQR 77.6 to 95.4) and SMM in women (23.3 kg (21.3 to 
25.6)) and men (34.3 kg (31.7 to 36.8)), this subgroup did not differ from the total group 
as well as from the participants without a knee MRI in age, sex or body compositions 
(data not shown).  
Structural OA was present in 14% of women and 13% of men. To compare this prevalence 
to clinical knee OA, we assessed the presence of clinical OA of only the right knee in the 
MRI subgroup, showing a prevalence of 18% in women and 10% in men (total group 
14%). Of the individuals with structural knee OA, 39% of women and 31% of men also was 
defined as having clinical OA. Of the individuals with clinical OA, 31% of women and 40% 
of men also had structural OA.
Association of body composition measures with clinical knee OA (n = 5284)
Next, we investigated the associations of body composition measures with clinical knee 
OA in men and women, adjusted for age and height (Table 2). FM and fat percentage 
were positively associated with knee OA in both men and women. For example, the OR 
of 1.34 in men for FM mean that one SD increase in FM (9.39 kg) is associated with a 34% 
higher odds of having knee OA. SMM was positively associated with knee OA as well. On 
the contrary, SM percentage was negatively associated with knee OA, this was statistically 
significant in women only. Additional adjustment for the level of physical activity did not 
Table 1. Baseline characteristics of the total NEO study population and stratified by sex
Total population, n = 5,284 Men, n = 2,490 Women, n = 2,794
Age (year) 56 (51-61) 57 (51-61) 56 (51-61)
BMI (kg/m2) 29.9 (27.8-32.8) 29.6 (27.9-32.0)) 30.3 (27.8-33.5)
Height (m) 1.73 (1.66-1.80) 1.80 (1.76-1.85) 1.67 (1.62-1.71)
Weight (kg) 90.6 (80.6-100.8) 96.6 (89.2-106.0) 84.0 (75.8-94.2)
FM (kg) 32.4 (26.1-40.0) 28.1 (23.6-34.0) 36.4 (30.4-43.1)
Fat percentage (%) 37.5 (29.0-43.7) 29.0 (25.9-32.7) 43.3 (39.9-46.4)
SMM (kg) 27.7 (22.6-33.5) 33.6 (31.2-36.4) 22.8 (20.8-25.2)
SM (%) 30.7 (26.9-34.9) 34.8 (32.5-37.1) 27.2 (25.1-29.6)
FM/SMM ratio 1.22 (0.83-1.63) 0.83 (0.70-1.00) 1.59 (1.35-1.84)
Clinical knee OA, no. (%) 991 (18.8) 306 (12.3) 685 (24.5)
Structural knee OA, no. (%)* 156 (13.7) 65 (12.8) 91 (14.4)
Numbers represent medians (interquartile ranges) unless stated otherwise. 
 *n = 1,142 (508 men, 634 women)




change the results (data not shown). Finally, the FM/SMM ratio was positively associated 
with knee OA in both men and women. 
Association of body composition measures with structural knee OA (n = 1142)
In addition to the analyses on clinical knee OA, we investigated the associations of meas-
ures of body compositions with structural knee OA (Table 3). FM, fat percentage, SMM 
and SM percentage were even stronger associated with structural OA than with clinical 
OA in both men and women. However, in structural OA the association of SM percentage 
was statistically significant in women only. Again, additional adjustment for physical ac-
tivity did not alter the observed associations of SMM and SM percentage with OA (data 
not shown).
The FM/SMM ratio was positively associated with structural knee OA. When comparing 
the ORs of the different body composition measures for knee OA as shown in Table 3, in 
men the association of SMM (OR 1.94 (95% CI 1.18 to 3.17)) was somewhat stronger than 
the association of FM (OR 1.50 (1.09 to 2.07)). In women this is different; the association 
of FM (OR 2.20 (1.41 to 3.43)) was stronger than the association of SMM (OR 1.86 (1.31 to 
2.63)). 
Table 2. Associations of body composition measures with clinical knee OA
SD OR (95% CI)
Men Women Men, n = 2,490 Women, n = 2,794
FM (kg) 9.39 10.76 1.34 (1.12-1.59) 1.44 (1.27-1.63)
Fat percentage (%) 6.22 6.88 1.33 (1.08-1.63) 1.47 (1.21-1.77)
SMM (kg) 4.16 3.19 1.28 (1.02-1.60) 1.36 (1.19-1.56)
SM percentage (%) 4.50 4.40 0.80 (0.60-1.06) 0.74 (0.61-0.91)
FM/SMM ratio 0.26 0.40 1.30 (1.09-1.55) 1.39 (1.20-1.61)
BMI  (kg/m2) 4.01 5.19 1.38 (1.14-1.68) 1.43 (1.28-1.61)
Weight (kg) 14.49 14.73 1.42 (1.14-1.78) 1.46 (1.30-1.64)
All ORs express the increase in odds on OA per SD and are adjusted for age and height.
BMI, body mass index; CI, confidence interval; FM, fat mass; no., number; OR, odds ratio; SD, standard deviation; 
SM, skeletal muscle; SMM, skeletal muscle mass.
Table 3. Associations of body composition measures with structural knee OA
SD OR (95% CI)
Men Women Men, n = 508 Women, n = 634
FM (kg) 9.39 10.76 1.50 (1.09-2.07) 2.20 (1.41-3.43)
Fat percentage (%) 6.22 6.88 1.42 (1.01-1.99) 2.36 (1.23-4.51)
SMM (kg) 4.16 3.19 1.94 (1.18-3.17) 1.86 (1.31-2.63)
SM percentage (%) 4.50 4.40 0.74 (0.50-1.09) 0.51 (0.29-0.88)
FM/SMM ratio 0.26 0.40 1.35 (0.99-1.85) 1.92 (1.23-3.00)
BMI  (kg/m2) 4.01 5.19 1.67 (1.15-2.42) 2.17 (1.48-3.20)
Weight (kg) 14.49 14.73 1.77 (1.19-2.65) 2.31 (1.48-3.63)
All ORs express the increase in odds on OA per SD and are adjusted for age and height.
BMI, body mass index; CI, confidence interval; FM, fat mass; no., number; OR, odds ratio; SD, standard deviation; 
SM, skeletal muscle; SMM, skeletal muscle mass.
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Since FM and SMM are positively correlated, we assessed the associations of both param-
eters with structural knee OA independently of each other in a logistic regression model 
including both FM and SMM (Table 4). In men, the association between SMM and OA be-
came stronger and was the most important predictor of knee OA (OR 1.67 (1.07 to 2.61)). 
In contrast, in women the association of FM with knee OA became stronger and was the 
most important predictor of knee OA (OR 1.93 (1.24 to 3.02)), independently of SMM.
DISCUSSION
In this study we aimed to investigate the relative importance of FM and SMM in knee OA. 
Both FM and fat percentage were positively associated with knee OA in men and women. 
The same was observed for SMM, whereas the SM percentage was negatively associated 
with knee OA. This suggests that especially a high FM relative to low SMM is unfavorable. 
The importance of the relative amounts of FM and SMM has been confirmed by the as-
sociation between the FM/SMM ratio and knee OA. 
In a subpopulation we had the opportunity to assess structural knee OA by MRI, provid-
ing a purely objective outcome measure. Of the individuals with clinical or structural OA, 
about one third did meet both definitions. The discrepancy underscores the difference 
between the definitions; whereas in clinical OA objective symptoms as pain are of impor-
tance, structural OA is based only on MRI features. All parameters associated with clinical 
OA were observed to be associated even stronger with structural OA, especially in wom-
en. In men, this stronger OR for SM percentage was not statistically significant, this might 
be due to the smaller number of participants included in the analyses on structural OA.
To date, most studies on knee OA examined predominantly or only women.5-7,10,12,24,25 
Since this study comprises a large group of men as well, we were able to investigate the 
underlying mechanisms mediating the association between BMI and knee OA in both 
sexes. In men, a higher OR was observed for SMM in relation to OA whereas in women, 
FM showed the highest OR for knee OA. This might suggest that the pathogenesis of 
knee OA in men might be more biomechanical whereas the etiology in women might be 
more inflammatory. Differences in the pathogenesis of knee OA between the sexes have 
been suggested before.12,26,27 The risk factors contributing to the development of knee 
OA could be different. Trauma and occupational stresses for example, which hypotheti-
cally could be associated with SMM, have been reported to be related to knee OA more 
strongly in men than in women.26 A larger amount of SMM could serve as a surrogate for 
individuals who have been more active and therefore more prone to injury, supporting 
the suggestion of a more biomechanical etiology of knee OA in men. Our results stress 
that in studies aiming to provide insight into the pathogenesis of knee OA, both sexes 
should be studied and stratified analyses should be performed.
Table 4. Logistic regression analyses including both FM and SMM with 
SD OR (95% CI)
Men Women Men, n = 508 Women, n = 634
FM (kg) 9.39 10.76 1.35 (0.99-1.84) 1.87 (1.18-2.95)
SMM (kg) 4.16 3.19 1.67 (1.07-2.61) 1.32 (0.98-1.78)
All ORs express the increase in odds on OA per SD and are adjusted for age and height. 
CI, confidence interval; FM, fat mass; OR, odds ratio; SD, standard deviation; SMM, skeletal muscle mass. 
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In the present study, we observed a positive association between SMM and knee OA in 
both women and men, but when assessing the amount of SM as a percentage of the total 
body weight, we observed a negative association with knee OA. 
The positive association between SMM and OA might be explained by differences in 
physical activity (and perhaps trauma) or joint loading that are associated with SMM. Al-
though adjustment for physical activity did not alter the observed associations between 
SMM and OA, the questionnaire on physical activity did not assess physical activity dur-
ing earlier years. However, the opposite associations of SMM and SM percentage with OA 
suggests that the positive relation of SMM with OA might be due to the increase of SMM 
in obese individuals as a consequence of increased loading (association of body weight 
with SMM: men β = 0.19, women β = 0.15 (P < 0.001)). However, this increase in SMM is 
not sufficient in relation to the total weight gain since FM increases more with increasing 
weight (association of body weight with FM: men β = 0.59, women β = 0.72 (P < 0.001)), 
resulting in a lower SM percentage in obese individuals. 
An alternative explanation for the association of low SM percentage with knee OA is the 
metabolic syndrome, frequently occurring in individuals with greater adiposity. In obese 
individuals with the metabolic syndrome, insulin resistance and systemic inflammation 
might result in changes in striated muscle, causing loss of muscle mass and muscle weak-
ness.28 This is supported by a study in exercising and sedentary mice, showing that a 
high-fat diet induces knee OA in association with increased adiposity, glucose intoler-
ance and systemic pro-inflammatory mediators. Exercise improved glucose tolerance and 
disrupted the co-expression of pro-inflammatory cytokines. Furthermore, exercise was 
associated with less severe OA.29 
Since a lower FM/SMM ratio seems to be beneficial, interventions aiming at improvement 
of SMM in addition to weight reduction might be useful in the prevention and treatment 
of knee OA. 
This is supported by studies on the effect of weight loss and exercise on physical perfor-
mance, showing that a combination of both interventions provides greater improvement 
in physical performance than either intervention alone. In these individuals, more FM 
relative to fat free mass was lost.30,31 In addition, a study on weight loss alone observed 
an increase in physical function but a loss of leg muscle tissue and knee muscle strengths, 
supporting the need to restore or increase muscle mass during weight loss.32 Other stud-
ies on weight reduction showed that specifically a reduction in FM reduces the risk for 
knee OA and relieves clinical symptoms.24,25 This greater reduction in FM relative to loss 
of fat free mass has been shown to be associated with greater gains in muscle quality as 
well.33 As a proxy for SMM, an increase in fat free mass has been shown to be positively 
associated with tibial cartilage volume.4
There are some potential limitations of this study. We measured SMM and SM percent-
age by BIA and did not have information regarding muscle strength or specific lower limb 
SMM. However, muscle strength has been shown to be highly correlated with SMM.13 
Furthermore, since muscle parameters were measured using a FF-BIA, measurements 
depend predominantly on the lower limb amount of SMM. 
It has been suggested that FF-BIA might overestimate the amount of FM,34 however com-
parative studies reported a strong correlation of the FF-BIA to hand-to-foot BIA (r = 0.84), 
and underwater weighing and dual-energy X-ray absorptiometry (r = 0.89).17,35
Structural knee OA was defined following the definition suggested by Hunter et al.15 
4
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Since this definition has not been applied frequently and not been validated yet like 
the ACR criteria for clinical knee OA, further assessment of this definition is required. 
However, we observed all body composition measures to be associated similarly or even 
stronger with structural than clinical OA, suggesting that the structural OA definition 
discriminates knee OA very well.
Furthermore, since this is a cross-sectional study, causal relationships are difficult to iden-
tify.
This study suggests that the amount of SM relative to fat is of importance in knee OA 
and that the underlying mechanisms differ between men and women. More research is 
necessary to gain more insight into the precise underlying mechanisms. Future research 
should aim at clarifying the role of insulin resistance and inflammatory cytokines in the 
development of knee OA. Furthermore, research of interventions aiming at improvement 
of SMM in addition to weight reduction should be performed, as this may lead to poten-
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  CHAPTER 5
 Bakers’ cyst and tibiofemoral are more distinctive MRI features of 
 symptomatic osteoarthritis than patellofemoral abnormalities 
 A.W. Visser, B. Mertens, M. Reijnierse, J.L. Bloem, R. de Mutsert, S, le Cessie, F.R.  
 Rosendaal, M. Kloppenburg, for the NEO Study Group
 Submitted.
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ABSTRACT
Objective 
To investigate which structural magnetic resonance (MR) abnormalities discriminate 
symptomatic knee osteoarthritis (OA), taking co-occurrence of abnormalities in all com-
partments into account. 
Methods 
The Netherlands Epidemiology of Obesity (NEO) study is a population-based cohort 
aged 45 to 65 years. In 1,285 participants (median age 56 years, 55% women, median 
body mass index (BMI) 30 kg/m2) MR images of the right knee were obtained. Structur-
al abnormalities (osteophytes, cartilage loss, bone marrow lesions (BMLs), subchondral 
cysts, meniscal abnormalities, effusion, Baker’s cyst) at nine patellofemoral and tibiofem-
oral locations were scored following the knee OA scoring system. Symptomatic OA in 
the imaged knee was defined following the American College of Rheumatology criteria. 
Logistic ridge regression analyses were used to investigate which structural abnormali-
ties discriminate best between individuals with and without symptomatic OA, crude and 
adjusted for age, sex and BMI.
Results 
Symptomatic knee OA was present in 177 individuals. Structural MR abnormalities were 
highly frequent both in individuals with OA and in those without. Baker’s cysts showed 
the highest adjusted regression coefficient (0.293) for presence of symptomatic OA, fol-
lowed by osteophytes and BMLs in the medial tibiofemoral compartment (0.185-0.279), 
osteophytes in the medial trochlear facet (0.262), and effusion (0.197). 
Conclusion 
Baker’s cysts discriminate best between individuals with and without symptomatic knee 
OA. Especially structural MR abnormalities in the medial side of the tibiofemoral joint and 
effusion add further in discriminating symptomatic OA. The presence of Baker’s cysts may 





The knee joint is composed of three compartments, the medial and lateral tibiofemoral 
compartment and the patellofemoral compartment. Research in knee osteoarthritis (OA) 
focused mainly on the tibiofemoral joint,1 although OA can occur in all these compart-
ments, isolated or concurrent.2 OA in all compartments have been related to symptoms 
as pain and disability.3,4 However the underlying relationships and attributions of osteo-
arthritic abnormalities in the different compartments to symptoms in OA are incomplete-
ly understood.
The knee joint comprises bone, cartilage, menisci and synovial tissue. Structural abnor-
malities have been observed in all these joint tissues, increasing with age.5 These struc-
tural abnormalities are not specific for OA, since they have also been observed in persons 
without OA.6-9 Clinical or symptomatic OA is classified based on presence of pain, clini-
cal characteristics and abnormalities observed during physical examination,10 but which 
structural abnormalities contribute to symptoms and whether and which structural ab-
normalities can discriminate symptomatic OA is not clear. 
Previous studies on the association between structural abnormalities, such as bone mar-
row lesions (BMLs), synovitis or cartilage defects, and symptoms in OA showed conflict-
ing results; where some studies found an association between these structural abnormal-
ities and OA symptoms, other studies did not.11-14 These discrepancies could be caused by 
co-occurrence of structural abnormalities in different tissues, but it may all have resulted 
from the analyses, which were univariate or limited multivariate analyses, not adjusting 
for all tissue abnormalities in all joint locations. 
Therefore, this study investigates which specific structural abnormalities in all compart-
ments of the knee joint as assessed by magnetic resonance (MR) imaging can best dis-
criminate between individuals with and without symptomatic OA within the same knee, 
using a model that takes co-occurrence of all structural abnormalities into account. 
PATIENTS AND METHODS
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based prospective 
cohort study including 6,671 individuals aged 45 to 65 years, with an oversampling of 
persons with overweight or obesity. Detailed information about the study design and 
data collection has been described elsewhere.15 In short, men and women between 45 
and 65 years with a self-reported body mass index (BMI) of 27 kg/m2 or higher living in 
the greater area of Leiden were eligible to participate. In addition, all inhabitants aged 
45 to 65 years from one municipality (Leiderdorp) were invited irrespective of their BMI. 
All participants completed questionnaires on demographic and clinical data and visit-
ed the NEO study center for several baseline measurements, including measurement of 
weight (kg) and height (cm) that were used to calculate the BMI (kg/m2), and an extensive 
physical examination. A random sample of 1,285 study participants without contraindi-
cations (metallic devices, claustrophobia, body circumference >170 cm) underwent MR 
imaging of the right knee. The present study is a cross-sectional analysis of baseline 
measurements of these 1,285 participants. 
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The study was approved by the medical ethics committee of the Leiden University Medi-
cal Center and all participants gave written informed consent. 
MR imaging
MR imaging was performed using a dedicated knee coil in a 1.5T system (Philips, Medical 
Systems, Best, The Netherlands). Our standardized scanning protocol consisted of (1) 
Coronal proton density (PD) turbo spin echo (TSE), repetition time (TR)/echo time (TE) 
2335/35 ms; echo train length (ETL) 6, (2) coronal frequency selective fat-suppressed PD 
TSE (TR/TE 2334/35 ms; ETL 6, 3 mm slice thickness); (3) sagittal PD TSE (TR/TE 2338/35; 
ETL 6; 3.5 mm slice thickness); (4) sagittal frequency selective fat-suppressed T1-weight-
ed 3D gradient echo (GE) sequence (TR/TE 11/5.5; 25o flip angle; 150 mm field of view, 
272x512 acquisition matrix, 2 mm slice thickness with a 1 mm overlap between images); 
(5) axial frequency selective fat-suppressed PD TSE (TR/TE 3225/15; ETL 6, 4 mm slice 
thickness). In all TSE sequences we used a 150-160 mm field of view and a 304x512 ac-
quisition matrix. Total acquisition time, including the initial survey sequence, was 30 min.
Scoring of MR images
A trained reader (AWV, supervised by JLB), used the validated semi-quantitative knee OA 
scoring system blinded to clinical data.16 Presence or absence of osteophytes, cartilage 
loss, subchondral BMLs and subchondral cysts was scored at the following locations: 
patellar crest, medial and lateral patellar facet, medial and lateral trochlear articular facet, 
medial and lateral femoral condyle and medial and lateral tibial plateau. 
Osteophytes were defined as focal bony excrescences, extending from a cortical surface 
and measured from base to tip, graded as 0 (absent), 1 (<3 mm), 2 (3-5 mm) or 3 (5 mm). 
Cartilage loss was graded as 0 (absent), 1 (<50% reduction), 2 (≥50% reduction) or 3 
(full-thickness cartilage loss). 
BMLs were defined as ill-defined areas of increased signal intensity on T2-weighted im-
ages in the subchondral bone extending away from the articular surface and graded 0 
(absent), 1 (diameter <5mm), 2 (5 mm-2cm) or 3 (>2 cm). 
Subchondral cysts were defined as well-defined foci of high signal intensity on T2-weight-
ed images in the subchondral bone and graded based on their measured greatest dimen-
sion as 0 (absent), 1 (<3 mm), 2 (3-5 mm) or 3 (>5 mm). Both BMLs and cysts were required 
not to be associated with meniscal or ligamentous attachments. 
The menisci were reviewed for presence of subluxation, maceration and degenerative 
tears. Subluxation was defined as protrusion over the tibial plateau edge and graded 0 
(absent), 1 (<1/3 meniscal width bulging), 2 (1/3-2/3 bulging) or 3 (>2/3 involved). Macer-
ation was defined as an intrameniscal focus of intermediate signal intensity and graded 0 
(absent), 1 (small, central focus in meniscus), 2 (intrameniscal focus surrounded by broad, 
hypointense peripheral rim) or 3 (thin, hypointense peripheral rim outlining the intrame-
niscal focus). Tears were defined as regions of intermediate signal intensity within the 
meniscus, communicating with the surface or inner margin on more than one section, 
graded 0 (absent) or 1 (present).
Joint effusion was graded 0 (small, physiological sliver of synovial fluid), 1 (small amount 
of fluid distended 1 or 2 joint recesses), 2 (>2 joint recesses partially distended), or 3 (full, 
marked distention of all joint recesses). 
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A Baker’s cyst was defined when a circumscribed mass with intermediate signal inten-
sity on PD-weighted and high signal intensity on T2-weighted dual SE sequences was 
observed, originating from the dorsomedial tibiofemoral joint space. Baker’s cysts were 
graded 0 (absent), 1 (minimal), 2 (moderate) or 3 (severe).
A random 10% of the MR images (n = 120) were scored twice to test the reproducibility; 
intraclass correlation coefficients were for meniscal maceration 0.61, meniscal tear 0.87, 
meniscal subluxation 0.93, cyst 0.64, BML 0.93, cartilage loss 0.90, osteophyte 0.97.
Symptomatic knee OA
Self-reported pain and morning stiffness were measured using standardized question-
naires. Physical examination of both knee joints was performed by trained research nurs-
es, using a standardized scoring form. OA was defined based on the clinical criteria of the 
American College of Rheumatology as presence of pain on most days of the prior month 
and at least three of the following criteria: (1) age >50 years, (2) stiffness <30 minutes 
duration, (3) crepitus on active motion, (4) bony tenderness, (5) bony enlargement, (6) no 
palpable warmth.10 
Statistical analysis
Data were analyzed using SPSS version 20 (SPSS Inc., Chicago, IL), Matlab version R2014a 
(MathWorks, Natick, MA) and R version 3.0.1 (R foundation; www.r-project.org).
The prevalence of structural abnormalities was analyzed in the total study population 
and stratified by symptomatic OA status. The relation between different structural ab-
normalities was visualized by network graphs, constructed using R (package ‘glasso’), by 
estimating a sparse inverse covariance matrix using a lasso (L1) penalty. The basis for the 
graphical lasso calculation was the pooled variance-covariance matrix across both out-
come groups (individuals with and without symptomatic OA).
To investigate which specific abnormalities discriminate best between individuals with 
and without symptomatic OA, the following analyses were performed including all struc-
tural abnormalities graded 0 to 3 (only meniscal tears were graded 0/1). 
As the number of individuals without symptomatic OA was much higher than the num-
ber of OA cases, we split the set of individuals without OA into three parts and repeated 
the subsequently described model analysis for each of these three parts to assess sta-
bility of computations. Individuals without OA were randomly assigned to three mutu-
ally exclusive sets, each of these sets was then combined with the OA cases, rendering 
three calibration sets. The subsequently described discriminant analysis was then ap-
plied (repeated) for each of these sets. A logistic ridge regression model (see Hastie et 
al., 2007 for description) was fit to each of the above constructed calibration sets using 
a double cross-validatory approach.17,18  The double cross-validatory approach provides 
unbiased class probabilities for each individual in each of the above three calibration 
sets. Cross-validated deviances were used to select optimal models within the double 
cross-validatory assessment. ROC curves, AUC and classification statistics were used to 
summarize the double cross-validatory classifications. Double cross-validation uses a 
separate model fit for each left-out datum to generate unbiased classification summaries. 
For model parameter interpretation, we therefore refitted the logistic ridge regression 
model to the calibration data, using the optimum shrinkage (penalty) term identified 
in the preceding double cross-validatory calculation. Regression coefficients for all as-
5
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sessed structural abnormalities in the different locations within the joint were calculated 
based on this final fitted model. Penalized estimates such as those provided by the ridge 
regression reduce variance of estimation by allowing for bias in the estimation of effects, 
which implies that classical estimates of the variance of these estimates can no longer be 
meaningfully interpreted.
Both crude analyses and analyses adjusted for age, sex and BMI were performed. High-
er regression coefficients reflect better discrimination between presence or absence of 
symptomatic OA, taking co-occurrence of all abnormalities in different locations within 
the joint into account. 
RESULTS
Population characteristics
After exclusion of individuals with missing data of physical examination (n = 1) data from 
1,284 participants were analyzed. Of the studied individuals, 55% were women. Median 
age was 56 years (interquartile range 50 to 61), median BMI 30.0 kg/m2 (27.9 to 33.0). 
Symptomatic OA in the imaged knee was present in 177 individuals. The 1,107 individuals 
without symptomatic OA were divided in three mutually exclusive sets of 369 individuals 
for further analyses.
Prevalence of structural MR abnormalities
The prevalence of structural abnormalities in the total study population is presented in 
Table 1. All assessed structural abnormalities except for subchondral cysts were observed 
frequently. However, the prevalence differed across locations within the joint. 
In the tibiofemoral and patellofemoral compartment osteophytes were commonly ob-
served, especially in the medial tibiofemoral compartment (medial femoral condyle 86%, 
medial tibial plateau 38%) and the medial patellar facet (59%). Cartilage defects were also 
frequently observed in both compartments, especially medially (medial femoral condyle 
58%, medial tibial plateau 68%, medial patellar facet 65%, medial trochlear facet 53%) 
and in the patellar crest (65%). BMLs were observed less frequently, mostly located in the 
patellar crest (22%). 
Meniscal abnormalities were observed most commonly in the medial meniscus, macera-
tion was most prevalent (35%), followed by tears (23%) and subluxation (15%). 
As presented in Table 2, a higher prevalence of osteophytes, cartilage defects, BMLs and 
meniscal abnormalities were seen in individuals with symptomatic OA as compared to 
individuals without. 
Effusion was also highly prevalent (80%), both in individuals with and without sympto-
matic OA. Especially higher grades of effusion were observed more often in individuals 
with symptomatic OA than in those without. The same was observed for Baker’s cysts 




Table 1. Prevalence of structural abnormalities as assessed on magnetic resonance imaging on different locations 
in the knee in the total NEO study population
n = 1284
Grade 0 (n (%)) Grade 1 (n (%)) Grade 2 (n (%)) Grade 3 (n (%))
Baker’s cyst 894 (70) 245 (19) 100 (8) 45 (4)
Effusion 253 (20) 848 (66) 163 (13) 20 (2)
Tibiofemoral compartment:
Osteophytes
- femoral condyle medial / 
lateral
186 (14) / 293 (23) 946 (74) / 882 (69) 122 (10) / 88 (7) 30 (2) / 21 (2)
- tibial plateau medial / 
lateral
801 (62) / 929 (72) 436 (34) / 310 (24) 41 (3) / 36 (3) 6 (0) / 9 (1)
Cartilage defects
- femoral condyle medial / 
lateral
544 (42) / 1031 (80) 563 (44) / 180 (14) 142 (11) / 65 (5) 35 (3) / 8 (1)
- tibial plateau medial / 
lateral
409 (32) / 1077 (84) 733 (57) / 102 (8) 129 (10) / 88 (7) 13 (1) / 17 (1)
Bone marrow lesions
- femoral condyle medial / 
lateral
1078(84) / 1185(92) 109 (8) / 49 (4) 95 (7) / 48 (4) 2 (0) / 2 (0)
- tibial plateau medial / 
lateral
1136(88) / 1199(93) 61 (5) / 36 (3) 82 (6) / 45 (4) 5 (0) / 4 (0)
Cysts
- femoral condyle medial / 
lateral
1268(99) / 1268(99) 15 (1) / 12 (1) 0 (0) / 4 (0) 1 (0) / 0 (0)
- tibial plateau medial / 
lateral
1251(97) / 1257(98) 18 (1) / 15 (1) 11 (1) / 6 (0) 4 (0) / 6 (0)
Patellofemoral compartment:
Osteophytes
- patellar crest 1270 (99) 7 (1) 5 (0) 2 (0)
- patellar facet medial / 
lateral
527 (41) / 1057 (82) 642 (50) / 200 (16) 103 (8) / 27 (2) 12 (1) / 0 (0)
- trochlear facet medial / 
lateral
897 (70) / 1006 (78) 325 (25) / 241 (19) 42 (3) / 28 (2) 19 (1) / 9 (1)
Cartilage defects 
- patellar crest 448 (35) 393 (31) 275 (21) 168 (13)
- patellar facet medial / 
lateral
445 (35) / 770 (60) 346 (27) / 336 (26) 332 (26) / 126 
(10)
161 (13) / 52 (4)
- trochlear facet medial / 
lateral 
607 (47) / 837 (65) 513 (40) / 362 (28) 149 (12) / 58 (5) 15 (1) / 27 (2)
Bone marrow lesions
- patellar crest 1005 (78) 109 (8) 170 (13) 0 (0)
- patellar facet medial / 
lateral
1173(91) / 1218(95) 69 (5) / 41 (3) 42 (3) / 24 (2) 0 (0) / 1 (0)
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Table 1. Continued
n = 1284
Grade 0 (n (%)) Grade 1 (n (%)) Grade 2 (n (%)) Grade 3 (n (%))
- trochlear facet medial / 
lateral
1208(94) / 1210(94) 45 (4) / 27 (2) 30 (2) / 45 (4) 1 (0) / 2 (0)
Cysts
- patellar crest 1244 (97) 35 (3) 5 (0) 0 (0)
- patellar facet medial / 
lateral
1269(99)/1280(100) 14 (1) / 4 (0) 1 (0) / 0 (0) 0 (0) / 0 (0)
- trochlear facet medial / 
lateral
1274(99) / 1274(99) 9 (1) / 8 (1) 1 (0) / 2 (0) 0 (0) / 0 (0)
Menisci:
- subluxation medial / lateral 1092(85) / 1112(87) 171 (13) / 156 (12) 19 (1) / 16 (1) 2 (0) / 0 (0)
- maceration medial / lateral 837 (65) / 955 (74) 341 (27) / 262 (20) 102 (8) / 63 (5) 4 (0) / 4 (0)
- tear medial / lateral 985 (77) / 1090 (85) 299 (23) / 194 (15) na na
Numbers (%, rounded to whole numbers).
na = not applicable.
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Table 2. Prevalence of structural abnormalities as assessed on magnetic resonance imaging on different locations 
in the knee stratified by symptomatic knee osteoarthritis (OA) status
No symptomatic OA  (n = 1107) Symptomatic OA (n = 177)
Grade 0-1-2-3 (%) Grade 0-1-2-3 (%)




- femoral condyle medial / lateral 16-76-8-1 / 24-70-5-1 8-59-20-12 / 16-59-19-6
- tibial plateau medial / lateral 66-32-2-0 / 76-22-2-1 38-47-12-3 / 53-36-9-2
Cartilage defects
- femoral condyle medial / lateral 44-44-10-2 / 82-13-4-0 30-42-20-8 / 70-18-10-2
- tibial plateau medial / lateral 33-58-9-1 / 85-7-7-1 28-53-15-5 / 76-12-9-2
Bone marrow lesions
- femoral condyle medial / lateral 87-8-6-0 / 93-3-3-0 67-15-19-np / 88-6-6-np
- tibial plateau medial / lateral 91-5-4-0 / 94-3-3-0 75-5-19-2 / 88-4-7-2
Cysts
- femoral condyle medial / lateral 99-1-np-0 / 99-1-0-np 98-2-np-np / 98-2-1-np
- tibial plateau medial / lateral 98-1-1-0 / 98-1-1-0 96-3-1-1 / 97-1-1-1
Patellofemoral compartment:
Osteophytes
- patellar crest 99-0-0-0 96-2-2-0
- patellar facet medial / lateral 44-49-7-0 / 85-14-1-np 25-54-17-6 / 68-25-7-np
- trochlear facet medial / lateral 74-24-2-1 / 81-17-1-0 46-36-11-7 / 61-28-8-3
Cartilage defects 
- patellar crest 37-30-21-12 22-32-25-22
- patellar facet medial / lateral 36-28-25-12 / 62-26-9-3 27-24-32-18 / 50-29-12-9
- trochlear facet medial / lateral 48-40-11-1 / 66-28-5-1 42-37-16-5 / 59-29-5-7
Bone marrow lesions
- patellar crest 80-8-12-np 71-10-20-np
- patellar facet medial / lateral 91-5-4-np / 95-3-2-0 93-6-1-np / 92-5-3-np
- trochlear facet medial / lateral 94-4-2-0 / 95-2-3-0 94-3-3-np / 88-5-7-np
Cysts
- patellar crest 97-3-1-np 97-3-np-np
- patellar facet medial / lateral 99-1-0-np / 100-0-np-np 100-np-np-np / 99-1-np-np
- trochlear facet medial / lateral 99-1-0-np / 99-1-0-np 98-2-np-np / 99-1-np-np
Menisci:
- subluxation medial / lateral 87-12-1-0 / 87-12-1-np 75-19-6-1 / 83-16-1-np
- maceration medial / lateral 66-27-7-0 / 75-20-5-0 63-23-14-1 / 71-21-6-2
- tear medial / lateral 78-22-na-na / 86-14-na-na 71-29-na-na / 79-22-na-na
 Numbers are rounded to percentages as whole numbers.
np = not present, na = not applicable.
5
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Figure 1. Network graph illustrating the relation between the assessed structural abnormalities on different 














































































































































































































































Relation between structural abnormalities
In the total study population, including individuals with and without symptomatic OA, 
the relation between structural abnormalities was visualized by network graphs, showing 
multiple relations between abnormalities on different locations within the joint. A num-
ber of network graphs was performed, the number of relations shown in the graph de-
pending on the used lasso penalty. All network graphs showed relations between osteo-
phytes on different locations within all compartments of the knee and between cartilage 
defects on different locations. Furthermore, osteophytes and cartilage defects within the 
same compartment were also related. Figure 1 shows 15 structural abnormalities with 22 
relations between them.  Besides osteophytes and cartilage defects on different loca-
tions within the joint, BMLs in the patellar crest were also present in the network graph, 
related to cartilage defects in the patellar crest and medial patellar facet.
Structural abnormalities discriminating symptomatic OA
Next, we investigated which specific abnormalities could best discriminate between indi-
viduals with and without symptomatic OA, taking co-occurrence of all structural abnor-
malities into account. 
Regression coefficients of the assessed structural abnormalities for presence of OA as 
obtained by logistic ridge regression analyses are listed in Table 3. Depicted are regres-
sion coefficients for all three analyses sets and a mean regression coefficient for these 
sets. The higher the regression coefficient, the better the corresponding structural ab-
normality discriminates symptomatic OA, adjusted for co-occurrence of other structural 
abnormalities. The regression coefficients for subchondral cysts were all below 0.030. 
Baker’s cysts showed the highest regression coefficient for OA, followed by osteophytes 
in the medial tibial plateau and medial trochlear facet. The next strongest regression 
coefficient was found for effusion, followed by BMLs in the medial tibiofemoral compart-
ment and osteophytes in the medial femoral condyle. 
The three separate analyses sets were comparable. After adjustment for age, sex and BMI, 
the same structural abnormalities were observed to discriminate symptomatic OA best. 
The area under the curve for the three sets were 0.719, 0.698 and 0.693 (Figure 2). Figure 
3 illustrates the structural abnormalities best discriminating symptomatic knee OA.
5
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Figure 2. ROC curve of one of the three analyses sets (set 1, AUC = 0.7189). The ROC curves of set 2 and set 3 were 
comparable (AUC set 2 = 0.698, AUC set 3 = 0.693).
Figure 3. Magnetic resonance (MR) images in individuals with symptomatic knee osteoarthritis illustrating the 




Axial fat suppressed proton density (PD) MR image showing a Baker’s cyst, effusion and an osteophyte in 
the medial trochlear facet
Coronal PD MR image showing osteophytes in the medial femoral condyle and medial tibial plateau











Table 3. Regression coefficients for presence of symptomatic knee osteoarthritis (OA) as obtained by logistic ridge 
regression analyses 
Set 1 Set 2 Set 3 Mean coeff.
Baker’s cyst 0.391 0.235 0.254 0.293
Effusion 0.255 0.220 0.116 0.197
Tibiofemoral compartment:
Osteophytes
- medial femoral condyle 0.184 0.205 0.166 0.185
- lateral femoral condyle 0.008 0.066 0.123 0.065
- medial tibial plateau 0.314 0.250 0.273 0.279
- lateral tibial plateau 0.019 0.081 0.149 0.083
Cartilage defects
- medial femoral condyle 0.245 0.075 0.154 0.158
- lateral femoral condyle 0.038 0.074 0.130 0.081
- medial tibial plateau -0.054 0.046 0.041 0.011
- lateral tibial plateau -0.119 -0.028 -0.018 -0.055
Bone marrow lesions
- medial femoral condyle 0.211 0.138 0.230 0.193
- lateral femoral condyle 0.003 0.013 -0.053 -0.012
- medial tibial plateau 0.101 0.179 0.283 0.188
- lateral tibial plateau 0.175 0.056 0.034 0.088
Patellofemoral compartment:
Osteophytes
- patellar crest 0.033 0.009 0.024 0.022
- medial patellar facet 0.135 0.170 0.124 0.143
- lateral patellar facet 0.158 0.037 0.099 0.098
- medial trochlear facet 0.275 0.258 0.252 0.262
- lateral trochlear facet 0.047 0.048 0.135 0.077
Cartilage defects 
- patellar crest 0.188 0.123 0.127 0.146
- medial patellar facet 0.184 0.133 0.011 0.109
- lateral patellar facet 0.073 0.095 0.120 0.096
- medial trochlear facet 0.078 0.117 0.021 0.072
- lateral trochlear facet -0.035 0.105 0.020 0.030
Bone marrow lesions
- patellar crest 0.070 0.179 0.149 0.133
- medial patellar facet -0.077 -0.061 -0.097 -0.078
- lateral patellar facet 0.071 0.000 0.014 0.029
- medial trochlear facet -0.026 -0.024 -0.062 -0.037
- lateral trochlear facet 0.016 0.039 -0.017 0.012
Menisci:
- subluxation medial / lateral 0.053 / 0.050 0.035 / -0.021 0.016 / -0.021 0.035 / 0.003
- maceration medial / lateral 0.202 / 0.090 0.052 / -0.013 0.070 / 0.109 0.108 / 0.062
- tear medial / lateral 0.004 / 0.092 0.009 / 0.014 0.050 / 0.034 0.021 / 0.047
In bold within the gray rows the strongest mean regression coefficients for presence of symptomatic knee OA. All 
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DISCUSSION
This large population-based study investigates which structural abnormalities as as-
sessed on MR imaging discriminates symptomatic OA within the same knee best, taking 
co-occurrence of all structural abnormalities on different locations within the joint into 
account. In the entire study population, comprising individuals with and without sympto-
matic OA, structural abnormalities were highly frequent in both the tibiofemoral and pa-
tellofemoral compartments, most prominent at the medial side. Presence of osteophytes 
and cartilage defects in different locations were related to each other. The structural 
abnormalities that discriminates best between individuals with and without symptomatic 
OA were general abnormalities as Baker’s cysts and effusion, in addition to osteophytes 
and BMLs in the medial tibiofemoral compartment. In the patellofemoral joint only oste-
ophytes in the medial trochlear facet seemed of importance. 
This is not the first study associating structural abnormalities with symptomatic knee OA 
or symptoms as pain, but it is the first investigating this relationship involving structur-
al abnormalities in all patellofemoral and tibiofemoral locations, using a model taking 
co-occurrence of all abnormalities into account. 
Baker’s cysts showed the highest regression coefficient for symptomatic OA. The rela-
tionship between Baker’s cysts and OA symptoms has been assessed in a few studies, 
showing conflicting results.11,19-21 Bakers’ cysts have not been studied before to discrim-
inate symptomatic OA. Inflammation seems to play a role in development of Baker’s 
cysts since presence and grade of synovial inflammation has been associated with Baker’s 
cysts.22 Although grade of synovial inflammation has not been assessed in this study, 
effusion also discriminated symptomatic OA. The prevalence of grade 2 and 3 Baker’s 
cysts was 23% in individuals with symptomatic OA compared to 9% in those without. Per-
haps, treatment of knee OA has to focus on prevention of development of Baker’s cysts 
by treatment of synovial inflammation. Studies on treatment of Baker’s cysts by steroid 
injections showed significant reduction of symptoms after intra-articular infiltration, and 
even more after direct injection into the cyst.23,24
As described in a systematic review on structural abnormalities in relation to symptoms in 
OA, the discriminative role of effusion and BMLs found in this study is in accordance with 
previous literature.14 Osteophytes and cartilage defects does not show a clear relation 
with OA symptoms.14 This study, taking co-occurrence of structural abnormalities into 
account, showed osteophytes especially in the medial tibiofemoral joint to discriminate 
symptomatic OA. Although a high prevalence of cartilage defects was observed, they 
were found to discriminate symptomatic OA less good. This can be understood when 
looking at the network graph presented in Figure 1, showing relations between structural 
abnormalities that co-occur frequently within the total study population. Since cartilage 
defects co-occur frequently with osteophytes, only one of these abnormalities will dis-
criminate symptomatic OA when taking this co-occurrence into account. 
The Baker’s cyst, found to discriminate individuals with symptomatic OA best, was not 
present in the network graph. This is probably due to the lower prevalence of Baker’s 
cysts. Although also Baker’s cysts co-occur with other structural abnormalities in the 
knee, they especially discriminate symptomatic OA.
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Although research on knee OA has been focusing increasingly on the patellofemoral 
compartment during last years,1,3 this study shows that most of the abnormalities dis-
criminating symptomatic OA are general abnormalities (Baker’s cysts and effusion) and 
structural abnormalities located within the medial tibiofemoral compartment. In current 
literature on patellofemoral OA, it has been suggested that abnormalities in the patel-
lofemoral compartment may represent an early stage of OA and precede tibiofemoral 
OA.25-27 This is in contrast with the minor role of the patellofemoral compartment in dis-
criminating symptomatic OA found in this study.
Strength of this study are the size of the study population, extensive assessment of struc-
tural abnormalities using MR imaging and analyses accounting for co-occurrence of all 
structural abnormalities on different locations within the joint. Symptoms as pain, as-
sessed by self-report, may be influenced by unknown determinants or causes other than 
OA. Therefore we used symptomatic OA defined by highly sensitive and specific criteria10 
instead of only pain as outcome measure. 
Because of the large number of individuals without symptomatic OA, the logistic ridge 
regression analyses were performed in three sets of data, consisting of a random one 
third of individuals without symptomatic OA in addition to the individuals with sympto-
matic OA. Analyses of these three sets prevents loss of information due to the high pro-
portion of individuals without OA. Furthermore, structural abnormalities that were found 
to discriminate symptomatic OA in all three sets supports the importance of especially 
these abnormalities. The AUC of the three analyses (around 0.7) showed that assessment 
of all structural abnormalities results in fair discrimination of symptomatic OA.28
This study suggests that Baker’s cysts discriminate symptomatic knee OA best, followed 
by effusion and structural abnormalities as osteophytes and BMLs especially in the me-
dial side of the tibiofemoral joint. More research is necessary to gain more insight into 
the precise underlying mechanisms, longitudinal research will be of help. Especially the 
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ABSTRACT
Objective 
To investigate whether obesity and other risk factors interact with knee osteoarthritis 
(OA) in its adverse impact on health-related quality of life (HRQOL).
Methods 
In 1,262 participants of the Netherlands Epidemiology of Obesity study, a popula-
tion-based cohort (age 45 to 65 years, 53% women, and median body mass index (BMI) 
27 kg/m2), knee OA was defined following modified American College of Rheumatology 
criteria. BMI and fat-free mass (FFM) (as proxy for muscle mass) were assessed by bioel-
ectrical impedance analysis, and comorbidities by self-report. HRQOL was assessed using 
the Short Form 36 physical component summary (PCS) score. Linear regression analyses 
were performed to examine associations between knee OA and PCS score, adjusting for 
age and sex and stratified for BMI, FFM, and comorbidities. 
Results 
Knee OA (prevalence 16%) was associated with a 7.2-points lower PCS score (95% con-
fidence interval -9.5 to -4.8). PCS score was also negatively associated with obesity and 
comorbidities; however, no interaction with knee OA was seen. Low FFM was associated 
with a lower PCS score and interacted with knee OA in men. Interaction between concur-
ring OA and low FFM attributed to 64% of the decrease in PCS score, as compared with 
men without OA and with high FFM. 
Conclusion 
Knee OA was associated with a lower HRQOL, as were its risk factors, obesity, comorbidi-
ties, and low FFM. In men, FFM interacted with knee OA, leading to an additional decrease 
of HRQOL in the case of concurrence. Especially in the former, improvement of FFM may 





Of the musculoskeletal disorders, osteoarthritis (OA) is the second largest contributor to 
disability. Knee OA has been shown to account for 83% of the global years lived with disa-
bility that were due to the presence of any OA.1 In addition, knee OA has been associated 
with an impaired health-related quality of life (HRQOL).2-4 
Several risk factors for knee OA are known;5,6 some of these risk factors are not only 
associated with development of OA but also with a decreased HRQOL. It is possible that 
presence of knee OA together with a risk factor that is also associated with HRQOL results 
in strengthening of both adverse associations with HRQOL. The latter will be especially 
important when it concerns risk factors that can either be prevented or treated, as inter-
ventions aimed at prevention or treatment of these factors could then result in additional 
improvement of HRQOL in knee OA patients. 
Modifiable risk factors for OA that also decrease HRQOL could be potential targets for 
interventions. Obesity may be one of those factors; it has been related both to develop-
ment of knee OA and to impaired HRQOL.7-9 Another risk factor for knee OA that may be 
a target for intervention is muscle weakness.10 Although no studies related muscle weak-
ness or the actual amount of muscle mass to HRQOL, physical frailty (associated with low 
fat-free mass (FFM), a proxy for muscle mass) has been related to decreased HRQOL.11 A 
preventable risk factor is the presence of comorbidities, such as cardiovascular diseases 
and diabetes mellitus. Such comorbidities have been associated both with presence of 
knee OA and decreased HRQOL.12-14
Obesity, exercise (related to muscle mass), and comorbidities have been related to 
HRQOL, not only in the general population but also within knee OA patients.15-18 How-
ever, the relative contributions of knee OA and these risk factors to HRQOL, as well as a 
possible interaction when they concur, are not clear. 
To gain insight into possible targets for improvement or prevention of HRQOL in knee OA 
patients, we aimed to evaluate the impact of the presence of knee OA and its modifiable 
or preventable risk factors: obesity, FFM (as proxy for muscle mass), and comorbidities on 
HRQOL. In addition, we aimed to examine the presence of interaction between knee OA 
and these risk factors in relation to HRQOL.
PATIENTS AND METHODS
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based prospec-
tive cohort study including 6,673 individuals aged 45 to 65 years, with an oversampling 
of persons with overweight or obesity (members of the NEO Study Group are listed in 
Appendix A). Detailed information about the study design and data collection has been 
described previously.19 In short, men and women between ages 45 to 65 years with a 
self-reported body mass index (BMI) of ≥27 kg/m2 living in the greater area of Leiden (in 
the West of The Netherlands) were eligible to participate. In addition, all inhabitants aged 
45 to 65 years from one municipality (Leiderdorp) were invited irrespective of their BMI, 
allowing for a reference distribution of BMI. 
6
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All participants completed questionnaires on demographic and clinical data, in addition 
to the Short Form 36 (SF-36) Health Survey, and visited the NEO study center between 
September 2008 and September 2012 for an extensive physical examination, including 
anthropometry and blood sampling. All medication that was used in the month preced-
ing the study visit was recorded. A random sample of 1,285 study participants without 
contraindications (metallic devices, claustrophobia, body circumference >170 cm) un-
derwent magnetic resonance (MR) imaging of the right knee. The present study is a 
cross-sectional analysis of baseline measurements of these 1,285 participants. The study 
was approved by the medical ethics committee of the Leiden University Medical Center 
and all participants gave written informed consent. 
Data collection
Highest level of education was reported in categories according to the Dutch education 
system and grouped into low, medium, or high education. Reported professions were 
categorized into non-, light- and heavy physically demanding work, based on a classifica-
tion scheme of physical work demands by De Zwart et al.20 
MR imaging
MR imaging was performed using a dedicated knee coil in a 1.5T system (Philips, Medical 
Systems). Our standardized scanning protocol consisted of (1) coronal proton density 
(PD) turbo spin-echo (TSE), repetition time (TR)/echo time (TE) 2,335/35 msec; echo train 
length (ETL) 6; (2) coronal frequency selective fat-suppressed PD TSE (TR/TE 2,334/ 35 
msec, ETL 6, 3 mm slice thickness); (3) sagittal PD TSE (TR/TE 2,338/35 msec, ETL 6; 3.5 mm 
slice thickness); (4) sagittal frequency selective fat-suppressed T1-weighted 3-dimension-
al gradient echo sequence (TR/TE 11/5.5, 25o flip angle, 150 mm field of view, 272 x 512 
acquisition matrix, 2 mm slice thickness with a 1 mm overlap between images); and (5) 
axial frequency selective fat-suppressed PD TSE (TR/TE 3,225/15 msec, ETL 6, 4 mm slice 
thickness). In all TSE sequences we used a 150-160 mm field of view and a 304 x 512 acqui-
sition matrix. Total acquisition time, including the initial survey sequence, was 30 minutes.
Definition of OA
Knee OA was defined, based on modified criteria of the American College of Rheumatol-
ogy (ACR), as presence of osteophytes, knee pain on most days of the prior month, and at 
least 1 of the following criteria: age >50 years, stiffness <30 minutes duration, and crepi-
tus on active motion.21 Instead of the presence of radiographic osteophytes as described 
in the original ACR criteria, osteophytes were assessed with MR imaging.
Assessment of the MR imaging was done by a trained reader (AWV, supervised by JLB), 
using the validated semiquantitative knee OA scoring system, blinded to clinical data. Os-
teophytes were defined as focal bony excrescences extending from a cortical surface and 
measured from base to tip. Osteophytes were either absent (grade 0), or present (grade 
1 (<3 mm), grade 2 (3-5 mm), or grade 3 (>5 mm)).22 A random 10% of the MR images (n 
= 120) were scored twice to test the reproducibility; the calculated intraclass correlation 
coefficient was 0.97.
Physical examination of the knees was performed by trained research nurses, using a 
standardized scoring form. Self-reported knee pain and morning stiffness were meas-




Height was measured with a calibrated tape measure. Body weight, fat mass, and body 
fat percentage were measured using the Tanita foot-to-foot bio impedance balance (TBF-
310, Tanita International Division).23 BMI was calculated by dividing the weight in kilo-
grams by the height in meters squared (kg/m2). According to the classification of the 
World Health Organization, BMI was categorized into normal weight (BMI <25 kg/m2), 
overweight (BMI 25-30 kg/m2), and obesity (BMI ≥30 kg/m2).
The percentage of FFM was calculated as 100 minus the percentage of body fat measured 
by bioelectrical impedance analysis using the Tanita balance.23 Percentage of FFM was 
divided in tertiles separately in men and women because of the major difference in FFM 
between the sexes.24 Low FFM was defined as the lowest tertile of percentage FFM.
Comorbidities 
The presence of cerebrovascular disease, lung disease, cardiovascular diseases (myocar-
dial infarction, angina, congestive heart failure, stroke, peripheral vascular disease), and 
diabetes was self-reported using a standardized questionnaire. In addition, use of glu-
cose-lowering therapy or a measured fasting plasma glucose of ≥7.0 mmol/liter at the 
time of the study visit were also defined as diabetes mellitus. 
HRQOL
HRQOL was assessed using the physical component summary (PCS) score of the generic 
SF-36. The SF-36 PCS and mental component summary scores were derived using norm-
based data from the Dutch population, standardized to a mean of 50 and SD of 10.25 The 
total scores range from 0 to 100, and higher scores indicate better HRQOL.26 The mini-
mal clinical important difference is 2.5 to 5.0 points.27
Statistical analysis
Data were analyzed using STATA, version 12. In the NEO study there is an oversampling of 
persons with a BMI ≥27 kg/m2. To correctly represent associations in the general popula-
tion, adjustments for the oversampling of individuals with a BMI ≥27 kg/m2 were made.28 
This was done by weighting individuals towards the BMI distribution of participants from 
the Leiderdorp municipality (n = 1,671),29 whose BMI distribution was similar to the BMI 
distribution in the general Dutch population.30 Consequently, results apply to a popula-
tion-based study without oversampling of BMI ≥27 kg/m2. 
First, we performed linear regression analyses to examine the association of knee OA with 
the SF-36 PCS score. Regression coefficients with 95% confidence intervals (95% CI) were 
reported and can be interpreted as the mean difference in PCS score of participants with 
knee OA as compared with participants without knee OA. Adjustments were made for 
age, sex, BMI, FFM, and presence of comorbidities. 
Second, we examined the presence of interaction of knee OA with obesity, low percent-
age FFM, or comorbidities in relation to HRQOL by including interaction terms between 
knee OA and BMI, knee OA and percentage FFM, and knee OA, and presence of co-
morbidities in the model. These regression analyses were performed separately for the 
3 interaction terms. Interaction was considered present when the interaction term was 
significant (P < 0.05).
6
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Finally, for a transparent presentation of the joint associations, we stratified all analyses 
by knee OA and categories of BMI, FFM and comorbidities to report all associations com-
pared with the unexposed group as a joint reference category.31,32
For example, the adjusted difference in PCS scores were calculated for each stratum of 
BMI, using individuals without knee OA and with normal weight as reference. Similar 
analyses were performed with tertiles of FFM and presence/absence of comorbidities. 
Since BMI is a cumulative measure of fat, muscle, and bone, we performed sensitivity 
analyses including fat mass as specific measure of adiposity instead of BMI as robust 
measure of obesity. Furthermore, since MR imaging is a very sensitive tool for detection 
of osteophytes, sensitivity analyses excluding small osteophytes (grade 1) from the knee 
OA definition were performed. 
RESULTS
Population characteristics
After exclusion of individuals with missing SF-36 data (n = 23), data from 1,262 partici-
pants were analyzed. The unweighted baseline characteristics, i.e. without taking over-
sampling of BMI ≥27 kg/m2 into account, are shown in Supplementary Table 1. Table 1 
shows the weighted baseline characteristics of the total study population and stratified 
by knee OA. These characteristics represent the population to which all subsequent re-
sults apply. Median (25th to 75th percentiles) age of the total study population was 56 years 
(51 to 61 years), BMI 27 kg/m2 (24 to 29 kg/m2), and 56% were women.
The prevalence of knee OA, including osteophytes of at least grade 1 as assessed on MR 
imaging, was 16% (95% CI 13% to 19%). The prevalence of knee OA when including only 
osteophytes of at least grade 2 was 5% (95% CI 4% to 7%). Median age and percentage 
of women were higher in individuals with knee OA. Furthermore, individuals with knee 
OA had a higher median BMI and more comorbidities as compared with participants 
without knee OA. Mean SF-36 PCS score was lower in individuals with knee OA than in 
those without (Table 1). 
Knee OA in relation to HRQOL
First, we investigated the association between knee OA and PCS score (Table 2). The 
crude mean PCS score in individuals with knee OA was 7.4 points lower (95% CI -9.3 to 
-5.4) than in individuals without knee OA. After adjustment for age, sex, and the assessed 
risk factors, the mean difference in PCS score between individuals with and without OA 
was -6.2 points (95% CI -8.0 to -4.4).
Sensitivity analysis, including fat mass as specific measure of adiposity instead of BMI 
as robust measure of obesity, provided the same mean difference in PCS score between 
individuals with and without OA (-6.2 points (95% CI -8.1 to -4.4)). Sensitivity analyses, 
including knee OA based on osteophytes of at least grade 2 instead of all observed oste-
ophytes, yielded similar results.
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 Table 1. Baseline characteristics of the NEO study population
Total population Knee OA 
(prevalence 16%)
No knee OA 
(prevalence 84%)
Age (years) 56 (51-61) 57 (53-61) 56 (50-61)
Sex (% women) 56 61 55




BMI (kg/m2) 26.7 (23.8-29.4) 27.1 (24.8-30.7) 26.6 (23.4-29.2)
FFM (kg) Men 74.7 (71.2-79.3) 74.7 (71.4-79.0) 74.8 (71.2-79.3)
Women 61.6 (57.2-66.7) 59.8 (55.2-63.7) 61.7 (57.4-67.3)
Comorbidities 14 24 13
- Cardiovascular disease 6 8 5
- Cerebrovascular accident 3 2 3
- Diabetes 7 12 6
- Lung disease 4 9 2
SF-36 MCS score 51.5 ± 8.7 51.2 ± 9.9 51.5 ± 8.5
SF-36 PCS score 53.0 ± 8.6 46.9 ± 9.5 54.2 ± 7.9
Values are the percentage, median (25th to 75th percentiles), or mean ± SD. Results are based on weighted analyses 
of the study population (n = 1,262). 
BMI, body mass index; FFM, fat-free mass; MCS, mental component summary; NEO, Netherlands Epidemiology of 
Obesity; OA, osteoarthritis; PCS, physical component summary; SF-36, Short Form 36 health survey.
 Table 2. Association of knee OA with PCS score in 1,262 participants of the NEO study
Mean difference PCS score 95% CI
Crude -7.4 -9.3, -5.4
Adjusted for age and sex -7.2 -9.1, -5.3
Adjusted for age, sex, and BMI -6.5 -8.3, -4.7
Adjusted for age, sex, and FFM -6.7 -8.4, -4.9
Adjusted for age, sex, and comorbidities -6.6 -8.5, -4.8
Adjusted for age, sex, BMI, FFM, and comorbidities -6.2 -8.0, -4.4
Results are based on weighted analyses of the study population. 
BMI, body mass index; FFM, fat-free mass; CI, confidence interval; NEO, Netherlands Epidemiology of Obesity; OA, 
osteoarthritis; PCS, physical component summary.
6
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Interaction between knee OA and its risk factors in relation to HRQOL
Next, we investigated whether knee OA interacts with obesity, low FFM, or comorbidities 
in relation to HRQOL. In men, a significant interaction term (P = 0.002) was observed 
between the presence of knee OA and low FFM in relation to HRQOL. There was no inter-
action between knee OA and obesity and knee OA and comorbidities. When performing 
a sensitivity analysis including fat mass instead of BMI, again no interaction with presence 
of knee OA was observed in relation to HRQOL. Sensitivity analyses including knee OA 
based on osteophytes of at least grade 2 instead of all observed osteophytes provided 
similar results.
Table 3 shows the mean PCS score stratified by presence of knee OA and BMI categories, 
as well as the adjusted mean difference in PCS score between the strata, using individuals 
with a normal weight and without knee OA as reference. The adjusted mean difference 
in PCS score due to the presence of only knee OA (within normal weight individuals) was 
-5.3 points (95% CI -9.9 to -0.6), the difference in PCS score due to presence of obesity 
within individuals without knee OA was -2.6 points (95% CI -5.2 to -0.02). When knee OA 
and obesity concurred, the mean PCS score was -9.4 (95% CI -12.3 to -6.4). 
Table 4 shows the mean PCS score and adjusted difference stratified by presence of knee 
OA and tertiles of percentage FFM, separately in men and women. In men with knee OA 
in the lowest tertile of FFM the mean PCS score was 10.2 (95% CI -14.6 to -5.8) points 
lower than in the reference category. If no interaction would have been present we would 
expect a lower PCS score of 3.7 points in men with knee OA (-0.7 points) and in the low-
est tertile of FFM (-3.0 points). However, as illustrated in Figure 1, the decrease in mean 
PCS score between men with concurring knee OA and low FFM as compared with the 
reference category is higher (-10.2 points) than the summed decreases due to only knee 
OA or low FFM (-3.7 points). In absence of bias, the additional 64% (6.5 of 10.2 points) 
of the decrease in PCS score can be attributed to interaction between knee OA and low 
percentage FFM. No such association was observed in women.
 
Table 3. PCS mean score and difference, stratified by knee OA and BMI category
PCS score (mean ± SD) Mean difference PCS score (95%CI)*
BMI No knee OA Knee OA No knee OA Knee OA
< 25 kg/m2 56.1 ± 6.4 50.4 ± 8.7 reference -5.3 (-9.9, -0.6)
25-30 kg/m2 54.2 ± 8.0 46.8 ± 9.3 -0.9 (-2.8, 1.0) -7.5 (-10.4, -4.6)
>30 kg/m2 50.8 ± 9.2 43.4 ± 9.7 -2.6 (-5.2, -0.02) -9.4 (-12.3, -6.4)
Results are based on weighted analyses of the study population (n = 1,262). 
* As compared with reference (BMI <25 kg/m2, without knee OA), adjusted for age, sex, comorbidities, and per-
centage FFM.
BMI, body mass index; CI, confidence interval, OA, osteoarthritis; PCS, physical component summary.
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Figure 1. Adjusted decrease in mean physical component summary (PCS) score in men with knee osteoarthritis 
(OA), low FFM (FFM), or both, compared with men without knee OA and high FFM: decrease due to knee OA 
(white), decrease due to low FFM (gray), and additional decrease in PCS score due to interaction between concur-
ring knee OA and low FFM (dark gray). The broken  line indicates exact additivity of effects. Results are based on 
weighted analyses of the study population, adjusted for age, sex, comorbidities, and body mass index.
Table 4. PCS mean score and difference, stratified by knee OA and percentage fat-free mass separately in men and 
women
PCS score (mean ± SD) Mean difference PCS score (95%CI)*
FFM (%) No knee OA Knee OA No knee OA Knee OA
Men#
Highest tertile 57.3 ± 6.1 56.3 ± 3.6 reference -0.7 (-2.9, 1.5)
Middle tertile 54.7 ± 7.5 44.6 ± 8.3 -2.7 (-5.2, -0.1) -11.8 (-17.1, -6.6)
Lowest  tertile 53.2 ± 8.0 45.2 ± 10.7 -3.0 (-5.8, -0.2) -10.2 (-14.6, -5.8)
Women§
Highest tertile 55.4 ± 7.1 46.2 ± 9.8 reference -9.5 (-18.0, -1.0)
Middle tertile 55.1 ± 7.3 48.9 ± 8.8 1.5 (-1.1, 4.2) -4.4 (-9.1, 0.3)
Lowest  tertile 51.2 ± 9.2 44.5 ± 9.5 0.7 (-2.3, 3.6) -5.0 (-8.8, -1.3)
Results are based on weighted analyses of the study population (n = 568 for men, n = 694 for women). 
* As compared with reference (BMI <25 kg/m2, without knee OA), adjusted for age, comorbidities, and BMI. 
# Men: highest tertile ≥73.2%, middle tertile 68.7-73.1%, lowest tertile <68.7%.
§ Women: highest tertile ≥58.7%, middle tertile 54.5-58.6%, lowest tertile <54.5%.
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Finally, Table 5 shows the PCS score stratified by presence of knee OA and presence of 
comorbidities. The adjusted difference in mean PCS score was -6.6 points (95% CI -8.7 to 
-4.5) due to presence of knee OA and -4.4 points (95% CI -6.2 to -2.7) due to comorbid-
ities. When knee OA and comorbidities concurred, mean PCS score was 9.1 points lower 
(95% CI -12.6 to -5.7) as compared with the reference category. 
DISCUSSION
This study aimed at evaluating the interaction between knee OA and its risk factors obe-
sity, low percentage FFM (as proxy for muscle mass), and comorbidities in their associa-
tion with HRQOL, measured by the PCS score. After adjusting for age and sex, the mean 
PCS score was observed to be 6.2 points lower in individuals with knee OA than in those 
without. Because 2.5 to 5.0 points difference in PCS score has been described as the 
minimum clinically important difference in arthritis patients,27 the observed decrease is 
clinically relevant.  
When knee OA concurred with obesity, low FFM, and comorbidities, interaction was ob-
served between knee OA and low percentage FFM in men, but not with the other risk 
factors.
Although knee OA and its assessed risk factors have been related to impairment of 
HRQOL before, this study is the first showing that knee OA may interact with FFM in its 
relation with HRQOL in a population-based cohort. To our knowledge, an interaction of 
knee OA with low FFM in relation to HRQOL has not been described before. 
The presence of knee OA together with low FFM was associated with a larger impairment 
of HRQOL than would be expected on the basis of the separate associations of knee OA 
and low FFM with HRQOL. This observation suggests that concurrence of knee OA and 
low FFM may result in strengthening of their separate adverse associations with HRQOL. 
Therefore, it will be of importance to increase FFM in knee OA patients. Although dis-
ease-modifying treatment is not yet available for knee OA, the decreased HRQOL in knee 
OA patients may be prevented by interventions aiming at obesity and the amount of 
FFM (i.e., reducing weight and strengthening of muscle). Although to a lesser extent, pre-
vention, but also strict control and treatment of comorbidities may maintain or improve 
HRQOL in knee OA patients. 
Our results are supported by a recent study of Messier et al., showing that reducing 
weight and performing exercises improved HRQOL within knee OA patients.18 The knowl-
edge that exercising reduces pain and improves physical function in knee OA patients 
Table 5. PCS mean score and difference, stratified by knee OA and comorbidities
PCS score (mean ± SD) Mean difference PCS score (95%CI)*
Comorbidities No knee OA Knee OA No knee OA Knee OA
Absent 54.9 ± 7.5 47.7 ± 9.1 reference -6.6 (-8.7, -4.5)
Present 49.4 ± 9.0 44.1 ± 10.5 -4.4 (-6.2, -2.7) -9.1 (-12.6, -5.7)
Results are based on weighted analyses of the study population (n = 1,262). Comorbidities include cardiovascular 
disease, cerebrovascular accident, diabetes and lung disease. 
*As compared with reference (BMI <25 kg/m2, without knee OA), adjusted for age, sex, percentage FFM, and BMI.
CI, confidence interval; OA, osteoarthritis; PCS, Physical Component Summary.
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may provide an explanation.33 The effect of prevention or treatment of comorbidities on 
HRQOL in knee OA patients has not been evaluated in a longitudinal study. 
In the present study, analyses on FFM were stratified by sex because of the large differ-
ences in amount of FFM between men and women. Although previous studies on proxies 
for muscle mass in relation to HRQOL did not assess men and women separately, our 
study underscores the utility of sex-stratified analyses. Different results were observed 
for men and women, as percentage FFM was associated with impaired HRQOL only in 
men. Within women, the most impaired HRQOL was observed in individuals with knee 
OA in the highest tertile of FFM. The underlying mechanism for the observed difference 
is not clear. The amount and intensity of physical activity, probably related to the amount 
of muscle mass and to HRQOL, may be higher in men than in women. However, additional 
adjustment for physical activity did not change the results (data not shown). In addition to 
the observed importance of FFM for HRQOL in men, we observed a stronger association 
between the amount of muscle mass and presence of knee OA in men than in women in 
a previous study.34 Perhaps, the role of muscle mass in both the pathogenesis of knee OA 
and HRQOL is different between men and women.
A strength of this study is the size of the study population. However, since this is an 
observational cross-sectional study, residual confounding may still be present. Since the 
direction of associations cannot be determined, reverse causation may be present. Al-
though several determinants have been measured in this study, not all determinants that 
may affect quality of life in knee OA patients could be accounted for. An example of such 
a determinant is the presence and severity of chronic pain.
Knee OA was defined based on the presence of osteophytes assessed by MR imaging 
instead of, as incorporated in the original ACR criteria, by radiography. Since MR imaging 
is a more sensitive tool for detection of osteophytes,35 it could be that we observed more 
osteophytes than would be detected by radiography, leading to a higher prevalence of 
knee OA. Therefore, we repeated all analyses including knee OA based on the presence 
of osteophytes of at least 3 mm (defined as grade 2 and 3) instead of all observed osteo-
phytes. These analyses did not change the results. 
We did have MR images of the right knee only. The presence of OA of the left knee (or 
presence of bilateral knee OA) could therefore not be assessed.
Another limitation is that we did not have information regarding the actual amount of 
muscle mass or muscle strength. However, FFM consists for a substantial part of muscle 
mass and has been shown to be correlated with both muscle mass and muscle strength.36 
Therefore the percentage FFM is a valuable proxy for muscle mass. 
Although we mentioned low muscle mass as a risk factor for knee OA in this study, it may 
also be a consequence of knee OA because of disuse of muscles due to OA associated 
knee pain. However, the association between low FFM and impaired HRQOL within knee 
OA patients applies to all men with knee OA, independent of having low muscle mass as 
cause or consequence of their knee OA. We also did not have information on history of 
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Finally, the presence of comorbidities was based on self-report; unfortunately we did 
not have information of medical records to check the reliability of the reported comor-
bidities. However, studies on agreement of self-report and medical record data showed 
substantial agreement for most of the assessed comorbidities.37-39
In conclusion, this study confirms that knee OA is associated with impaired HRQOL. Addi-
tional impairment of HRQOL was observed in men because of interaction between con-
curring knee OA and low FFM. No such interaction with obesity was seen. Interventions 
aiming at prevention or treatment of obesity or comorbidities could maintain HRQOL in 
knee OA patients, and interventions aiming at increasing the percentage FFM may result 
in additional improvement of HRQOL in men with knee OA. Longitudinal research could 
help to confirm and quantify the beneficial effect of these interventions on HRQOL in 
knee OA patients. 
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Supplementary table. Unweighted baseline characteristics of 1,262 participants of the NEO study with an over-





No knee OA 
n = 1,033
Age (year) 56 (50-61) 57 (53-61) 56 (50-61)
Sex (% women) 55 66 52
Education (% high) 32 31 32
Profession (% high physically demanding) 12 11 12
BMI (kg/m2) 30.0 (27.9-33.0) 31.0 (28.3-34.3) 29.9 (27.8-32.6)
FFM (kg) Men 71.3 (67.6-74.5) 70.6 (67.4-73.8) 71.5 (67.8-74.5)
Women 56.6 (53.5-59.9) 55.8 (52.4-58.7) 56.8 (53.7-60.1)
Comorbidities (%) 20 30 18
- Cardiovascular disease 7 8 6
- Cerebrovascular accident 2 2 2
- Diabetes 11 15 10
- Lung disease 7 15 4
SF-36 MCS score 50.5 ± 9.5 50.8 ± 10.2 50.4 ± 9.4
SF-36 PCS score 51.2 ± 9.4 44.9 ± 9.7 52.6 ± 8.7
Values are the percentage, median (25th to 75th percentiles), or mean ± SD. 
BMI, body mass index; FFM, fat-free mass; MCS, mental component summary; NEO, Netherlands Epidemiology of 
Obesity; OA, osteoarthritis; PCS, physical component summary; SF-36, Short Form 36 health survey.
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Instruments measuring pain, physical function or patient global assessment 
in hand osteoarthritis – a systematic literature search 
A.W. Visser, P. Bøyesen, I.K. Haugen, J.W. Schoones, D.M. van der Heijde, 
F.R. Rosendaal, M. Kloppenburg





Description of use and metric properties of instruments measuring pain, physical func-
tion or patient global assessment in hand osteoarthritis (OA).
Methods 
Medical literature databases up to January 2014 were systematically reviewed for studies 
reporting on instruments measuring pain, physical function or patient global assessment 
in hand OA. The frequency of the use of these instruments were described, as well as their 
metric properties, including discrimination (reliability, sensitivity to change), feasibility 
and validity.
Results 
In 66 included studies, various questionnaires and performance- or assessor-based in-
struments were applied for evaluation of pain, physical function or patient global as-
sessment. No major differences regarding metric properties were observed between the 
instruments although the amount of supporting evidence varied. The most frequently 
evaluated questionnaires were the Australian/Canadian Hand OA Index (AUSCAN) pain 
subscale and visual analogue scale (VAS) pain for pain assessment and the AUSCAN func-
tion subscale and Functional Index for Hand OA (FIHOA) for physical function assess-
ment. Excellent reliability was shown for the AUSCAN and FIHOA and good sensitivity to 
change for all mentioned instruments; additionally the FIHOA had good feasibility. Good 
construct validity was suggested for all mentioned questionnaires. The most commonly 
applied performance- or assessor-based instrument were grip and pinch strength for 
assessment of physical function, in addition to assessment of pain by palpation. For these 
measures good sensitivity to change and construct validity were established.  
Conclusion 
The AUSCAN, FIHOA, VAS pain, grip and pinch strength and pain on palpation were most 
frequently tested and provided most supporting evidence for good metric properties. 





Hand osteoarthritis (OA) is a highly prevalent disorder, characterized by bony enlarge-
ments and deformities.1-3 Most studies on individuals with OA are based on the general 
population. Individuals with hand OA can experience symptoms as pain, decreased grip 
strength and disability, leading to a high clinical burden.4-6 In clinical practice, treatment 
for patients with hand OA (individuals with hand OA seeking health care) is administrated 
to decrease symptoms and improve function, however the evidence to support these 
treatments is limited since few high-quality clinical trials have been performed in hand 
OA.7,8 
An important problem in the lack of high-quality clinical trials in hand OA is the lack of 
standardization of outcome measures.8 Therefore, the Outcome Measures in Rheumatol-
ogy (OMERACT) and Osteoarthritis Research Society International Task Force on Clinical 
Trials Guidelines defined core domains to describe outcomes in clinical trials on symptom 
modification, comprising pain, physical function and patient global assessment.9-12  
For assessment of these domains, several patient reported outcome (PRO) measures are 
available. Hand OA specific questionnaires as the Functional Index for Hand OA (FIHOA) 
and Australian/Canadian Hand OA Index (AUSCAN),13,14 but also hand disorder or arthritis 
specific questionnaires as the Michigan Hand Outcomes Questionnaire (MHQ), Arthritis 
Impact Measurement Scale-2 (AIMS-2) and Health Assessment Questionnaire (HAQ) have 
been developed to assess one or more of these domains.15-17 In addition, physical function 
can be assessed using performance-based measures such as grip or pinch strength or the 
Arthritis Hand Function Test (AHFT). In addition to self-report and performance-based 
instruments, assessor-based measures such as joint tenderness upon palpation are used 
for assessment of pain.18,19 Besides the above mentioned questionnaires and assessor- 
or performance-based measures, several other instruments, which will be described in 
this manuscript, are used for clinical assessment of hand OA. Although most available 
instruments have been shown to be reliable for measurement of pain, physical function 
or patient global assessment, a systematic comparison of the different instruments for 
assessment of hand OA has not been performed. 
Our study was conducted in the framework of the OMERACT hand OA working group, 
aiming to identify instruments for measurement of pain, physical function and patient 
global assessment in hand OA which can be recommended for use in clinical trials on OA. 
Therefore, insight into available instruments and their metric properties is needed. To this 
end, we performed a systematic literature review aiming to describe the frequency of use 
of available instruments measuring pain, physical function or patient global assessment 
in studies on hand OA, and to describe the metric properties of these instruments.20 
Metric properties were described using the OMERACT filter,21 focusing on aspects of dis-
crimination (reliability and sensitivity to change), feasibility and truth (validity).
METHODS
Study design and identification of studies
The study design and performance followed the PRISMA guidelines.20 In cooperation with 




uscripts reporting on instruments measuring pain, physical function or patient global 
assessment in hand OA. Medical literature databases (PubMed, Embase, Web of Science, 
COCHRANE, CINAHL, Academic Search Premier and ScienceDirect) were searched from 
the date of their inception up to January 2014, using all variations of the following key 
words ‘hand’, ‘osteoarthritis’, ‘outcome assessment’, ‘reliability’, ‘sensitive’, ‘feasibility’ and 
‘validity’ (see supplementary file for exact search strings). 
Inclusion and exclusion criteria
First all retrieved titles were screened, subsequently selected abstracts were reviewed 
and finally full text articles of the remaining references were read by one reviewer (AWV). 
A random sample of 200 titles (9% of the titles identified by literature search) was also 
reviewed by a second reviewer (MK). Because of the similar selection of titles further ex-
traction was done by a single reviewer but in case of uncertainties, these were discussed 
and solved by consensus. 
Studies reporting on metric properties of instruments assessing pain, physical function 
and patient global assessment in hand OA were included. The metric properties of the 
studied instruments were described according to four items: reliability, sensitivity to 
change, feasibility and validity, inclusion criteria differed per item: 
Studies that fulfilled the requirements for at least one of these four items were included 
in this review. In order to be able to generalize the description of metric properties of the 
applied instruments to different populations, evaluation by only one study was consid-
ered as insufficient evidence to draw conclusions. Therefore, only instruments that were 
assessed by at least two studies were included in the description of metric properties.
Studies reporting on surgical interventions, less than 25 patients having hand OA or on 
diseases other than hand OA were excluded, as well as animal studies, reviews, abstracts, 
letters to the editor and studies in languages other than English. Because of the recently 
published systematic literature review on outcome measures in trapeziometacarpal OA 
by Marks et al.,22 studies reporting only on trapeziometacarpal OA were also excluded.
Data extraction
A self-made standardized form was used to extract information on the following data: 
(1) Study population (population size, setting, age, sex), (2) Instruments and assessed 
domains, (3) Study design and follow-up duration, (4) Results concerning: measures of 
Reliability was described based on studies evaluating the reliability of one or more 
instruments performed more than once in the same group of patients, either by the 
same performer over time or by different performers during one study visit. Both 
cross-sectional and longitudinal studies were included. 
Sensitivity to change was described based on longitudinal studies evaluating change 
of pain, physical function or patient global assessment in hand OA measured by one 
or more instruments. 
Feasibility was described based on studies evaluating this item of one or more instru-
ments.
Validity was described based on studies comparing different instruments assessing 
pain, physical function or patient global assessment in the same patients. Again, both 







reliability (intraclass correlation coefficient (ICC), kappa-value, percentage of agree-
ment, smallest detectable difference (SDD)), sensitivity to change (percentage of change, 
amount of change, standardized response mean (SRM)), feasibility (time needed to per-
form outcome measure), validity (correlation, association and measures of agreement 
between different instruments assessing the same domain). From 6 random studies data 
were also extracted by MK, resulting in similar extracted data. All extracted results were 
discussed by both reviewers to avoid missing information.
Statistical analyses
Because of the heterogeneity of the studies with respect to the evaluated instruments 




In total 4,351 titles were identified, 2,244 unique references were left for screening after 
removing duplicate references (Figure 1). During the screening, 2,008 references could be 
removed based on title. After reviewing 236 abstracts and 92 full-text articles, 66 studies 
satisfied the inclusion criteria (Table 1). 
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- Grip/pinch strength
Allen, 200624 GOGO study, 878 
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Shin, 201375 Secondary care,  86 
(97), 58
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tion = control), 
duration 12 
weeks
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- HAQ
- VAS global
- No. tender joints
Stamm, 
200741
Secondary care, 100 
(87), 61
Bony swelling ≥1 
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Verbruggen, 
201179
Secondary care, 60 
(85), 61
ACR criteria RCT (interven-
tion = control), 
duration 1 year
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- Grip strength
- No. tender joints
Wenham, 
201280
Not specified, 70 
(81), 61
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*Intervention group performed better than control group, according to primary outcome measure.
# Intervention group did not perform better than control group, according to primary outcome measure.
ADL, activities of daily living; AHFT, Arthritis hand function test; AIMS-2, Arthritis Impact Measurement Scale; ASES, 
Arthritis Self Efficacy Scale; AUSCAN, Australian/Canadian Hand OA Index; ACR, American College of Rheumatol-
ogy; CMC1, 1st carpometacarpal joint; COPM, Canadian Occupational Performance Measure; DIP, distal inter-
phalangeal joint; FIHOA, Functional Index for Hand Osteoarthritis; FU, follow-up; GARP, Genenetics osteoArthritis 
and Progession; GAT, grip ability test; GOGO, Genetics of Generalized Osteoarthritis; HAQ, Health Assessment 
Questionnaire; JTHFT, Jebsen-Taylor Hand Function Test; KL, Kellgren-Lawrence; MAP-hand, Measure of Activity 
Performance; MHQ, Michigan Hand Outcomes Questionnaire; MPUT, Moberg Picking Up Test; no., number; OA, 
osteoarthritis; OMFAQ, OARS (Older Americans’ Resources and Services) Multidimensional Functional Assessment 
Questionnaire; PIP, proximal interphalangeal joint; PRWHE, Patient-Rated Wrist/Hand Evaluation; RCT, randomized 
controlled trial; SACRAH, Score for Assessment and Quantification of Chronic Rheumatoid Affections of the Hands; 





The instruments that were used for assessment of the OMERACT core domains pain, 
physical function and patient global assessment in the 66 identified studies are specified 
in Table 2. Different instruments were applied, comprising twelve questionnaires, one 
interview and a number of rating scales (visual analogue scale (VAS), numeric rating scale 
(NRS) or Likert). Furthermore, nine different performance- or assessor-based measures 
were applied for assessment of physical function; pain was assessed by palpation, using 
the number of painful or tender joints, the Doyle index or Ritchie articular index.
The AUSCAN was most frequently applied (n = 34), followed by the VAS pain (n = 30), VAS 
global (n = 16), FIHOA (n = 14) and HAQ (n = 12). The AIMS-2 was applied in five studies, 
the Cochin scale and Score for Assessment and Quantification of Chronic Rheumatoid 
Affections of the Hands (SACRAH) in four studies, the Canadian Occupational Perfor-
mance Measure (COPM) in three studies and the Arthritis Self Efficacy Scale (ASES) in two 
studies. The Measure of Activity Performance (MAP-hand), MHQ, Older Americans’ Re-
sources and Services Multidimensional Functional Assessment Questionnaire (OMFAQ), 
Patient-Rated Wrist/Hand Evaluation (PRWHE) and Revel functional index were all used 
in only one study each.
Of the performance- or assessor-based measures, grip strength was applied most fre-
quently (n = 35), followed by pain or tenderness on palpation (n = 21). Other applied per-
formance- or assessor-based measures were pinch strength (n = 17), the grip ability test 
(GAT) (n = 4), Moberg Pickup Test (MPUT) (n = 3), Arthritis Hand Function Test (AHFT) (n 
= 2), evaluation of dexterity (n = 3), button test (n = 1), Hand Mobility in Scleroderma Test 
(HAMIS) (n = 1), Hand Functional Index (HFI) (n = 1) and the Jebsen-Taylor Hand Function 
Test (JTHFT) (n = 1). 
502331-L-bw-Visser
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Table 2. Instruments measuring pain, physical function or patient global assessment applied in the included studies




AIMS-216 Physical function 78 items, rated on 5 point scale. Transformed into 12 scales, 
score range 0 - 10 (worst possible). 1 scale for hand/finger 
function.
5
ASES89 Pain, physical 
function
20 items, scored 10 (very uncertain) – 100 (very certain to 
can do).
3 subscales: pain/function /other symptoms, scored by 
taking mean of subscale items (range 10-100).
2
AUSCAN14 Pain, physical 
function, global 
assessment
15 items, Likert (0, none - 4, extreme) / VAS version. 
Summed into 3 subscales: pain (Likert range 0-20 / VAS 
range 0-100), stiffness (0-4 / 0-100), function (0-36 / 0-100).
34
Cochin scale90 Physical function 18 items, rated on Likert scale (0, without difficulty – 5, 
impossible). Summed to final score, range 0-90.
4
COPM91 Physical function Interview on most important activities. Five most impor-
tant activities scored for performance /satisfaction (1-10). 
Subscale scores range 0 (not able to do/satisfied) – 10 
(extremely able to do/satisfied). 
3
FIHOA13 Physical function 10 items, range 0 (no difficulty) – 3(impossible). 
Total score range 0-30. Original, VAS, Likert version.
15
HAQ17 Physical function 20 items. Total score range 0 to 3 (higher score indicates 
poorer functioning).
12
MAP-hand92 Physical function 18 items, range 0 (no difficulty) – 4 (not able to do). 
Total mean score calculated.
1
MHQ15 Pain, physical 
function,
37 items, rated on 5 point Likert (1,very good – 5, very poor). 
Scores normalized to 0-100 scale.
1
OMFAQ93 Physical function 5 domains of functioning, scored 1 (excellent) – 6 (total 
impaired). Total score range 5-30. Physical / instrumental 
ADL scale.
1
PRWHE94 Physical function 15 item scale, rated on 0-10 NRS. Summed to subscales: 




Physical function 10 questions, rated 0 (without difficulty) – 2 (impossible). 
Total score range 0-20.
1
SACRAH96 Pain, physical 
function 
23 questions, rated on VAS scale. 3 domains: functional sta-
tus, stiffness, pain. Original, Short-Form, Modified version.
4





Used for assessment of pain, patient global assessment, 






Domain Specifications No. 
studies 
applied
Performance- or assessor-based instruments
AHFT18 Physical function 11-item test, 4 subscales: grip/pinch strength, dexterity, 
applied dexterity, applied strength. Score per subscale.
2
Button Test98 Physical function Unbutton and button 5 buttons, using a standard board. 
Score recorded in seconds.
1
Dexterity Physical function Assessed using dexterity/purdue pegboard 2
GAT99 Physical function Modification of Grip Function Test. 3 items, timed (sec) and 
summed to total GAT score. GAT score <20 sec = normal. 
4
Grip strength Physical function Measured in mmHg or in kg. 35
HAMIS100 Physical function 9 items rated 0 (no problems performing the motion) – 3 
(unable). Total score range 0-27
1
HFI101 Physical function 9 wrist/hand items from Keitel Function Test, measuring 
motion patterns. Items ranged 0 (no difficulties) – 3 (much 
difficulties).  Total score 0-52 (0-26 for each upper extremity)
1
JTHFT102 Physical function 7 items, timed in seconds. Summed to total score. 1
MPUT103 Physical function Picking up 10 items and placing in container, timed in 
seconds.
3
Pinch strength Physical function Measured in mmHg or in kg. 17
Tenderness/
Pain on palpa-
tion, Doyle104 / 
Ritchie articu-
lar index105
Pain Tenderness on palpation. 
Score range Doyle total 0-144, Doyle hand 0-72
Score range Ritchie articular index 0-60
21
AHFT, Arthritis hand function test; AIMS-2, Arthritis Impact Measurement Scale; ADL, activities of daily living; OARS, 
Older Americans’ Resources and Services; ASES, Arthritis Self Efficacy Scale; AUSCAN, Australian/Canadian Hand 
OA Index; COPM, Canadian Occupational Performance Measure; FIHOA, Functional Index for Hand OA; GAT, Grip 
ability test; HAQ, Health Assessment Questionnaire; HAMIS, Hand Mobility in Scleroderma Test; HFI, hand function-
al index; JTHFT, Jebsen-Taylor Hand Function Test; MAP-hand, Measure of Activity Performance; MHQ, Michigan 
Hand Outcomes Questionnaire; MPUT, Moberg Picking Up Test; NRS, numeric rating scale; OMFAQ, OARS (Older 
Americans’ Resources and Services) Multidimensional Functional Assessment Questionnaire; PRWHE, Patient-Rat-
ed Wrist/ Hand Evaluation; ROM, Range of motion; SACRAH, Score for Assessment and Quantification of Chronic 
Rheumatoid Affections of the Hands; VAS, Visual Analogue Scale.
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Table 3. Metric properties of instruments measuring pain, physical function or patient global assessment – reliability*
First author Relevant results
Questionnaires
AUSCAN Bellamy25 ICC (Likert / VAS):
- pain: 0.70 / 0.84









- pain: 0.80, 1.06
- function: 0.92, 0.80
- total: 0.87, 0.76
Cochin scale Poiraudeau36 Interrater ICC: 0.96
Poole37 ICC: 0.94
FIHOA Dreiser13 ICC: 0.95, mean difference 0.17 ± 1.64
Haugen30 ICC: 0.88
Moe34 ICC: 0.94, SDD 5.55
Poole37 ICC: 0.74
Wittoek43 ICC: 0.96 
Performance- or assessor-based instruments
Grip strength Myers35 Inter-/intra-observer ICC: range per hand 0.91-0.94 / 0.90-
0.92
Ziv44 SDD (right, left): 2.48, 1.94
Pinch strength Myers35 Inter-/intra-observer ICC: range per test/hand 0.87-0.94 / 
0.89-0.96
Ziv44 SDD (right, left): range per test 0.40-0.54, 0.42-0.63
Tenderness/pain on 
palpation
Bijsterbosch19 Inter-/intrarater ICC of Doyle index: 0.88 / range per rater 
0.94-0.97
Myers35 Inter-/intra-observer κ (% agreement): 0.64 / 0.69 (95 / 96)
* Only instruments assessed in ≥2 studies were included in this table.
AUSCAN, Australian/Canadian Hand OA Index; FIHOA, Functional Index for Hand; ICC, intraclass correlation coeffi-





The characteristics of the 66 included studies are described in Table 1. The source pop-
ulations were predominantly secondary care (n = 41), in addition to primary care (n = 
6), population-based (n = 6) and familial OA studies (n = 5). All studies included more 
women than men and the mean age was >50 years in almost all studies. Different study 
designs were included; 26 observational studies, 35 randomized controlled trials and four 
intervention studies.
Of the included studies, 25 studies primarily aimed at evaluation of metric properties 
of one or more instruments measuring pain, physical function or patient global assess-
ment.13,18,19,23-44 The remaining studies applied these instruments to evaluate the effect of a 
treatment or intervention (n = 37),45-81 or to evaluate disease course over time (n = 4).82-85
Metric properties of clinical outcome measures
Discrimination: Reliability
Only eleven studies provided data on measures of reliability, including seven instru-
ments.13,19,25,27,30,34-37,43,44 The FIHOA and AUSCAN were most frequently evaluated (see Ta-
ble 3). The AHFT and GAT were evaluated in only one study each.18,35 The reported meas-
ures of reliability of instruments that were assessed in at least two studies are listed in 
Table 3. 
In general, all evaluated instruments showed good measures of reliability. Three stud-
ies evaluated two questionnaires for assessment of physical function, enabling direct 
comparison of these measures.34,37 Haugen et al. reported excellent reliability for both 
the AUSCAN function subscale and FIHOA,30 Moe et al. reported the same in addition to 
comparable SDDs for both questionnaires.34 Poole et al. evaluated the FIHOA in addition 
to the Cochin scale, reporting the highest ICC for the Cochin scale.37
Performance- or assessor-based measures were assessed less frequent but showed good 
measures of reliability.
In summary, only two instruments (AUSCAN and FIHOA) were extensively tested, show-
ing excellent measures of reliability for both questionnaires. Other instruments, whilst 
showing good measures of reliability, had only been tested in one or two studies. There-
fore, only tentative conclusions can be drawn for these instruments.
Discrimination: Sensitivity to change
Of the 45 studies assessing change over time in pain, physical function or patient global 
assessment,25,26,29,36,42,45,47-85 seven studies did not demonstrate any significant change (one 
observational study, six RCTs).62,69,75,78-81 Six studies only observed a statistically significant 
change in pain or patient global assessment (one observational study, five RCTs),29,50,54,60,61,77 
and five studies only observed change in physical function (all RCTs).45,47,59,65,76
The studies that detected change in at least one instrument assessing the correspond-
ing domain are summarized in Table 4. The results of these studies regarding measured 
change over time are described in the online supplementary table.
Pain was most frequently assessed using the VAS or NRS, detecting change in 88% of 
these studies. Other applied instruments were the AUSCAN pain scale and pain/tender-
ness assessed on palpation, detecting change in 78 and 92% of the studies, respectively 
(see Table 4).29,36,48,49,52,54,56,61,72-74,83,84 The ASES pain scale was applied in only one study and 
therefore not included in the table.50 
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Physical function was most frequently assessed by measured grip strength, detecting 
change in 75% of these studies. Other commonly applied instruments were the AUSCAN 
function scale (82% detecting change), FIHOA (67% detecting change), HAQ (50% de-
tecting change) and grip strength (57% detecting change). The Cochin scale and VAS or 
NRS were less frequently used (see Table 4). The AIMS-2,67 COPM,59 dexterity,68 GAT,50 and 
MPUT77 were all assessed in only one study each. 
Patient global assessment was assessed using the VAS global, detecting change in 60% of 
these studies. The 40% that did not detect change over time did measure change in AUS-
CAN function, COPM or the number of tender joints. A few number of studies assessed 
change in patient global assessment using the AUSCAN total (see Table 4). 
In summary, the VAS pain was by far the most frequently applied instrument for assess-
ment of change over time of pain in hand OA, followed by the AUSCAN pain subscale and 
pain on palpation. For assessment of change of physical function, the AUSCAN function 
subscale, FIHOA and grip strength assessment were commonly used. Change in patient 
global assessment was most frequently evaluated using the VAS global. The majority 
of studies that reported change in pain, physical function or patient global assessment 
detected this change by all applied instruments assessing the corresponding domain, 
suggesting good sensitivity to change for all evaluated instruments.
Feasibility
The number of items of the different applied instruments is described in Table 2. Al-
though most of these instruments are available in the public domain, payment is required 
for use of the AUSCAN.
Only four of the included studies reported data on time needed to apply the used in-
struments.13,19,37,39 Two studies reported the completion time of a questionnaire: for com-
pletion of the modified SACRAH, a median of 95 seconds was measured (range 80-175 
seconds),39 and for completion of the FIHOA, a mean of 165 seconds (standard deviation 
(SD) 119 seconds, range 50-600) was measured in patients with painful OA whereas in-
active OA patients needed on average 136 seconds (SD 97 seconds, range 20-240).13 The 
other two studies reported the time required to administer one or two assessor-/perfor-
mance-based measures: for the Doyle index, a mean time of 5.1 minutes (range 2.4-7.8) 
was reported,19 and the AHFT and HAMIS were reported to require 20-25 and 5 minutes, 
respectively.37 
In summary, questionnaires took less time than assessor-/performance-based measures. 
The completion time of both assessed questionnaires was short, so both the FIHOA and 
modified SACRAH are highly feasible.
Validity
Eighteen studies correlated different instruments (mostly questionnaires), providing in-
formation on construct validity. The reported correlations between instruments assess-
ing either pain or physical function or patient global assessment are presented in Table 
5. Most of the studies (n = 16) reported cross-sectional correlations, whereas correlations 





Table 4. Metric properties of instruments measuring pain, physical function or patient global assessment - sensitiv-
ity to change.* Only studies demonstrating significant change in pain, physical function or patient global assess-
ment by at least one of the applied instruments are shown.
No. of studies reporting 
change in corresponding 
instrument
No. of studies not 
reporting change, 
discordant with other 
instruments assessing 
corresponding domain




AUSCAN function 5 25,45,48,55,58 2 47,59 71%
AUSCAN pain 6 25,29,55,58,61,77 2 48,60 75%
AUSCAN total 2 55,57 0 100%
Cochin scale 1 57 0 100%
FIHOA 6 26,49,51,53,64,72 3 25,36,48 67%
HAQ 3 51,56,73  3 55,59,76 50%
VAS/NRS pain 21 26,29,42,48,49,51,53-
58,60,61,64,66,67,70-72
3 36,73,77 88%
VAS global 6 29,42,55,61,72,76 4 45,52,56,59 60%
VAS/NRS function 2 42,63 0 100%
Performance- or assessor-based instruments
Grip strength 11 26,47,56,63,65,67,68,72,74,76 4 48,53,55,57 73%
Pinch strength 4 56,63,65,68 3 47,48,57 57%
Tenderness/pain on 
palpation
9 48,49,52,54,56,61,72-74 1 29 90%
Observational studies 
Patient reported instruments
AUSCAN function 4 82-85 0 100%
AUSCAN pain 4 82-85 1 50 80%
Cochin scale 1 36 0 100%
VAS pain 1 50 0 100%
Performance- or assessor-based measures:
Grip strength 1 84 0 100%
Tenderness/pain on 
palpation
3 36,83,84 0 100%
 * Only instruments assessed in ≥2 studies were included in this table.
AUSCAN, Australian/Canadian Hand OA Index; FIHOA, Functional Index for Hand OA; HAQ, Health Assessment 
Questionnaire; no., number; NRS, numeric rating scale; VAS, visual analogue scale.
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The AUSCAN, grip strength and FIHOA scores were compared with other outcome meas-
ures most frequently (see Table 5). Correlations of the ASES pain scale, COPM and MAP-
hand with other clinical outcome measures were evaluated in only one study,28 as were 
the JTHFT,41 Revel functional index,36 PRWHE,33 MHQ, HFI and HAMIS.37 These studies 
were therefore not included in Table 5.
Varying correlation coefficients were reported among the different studies. In general, 
correlations between different questionnaires were stronger than correlations of per-
formance-based measures with other performance-based measures or with question-
naires. Correlations between different instruments assessing physical function ranged 
from 0.52 to 0.89 between questionnaires, from 0.05 to 0.67 between questionnaires and 
performance-based measures and from 0.25 to 0.96 between performance-based meas-
ures. For assessment of pain, correlations between 0.55 and 0.81 were observed between 
questionnaires, and correlations between 0.47 and 0.65 between questionnaires and pain 
on palpation. However, only few correlation coefficients above 0.90 were observed, sug-
gesting that different instruments catch different aspects of the assessed domain.
Two of the three studies associating change over time by different instruments presented 
correlation coefficients, which were in line with the results described above.28,46 The third 
study calculated beta coefficients for the association of change of the AUSCAN and grip 
and pinch strength with global assessment of change, adjusted for age, gender, number 
of osteoarthritic hand joints and time between assessments. The strongest association 
with global assessment of change was observed for the AUSCAN.23
In summary, construct validity of various instruments measuring pain, physical function 
or patient global assessment has been assessed in multiple cross-sectional studies but 
only few longitudinal data are available. Moderate to good correlations were observed, 
especially between questionnaires, suggesting good construct validity. 
Table 6 summarizes the available information of metric properties per domain for the six 
most frequently applied instruments for assessment of pain, physical function and patient 
global assessment. Information of metric properties was considered established when sup-
porting results were observed in at least three studies. The non-availability of the AUSCAN 




Table 5. Metric properties of instruments measuring pain, physical function or patient global assessment – validi-
ty.* Correlations between different instruments as observed in cross-sectional and longitudinal studies are shown.
First author Correlation with:
Cross-sectional studies
Questionnaires 
AIMS-2 MacIntyre32 - Dexterity small/large objects: r range per item 0.23 to 0.40 / 0.14 to 
0.31#
- Grip strength: r range per item -0.23 to -0.37#
Moe34 AIMS-2 physical / arm / hand:
- AUSCAN function: r 0.83 / 0.70 / 0.77***
- FIHOA: r 0.80 / 0.71 / 0.69***
AUSCAN function Stamm41 - JTHFT: r 0.67****
Allen24 - Grip strength right, left: r -0.42,-0.40***
- Pinch strength right, left: r -0.23,-0.16***
Bellamy25 Likert, VAS:
- Global function (0-4): r 0.72, 0.74**
- FIHOA (original): r 0.78, 0.86**- HAQ: r 0.65, 0.68**
- Grip strength: r -0.39, -0.45**
- Pinch grip: r -0.31, -0.36**
Dziedzic27 - GAT: r 0.54**
- Grip strength: r -0.56**
- Pinch strength: r -0.60**
Fernandes28 - MAP-hand: r 0.76#
Moe34 - AIMS-2 physical: r 0.83, arm: r 0.70, hand: r 0.77***
- FIHOA: r 0.88***
- HAQ: r 0.80***
- Grip strength: r -0.62***
- MPUT right, left: r 0.58,0.63***
Sautner40 - VAS global: r 0.55****
Stamm41 - JTHFT: r 0.386****
Wittoek43 - FIHOA: r 0.81***
AUSCAN pain Allen24 - Pain severity right, left: r 0.58,0.55***
Bellamy25 Likert, VAS:
- Global pain (0-4): r 0.57, 0.64**
- HAQ pain: r 0.57, 0.66**
- Doyle: r 0.56, 0.47**
Bijsterbosch19 - Doyle hand, total: r 0.65, 0.61***
Moe34 - VAS pain: r 0.77***
Wittoek43 - VAS pain: r 0.79***
Cochin scale Poiraudeau36 - FIHOA: r 0.87#
- Revel functional index: r 0.86
- VAS handicap: r 0.67
Poole37 - FIHOA: r 0.89**
- MHQ: r -0.82**
- AHFT: r range per item -0.64 to 0.57**




First author Correlation with:
Stamm41 - JTHFT: r 0.369**
FIHOA Bellamy25 Original / Likert / VAS:
- AUSCAN function (Likert, VAS): r 0.78, 0.86 / 0.80, 0.85 / 0.80, 0.88**
Moe34 - AIMS-2 physical / arm / hand: r 0.80 / 0.71 / 0.69***
- AUSCAN function: r 0.88***
- HAQ: r 0.73***
- Grip strength: r -0.5***
- MPUT right / left: r 0.55 / 0.59***
Poiraudeau36 - Cochin scale: r 0.87#
Poole37 - Cochin: r 0.89**
- MHQ: r -0.86**
- AHFT: r range per item -0.57 to 0.46**
- HFI: r 0.53, HAMIS: r  0.50**
Stamm41 - JTHFT: r 0.387****
Wittoek43 - AUSCAN function: r 0.81***
HAQ Bellamy25 - AUSCAN function (Likert, VAS): r 0.65, 0.68**
Fernandes28 Modified HAQ with MAP-hand: r 0.46#
Moe34 - AUSCAN function: r 0.80***
- FIHOA: r 0.73***
Stamm41 - JTHFT: r 0.424****
SACRAH Rintelen38 Short Form-SACRAH with Modified-SACRAH: r 0.699***
Sautner39 Modified-SACRAH: 
- SACRAH: r 0.978 (range subscales 0.912-0.958)****
- VAS global: r 0.64****
Sautner40 Modified-SACRAH function / total with VAS global: r 0.55 / 0.65****
Stamm41 SACRAH / M-SACRAH:
- JTHFT: r 0.436 (range per scale 0.371-0.437) / 0.388****
VAS global Sautner39 - Modified-SACRAH: r 0.64****
Sautner40 - Function AUSCAN / modified-SACRAH: r 0.55 / 0.55****
- Pain AUSCAN / modified-SACRAH: r 0.59 / 0.56****
- Total modified-SACRAH: r 0.65****
VAS pain Moe34 - AUSCAN pain: r 0.77***
Wittoek43 - AUSCAN pain: r 0.79***
Performance- or assessor-based instruments
AHFT Backman18 - OMFAQ instrumental ADL scale: range per item r -0.75 to 0.75***
- OMFAQ physical ADL scale: range per item r -0.67 to 0.68***
Poole37 - Cochin scale: r range per item -0.64 to 0.57**
- FIHOA: r range per item -0.57 to 0.46**
- MHQ: r range per item -0.48 to 0.65**
Dexterity MacIntyre32 Large / small objects:





First author Correlation with:
MacIntyre33 Large / small objects:
- Grip strength: r -0.32 (range digits -0.25 to -0.30) / -0.28 (-0.10 to -0.41)#
- Pinch (tripod, narrow, wide key): r -0.37, -0.30, -0.34 / -0.34, -0.25, -0.25#
GAT Dziedzic27 - AUSCAN function: r 0.54**
Fernandes28 - MAP-hand: r 0.43#
Grip strength Allen24 - AUSCAN function (right, left): r -0.42,-0.40***
Bellamy25 - AUSCAN function (Likert, VAS): r -0.39, -0.45**
Dziedzic27 - AUSCAN function: r -0.56**
Fernandes28 - MAP-hand: r -0.32#
MacIntyre32 - AIMS-2: r range per item -0.23 to -0.37#
MacIntyre33 - PRWHE activities: r -0.23#
- Dexterity large: r - 0.32, small: -0.28#
- Pinch strength (range per test): r 0.76 to 0.78#
Moe34 - AUSCAN function: r -0.62***
- FIHOA: r -0.50***
Stamm41 - JTHFT:  r -0.395****
MPUT Moe34 - AUSCAN function (right, left): r 0.58, 0.63***
- FIHOA (right, left): r 0.55, 0.59***
Stamm41 - JTHFT:  r 0.690****
Pinch strength Allen24 - AUSCAN function (right, left): r -0.23, -0.16***
Bellamy25 - AUSCAN function (Likert, VAS): r -0.31, -0.36**
Dziedzic27 - AUSCAN function: r -0.60**
MacIntyre33 - PRWHE activities (range per test): r -0.22 to -0.26#
- Dexterity (range per test) large: r -0.30 to -0.37, small: r -0.25 to -0.34#
- Grip strength (range per test): r 0.75 to 0.96#
Tenderness/pain 
on palpation
Bellamy25 Doyle with AUSCAN (Likert, VAS) pain: r 0.56, 0.47**
Bijsterbosch19 Doyle hand / total with AUSCAN pain: r 0.65 / 0.61***
Longitudinal studies
Questionnaires 
AUSCAN total Allen23 Association global assessment of change (right, left) with AUSCAN total: β 
0.29, 0.27 (P < 0.001). Stronger among greater radiographic OA severity.
AUSCAN function Fernandes28 - Change MAP-hand: r 0.52#
AUSCAN pain Barthel46 - Change VAS pain: r 0.81***
VAS global Barthel46 - Change AUSCAN function: r 0.71***, pain: r 0.75***
- Change VAS pain: r 0.76***
VAS pain Barthel46 - Change AUSCAN pain: r 0.81***
Performance- or assessor-based instruments
GAT Fernandes28 - Change MAP-hand: r 0.06#
Grip strength Allen23 - Global assessment of change (right, left): β -0.16, -0.13 (P 0.003, 0.015)
Stronger associations among greater radiographic OA severity.




First author Correlation with:
Pinch strength Allen23 - Global assessment of change (right, left): β -0.13, -0.11 (P 0.022, 0.060)
Stronger associations among greater radiographic OA severity.
* Only instruments assessed in ≥2 studies were included in this table.
# No p-values provided. ** p-value < 0.05. *** p-value < 0.001. **** p-value < 0.0001.
AHFT, Arthritis hand function test; AIMS-2, Arthritis Impact Measurement Scale; ADL, activities of daily living; ASES, 
Arthritis Self Efficacy Scale; AUSCAN, Australian/Canadian Hand OA Index; β, beta coefficient; CI, confidence inter-
val; COPM, Canadian Occupational Performance Measure; FIHOA, Functional Index for Hand OA; GAT, Grip ability 
test; HAQ, Health Assessment Questionnaire; JTHFT, Jebsen-Taylor Hand Function Test; MPUT, Moberg Picking Up 
Test; P, p-value; r, correlation coefficient; SACRAH, Score for Assessment and Quantification of Chronic Rheumatoid 
Affections of the Hands; VAS, Visual Analogue Scale.
Table 6. Available information of metric properties from at least 3 studies for the most frequently applied instru-
ments (in at least 15 clinical studies) for evaluation of pain, physical function or patient global assessment




AUSCAN + + - # +
FIHOA + + +** +
VAS pain + +
Performance- or assessor-based instruments
Grip strength +* + +




+ = established evidence
* supporting evidence in only 2 studies
** supporting evidence in only 1 study
# not available in public domain





The most frequently applied and evaluated instruments for assessment of pain were the 
AUSCAN pain subscale, VAS pain and pain on palpation. The AUSCAN function subscale, 
FIHOA and grip and pinch strength were most frequently applied and evaluated for as-
sessment of physical function. Patient global assessment was most frequently evaluated 
using the VAS global.
In the description of discrimination, the reliability of the AUSCAN and FIHOA were found 
to be extensively tested and shown to be excellent. The reliability of other instruments 
was suggested to be good, but only scarce evidence was available. 
The VAS pain was by far the most commonly used instrument for assessment of change 
of pain, followed by the AUSCAN pain subscale and pain on palpation. The AUSCAN func-
tion subscale, FIHOA and assessment of grip and pinch strength were regularly applied 
for assessment of change of physical function. Change of patient global assessment was 
most often evaluated by the VAS global. The majority of studies detected change by all 
used instruments, suggesting good sensitivity to change for the evaluated instruments. 
Change in pain was detected most frequently by the VAS pain or pain on palpation, 
whereas change in physical function was detected most frequently by the AUSCAN func-
tion subscale or measured grip strength. 
In the description of feasibility, only few studies reported on time needed to perform 
instruments. Questionnaires took less time than performance-based measures. Of the 
frequently applied instruments, only the FIHOA was evaluated and seemed feasible. This 
is supported by the availability of this questionnaire in the public domain, in contrast with 
the AUSCAN.  
For the description of validity, numerous cross-sectional studies assessed correlations 
between various instruments but only few longitudinal data was available. The strongest 
correlations were reported between different questionnaires assessing pain or physical 
function. Remarkably, the VAS pain, as one of the most frequently applied instruments, 
was evaluated in only a limited number of studies.
For further evaluation of validity, comparison to an external standard should be per-
formed. However, no external standards for evaluation of pain, physical function and 
patient global assessment have been agreed upon, perhaps due to varying definitions 
and measurement of these concepts. For assessment of physical function, observation of 
the performance of tasks as described by specific instruments assessing physical function 
may be useful in the evaluation of validity of these instruments.86 
Based on this review, it is not possible to decide on one instrument that should be recom-
mended for measurement of pain, physical function or patient global assessment in hand 
OA research. Although no major differences regarding metric properties of the evaluated 
instruments were observed, the amount of supporting evidence varied extensively be-
tween the instruments. 
Before consensus can be reached on which instruments should be applied, some as-
pects need further investigation. The reliability of especially the VAS pain, grip and pinch 
strength and pain on palpation needs to be further established in a variety of popula-
tions. Regarding the sensitivity to change, the minimal clinical important difference of 
instruments needs to be determined. Only for the AUSCAN a minimal clinically important 
improvement has been proposed.87 Validity of instruments assessing physical function 
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should be further investigated by comparing these instruments to an external stand-
ard. Furthermore, future research should evaluate instruments within specific subtypes 
of hand OA. 
This study has some limitations. We intended to include as many available studies as 
possible that provided information on instruments and their metric properties, not only 
studies that actually aimed at evaluating this. Because of the large heterogeneity across 
studies regarding their purpose (primarily aiming at evaluation instruments or applying 
instruments for other primary aims) and study design, the methodological quality of the 
included studies was not assessed. Furthermore, the heterogeneity did not enable pool-
ing of data into a meta-analysis and addressing the presence of publication bias. 
Limitations regarding the literature search are the included databases, restriction to Eng-
lish language and exclusion of abstracts and unpublished results.
Within all studies assessing the VAS pain or VAS global, different questions were used. 
The individual questions were observed to be highly variable, especially regarding the 
type of pain (global pain, overall disease severity, intensity, not specified) and time set-
tings (last 24 or 48 hours, two days, two weeks, not specified). In future research this 
phrasing should be standardized. Furthermore, the VAS pain score has been shown to 
be influenced by the information on the disease and its consequences that is given to 
patients when determining the VAS,88 which could not be addressed due to lack of  infor-
mation on this topic in the included studies. However, future studies evaluating the VAS 
should take the effect of patient information into account.
In conclusion, our systematic literature review provides an overview of the instruments 
that are used for measurement of pain, physical function and patient global assessment 
in hand OA. Most information on the metric properties of these instruments was available 
for the questionnaires AUSCAN (assessing pain and function), FIHOA (assessing function) 
and VAS pain, and for the performance- or assessor-based instruments grip and pinch 
strength and pain on palpation. To enhance comparability across future studies in hand 
OA, consensus has to be reached on recommended instruments for measurement of 
pain, physical function and patient global assessment in hand OA. More research has to 
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Supplementary table. Results of the studies that detected change in at least one instrument evaluating either 
pain or physical function of patient global assessment*
First author Relevant results
Questionnaires
AUSCAN function Altman45 Mean change intervention: 26.5, control: 19.2 (P 0.017)
Bellamy25 Mean change (Likert, VAS): -0.32 (p 0.001), -8.97 (P 0.001)
Average SRM (Likert, VAS): -0.67, -0.76
Bijsterbosch82 Mean change (95%CI): 2.1 (1.3-2.9)
Percentage change: 50% increased limitations, 26% decreased
Botha-Scheepers83 Mean change (95%CI): 1.4 (0.5, 2.3), SRM: 0.23
Percentage change:  53% increased,  12% no change, 36% decrease
Brosseau47 No significant change (in contrast with grip strength)
Dilek48 Median change intervention: -1.65 (P < 0.016), control no significant 
change.
Grifka55 Mean change intervention (1/2) vs control: -4.3 / -6.0 vs -3.1 (P < 0.01)
Haugen84 Mean change 1.2, SD 6.3
Keen58 Mean change: 159.5 (P < 0.05)
Kjeken59 No significant change (in contrast with COPM)
Marshall85 Increase: range 1-3 in symptomatic OA patients
AUSCAN pain Bellamy25 Mean change (Likert, VAS): -0.34 (P 0.001), -6.46 (P 0.003)
Average SRM (Likert, VAS):  -0.71, -0.84
Bijsterbosch82 Mean change (95%CI): 0.7 (0.3, 1.2)
Percentage change: 40% increased, 26% decreased
Botha-Scheepers83 Mean change (95%CI): 1.0 (0.4, 1.6), SRM: 0.25
Percentage change:  50% increased,  20% no change, 30% decrease
Dilek48 No significant change (in contrast with VAS pain)
Dziedzic50 No significant change (in contrast with ASES pain, average pain)
Grifka55 Mean change intervention (1/2) vs control: -3.0 / -3.9 vs -2.1 (P < 0.01)
Haugen29 Mean change intervention: -20.5, control: -6.2 (P 0.012), SRM 0.68
Haugen84 Mean change 0.8, SD 3.4
Keen58 Mean change: -117.5 (P < 0.05)
Kovacs60 No significant change (in contrast with VAS pain)
Kvien61 Mean change intervention vs control: -20.5 vs -6.2 (P 0.012)
Marshall85 Increase: range 0.5-1.5 in symptomatic OA patients
Stange-Rezende77 Mean change intervention: 0.62, control: -0.33 (P 0.034)
AUSCAN total Grifka55 Mean change intervention (1/2) vs control: -7.7 / -10.5 vs -5.6 (P < 
0.005)
Kanat57 Total: mean change intervention: -17, control: -2 (P < 0.001)
Cochin scale Kanat57 Mean change intervention: -12, control: -2 (P < 0.001)
Poiraudeau36 Mean change: -2.35, SRM: -0.26, effect size: -0.17
FIHOA Bellamy25 No significant change (in contrast with AUSCAN function)
SRM (original, Likert, VAS): -0.31, -0.28, -0.27
Dilek48 No significant change (in contrast with AUSCAN function)
Dreiser49 Mean change intervention: -5.7, control: -2.8 (P 0.005)




First author Relevant results
Fioravanti51 Intervention decreased, control no change (P < 0.001)
Gabay53 Mean change intervention: -2.9, control: -0.7 (P 0.008)
Myrer64 Mean change intervention: 3.42 (P < 0.05), control no significant 
change
Poiraudeau36 No significant change (in contrast with Cochin scale)
SRM: -0.03, effect size:-0.02
Saviola72 Mean change intervention 1 (1/2 year): -51/-41% (P 0.026), interven-
tion 2 no significant change.
HAQ Fioravanti51 Mean change intervention: -0.30, control: -0.02 (P < 0.001)
Grifka55 No significant change (in contrast with AUSCAN function)
Horvath56 Mean change intervention 2: -0.5, control: -0.1 (P < 0.01), intervention 
1 no significant change.
Kjeken59 No significant change (in contrast with COPM)
Schnitzer73 Mean change intervention: 1.5, control: 0.09 (p-value not specified)
Stamm76 No significant difference (in contrast with grip strength)
VAS/NRS pain Dilek48 Pain rest: median change intervention: -3.00, control no change (P 
0.01) Pain ADL no significant different change
Dreiser49 VAS pain: mean change intervention: -37.6, control: -16.5 (P 0.001)
No. joints pain movement grade 4/5: mean change intervention: -24, 
control: -13 (P 0.009)
Dreiser26 Mean change: -19.5, SRM: 0.87
Dziedzic50 Average pain severity (0-10): mean difference between intervention 2 
and control: 0.53. No difference between intervention 1 and control
Fioravanti51 Intervention reduced, control no change (P < 0.001)
Gabay53 Mean change intervention: -20.0, control: -11.3 (P 0.016)
Garfinkel54 Pain during activity: mean change intervention: -4.29, control: -1.00 
(P < 0.01). No significant change in pain at rest
Grifka55 Mean change intervention 1/2: -28.0 / -30.0, control: -19.3 (P < 0.001)
Haugen29 Mean change intervention: -23.5, control: -6.3 (P 0.005), SRM: 0.77
Horvath56 Mean change intervention 1/2 vs control: 
- pain rest: -28.9 / -21.5 (P < 0.05) vs no significant change
- pain exertion: -28.2 / -23.2 (P < 0.05) vs no significant change
Kanat57 Pain rest/motion (1-10): mean change intervention: -4 / -7, control no 
change (P < 0.001)
Keen58 Mean change most painful:-36.0, all joints:-36.0, global:-39.0 (P < 
0.001)
Kovacs60 Mean change intervention: -35.7, control: -10.5 (P 0.002) 
Kvien61 Mean change intervention: -23.5, control: -6.3 (P 0.005)
Myrer64 Pain rest/movement: mean change intervention: 21.8 / 29.8 (P < 0.05), 
control no significant change
Poiraudeau36 No significant change (in contrast with no. tender joints)
SRM: -0.10, effect size: -0.12
Reeves66 Pain movement: mean change intervention:-1.89, control:-0.62 (P 
0.027). No significant change in pain rest/grip





First author Relevant results
Rothacker70 Pain (0-5) decrease after 45 min intervention > control (P 0.046). 
Intervention vs control: time to pain peak relief 31 vs 48 min (P 0.018)
Rothacker71 Pain (0-5): mean change intervention: -1.3, control: -0.8 (P 0.026) 
Saviola72 Mean change intervention 1 (1/2 year): -54/-46% (P 0.001), interven-
tion 2 (1 year): 26% (P 0.018)
Schnitzer73 No significant change (in contrast with no. tender joints)
Stange-Rezende77 No significant change (in contrast with AUSCAN pain)
Tubach42 MCII (95%CI) absolute / relative improvement: 16 (13-19) / 23 (20-25), 
PASS: 41 (38-43)
VAS global Altman45 No significant change (in contrast with AUSCAN function)
Flynn52 No significant change (in contrast with no. tender joints)
Grifka55 Mean change intervention (1/2): -16.3 / -20.9, control: -9.4 (P < 0.001)
Haugen29 Mean change intervention: 23.4, control: -4.6 (P 0.001), SRM: 0.92
Horvath56 No significant change (in contrast with VAS pain, HAQ, grip/pinch 
strength, no. tender joints)
Kjeken59 No significant change (in contrast with COPM)
Kvien61 Mean change intervention: -23.4, control: -4.6 (P 0.001)
Saviola72 Mean change intervention 1 (1/2 year): 50/70 (P 0.021), intervention 2 
(1year): 10 (P < 0.001)
Stamm76 Intervention: 65% improvement, control: 20% improvement (P < 0.05)




Moratz63 Mean change disability score: -0.5 (P < 0.05)
Tubach42 VAS functional disability: MCII (95%CI) absolute / relative improve-
ment: 12 (9-14) / 18 (16-20), PASS: 42 (38-46) 
Performance- or assessor-based instruments
Grip strength Brosseau47 Improvement in intervention group (P 0.041)
Dilek48 No significant change (in contrast with AUSCAN function)
Dreiser26 Mean change: 4.9, SRM: 0.22
Gabay53 No significant change (in contrast with FIHOA)
Grifka55 No significant change (in contrast with VAS, AUSCAN)
Haugen84 Mean change (SD) right: -0.7 (6.9), left: -1.1 (6.9)
Horvath56 Mean change intervention (1 / 2) vs control: right hand 3.8 / 3.5 vs -0.1 
(P < 0.05 / not significant). Left hand not significant different.
Kanat57 No significant change (in contrast with Cochin scale)
Moratz63 Minimal improvement (3 lb)
Pastinen65 Change intervention vs control group: 118 vs 91% (P 0.014)
Rogers67 Mean change: isotonic strength 1.94 (p<0.0003), max. isometric right/
left 3.62 (P < 0.002) / 2.95 (P < 0.0005) 





First author Relevant results
Saviola72 Mean change intervention 1 (1/2 year):  right 25/25%, left 22/20%  
(P < 0.05), intervention 2 (1 year) no significant change
Schnitzer73 Mean change intervention: 32%, control: 3% (P 0.046)
Seiler74 Mean change intervention: 21.82 (18%), control: 6.58 (6%) (P < 0.05)
Stamm76 Mean change right/left intervention: 0.12/0.11, control: 0.03/0.03 (P < 
0.0005) 
Pinch strength Brosseau47 No significant change (in contrast with grip strength)
Dilek48 No significant change (in contrast with AUSCAN function)
Horvath56 Mean change intervention (1 / 2) vs control: right hand 0.6 / 0.7 vs 0.1 
(not significant / P < 0.05). Left hand not significant different.
Kanat57 No significant change (in contrast with Cochin scale)
Moratz63 Minimal improvement (3 lb)
Pastinen65 Change intervention vs control group: 118 vs 98% (P 0.018)




Botha-Scheepers83 Pain intensity score: mean change 4.2 (95%CI 3.2, 5.1), SRM: 0.67, 
increase / no change / decrease: 74 / 11 / 15%
Dilek48 No. painful joints: median change intervention: -4 (P < 0.016), control 
no significant change. No significant change in no. tender joints
Dreiser49 No. painful joints: mean change intervention: -19, control: -10 (P 
<0.001)
Flynn52 No. tender joints: mean change intervention 1: -1.0, control: -0.7 (P 
0.02) No significant change intervention 2
Garfinkel54 Tenderness right/left: mean change intervention: 2.20/2.14, control: 
0.40/0.41 (P < 0.01)
Haugen29 No. tender joints: mean change intervention: -4.8, control: -2.5 (P 
0.084) SRM: 0.46
Haugen84 Mean change -2, range -5 to 1
Horvath56 No. tender joints: mean change intervention 1/2: -4.2 / -5.1, control: 
-0.4 (P < 0.01)
Kvien61 No. tender joints: mean change intervention: -5.0, control: -2.6 (P 
0.083)
Poiraudeau36 Tenderness: mean change 1.68, SRM: 0.35, effect size: 0.22
Saviola72 No. tender joints: mean change intervention 1 (1/2 year): -83/-50% 
(P 0.011), intervention 2 (1 year) no significant change.
Schnitzer73 Tenderness: mean change intervention: 21.7%, control: 1.2% (P 0.02)
Seiler74 Mean change intervention vs control:
- No. of painful joints: -2.45 (43%) / -0.05 (1%) ( P < 0.05)
- Pain index: -6.09 (60%) / - 4.10 (30%) (P < 0.05)
* Only instruments assessed in ≥2 studies were included. 
AUSCAN, Australian/Canadian Hand OA Index; CI, confidence interval; FIHOA, Functional Index for Hand OA; HAQ, 
Health Assessment Questionnaire; MCII, minimum clinically important improvement; no., number; OA, osteoarthri-
tis; P, p-value; PASS, patient acceptable symptom state; SRM, standardized response mean; VAS, Visual Analogue 




OVERVIEW OF LITERATURE SEARCH PER DATABASE
Total d.d. 20-01-2014:   2244 references, extracted from the following 
    databases:
• PubMed:   1843
• MEDLINE:   840, of which 0 unique
• Embase:    870, of which 317 unique
• Web of Science:   344, of which 38 unique
• COCHRANE:   197, of which 101 unique
• CINAHL:   149, of which 41 unique
• Academic Search Premier:  53, of which 11 unique
• ScienceDirect:   80, of which 17 unique
PubMed
(“hand osteoarthritis” OR  “osteoarthritis hand” OR “thumb osteoarthritis” OR “finger os-
teoarthritis” OR “hand oa” OR “finger oa” OR ((“Hand Joints”[mesh] OR “Hand”[mesh] OR 
“Hand Bones”[mesh] OR “Hand Joints” OR “Hand Joint” OR “Carpal Joints” OR “Carpal 
Joint” OR “Carpometacarpal Joints” OR “Carpometacarpal Joint” OR “Finger Joint” OR “Fin-
ger Joints” OR “Metacarpophalangeal Joint” OR “Metacarpophalangeal Joints” OR “Volar 
Plate” OR “Wrist Joint” OR “Wrist Joints” OR “Triangular Fibrocartilage” OR “Intermetacarpal 
Joints” OR Hand OR Hands OR Finger OR Fingers OR Thumb OR Thumbs OR Metacarpus 
OR Metacarpal OR Wrist OR Wrists OR “Metacarpal Bones” OR “Metacarpal Bone”) AND 
(“Osteoarthritis”[Mesh] OR Osteoarthritis OR Osteoarthrit* OR Osteoarthritides OR Oste-
oarthrosis[tiab] OR Osteoarthroses OR “Degenerative Arthritis” OR “Osteoarthrosis Defor-
mans” OR OA[tiab]))) AND (“Treatment Outcome”[mesh] OR “Outcome Assessment (Health 
Care)”[Mesh] OR outcome[all fields] OR outcomes[all fields] OR “Severity of Illness Index-
”[mesh] OR “Patient Acuity”[mesh] OR “Health Status Indicators”[Mesh] OR “Pain Meas-
urement”[Mesh] OR “pain measurement”[all fields] OR “Pain Measurements”[all fields] OR 
“Pain Assessments”[all fields] OR “Pain Assessment”[all fields] OR “McGill Pain Question-
naire”[all fields] OR “McGill Pain Scale”[all fields] OR “Visual Analog Pain Scale”[all fields] 
OR “Visual Analogue Pain Scale”[all fields] OR “Pain Scale”[all fields] OR “Pain Scales”[all 
fields] OR “self reported pain”[all fields] OR (“Self Report”[Mesh] AND (“Pain”[mesh] OR 
pain[all fields])) OR “Diagnostic Self Evaluation”[mesh] OR “patient global”[all fields] OR 
“Muscle Strength”[mesh] OR “Hand Strength”[mesh] OR “Pinch Strength”[mesh] OR “Mus-
cle Strength”[all fields] OR “Hand Strength”[all fields] OR “Pinch Strength”[all fields] OR 
“grip strength”[all fields] OR grip[all fields] OR grasp[all fields] OR pinch[all fields] OR 
gripping[all fields] OR grasping[all fields] OR pinching[all fields] OR pinches[all fields] OR 
“Quality of Life”[mesh] OR “quality of life”[all fields] OR “qol”[all fields] OR “Measurements 
of hand function”[all fields] OR “Measurement of hand function”[all fields] OR “Arthritis 
Hand Function Test”[all fields] OR “AHFT”[tw] OR “Grip Ability Test”[all fields] OR “GAT”[tw] 
OR “Jebsen Hand Function Test”[all fields] OR “JHFT”[tw] OR “Jebsen-Taylor test”[all fields] 
OR “Pick-up test”[all fields] OR “pickup test”[all fields] OR “Pegboard test”[all fields] OR 
“Australian Canadian Osteoarthritis Hand Index”[all fields] OR “AUSCAN”[all fields] OR 
“Functional Index for Hand Osteoarthritis”[all fields] OR “FIHOA”[all fields] OR “Michi-
gan Hand Outcomes Questionnaire”[all fields] OR “MHQ”[tw] OR “Cochin hand function 
scale”[all fields] OR “Dreiser index”[all fields] OR “Disabilities of the ARM, Shoulder and 
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Hand”[all fields] OR “DASH”[tw] OR “Hand/Upper Extremity Function Scale”[all fields] OR 
“Health Assessment Questionnaire”[all fields] OR “HAQ”[tw] OR “Arthritis Impact Meas-
urement Scale”[all fields] OR “AIMS”[tw] OR (strength AND (grip OR pinch)) OR dexterity 
OR stiffness OR “Visual Analogue Scale”[all fields] OR “Visual Analog Scale”[all fields] OR 
“VAS”[tw] OR”Doyle index”[all fields] OR ((pain OR tenderness) AND (self report OR assess-
ment OR measurement)) OR “hand function” OR “hand functions” OR “hand functioning” 
OR “hand dysfunction” OR “hand dysfunctions” OR “hand dysfunctioning” OR “self report” 
OR selfreport* OR “Self Report”[Mesh])
MEDLINE
(“hand osteoarthritis”.ti OR “osteoarthritis hand”.ti OR “thumb osteoarthritis”.ti OR “finger 
osteoarthritis”.ti OR “hand oa”.ti OR “finger oa”.ti OR ((exp *”Hand Joints” OR exp *”Hand”/ 
OR exp *”Hand Bones”/ OR Hand.ti OR Carpal.ti OR Carpometacarpal.ti OR Finger.ti OR 
Metacarpophalangeal.ti OR Wrist.ti OR Intermetacarpal.ti OR Hands.ti OR Fingers.ti OR 
Thumb.ti OR Thumbs.ti OR Metacarpus.ti OR Metacarpal.ti OR Wrists.ti) AND (exp *”Oste-
oarthritis”/ OR Osteoarthritis.ti OR Osteoarthrit*.ti OR Osteoarthrosis.ti OR Osteoarthroses.
ti OR “Degenerative Arthritis”.ti OR “Osteoarthrosis Deformans”.ti OR OA.ti))) AND (exp 
“Treatment Outcome”/ OR exp “Outcome Assessment (Health Care)”/ OR outcome.mp OR 
outcomes.mp OR exp “Severity of Illness Index”/ OR exp “Patient Acuity”/ OR exp “Health 
Status Indicators”/ OR exp “Pain Measurement”/ OR “pain measurement”.mp OR “Pain 
Measurements”.mp OR “Pain Assessments”.mp OR “Pain Assessment”.mp OR “McGill Pain 
Questionnaire”.mp OR “McGill Pain Scale”.mp OR “Visual Analog Pain Scale”.mp OR “Visual 
Analogue Pain Scale”.mp OR “Pain Scale”.mp OR “Pain Scales”.mp OR “self reported pain”.
mp OR (exp “Self Report”/ AND (exp “Pain”/ OR pain.mp)) OR exp “Diagnostic Self Evalua-
tion”/ OR “patient global”.mp OR exp “Muscle Strength”/ OR exp “Hand Strength”/ OR exp 
“Pinch Strength”/ OR “Muscle Strength”.mp OR “Hand Strength”.mp OR “Pinch Strength”.
mp OR “grip strength”.mp OR grip.mp OR grasp.mp OR pinch.mp OR gripping.mp OR 
grasping.mp OR pinching.mp OR pinches.mp OR exp “Quality of Life”/ OR “quality of life”.
mp OR “qol”.mp OR “Measurements of hand function”.mp OR “Measurement of hand 
function”.mp OR “Arthritis Hand Function Test”.mp OR “AHFT”.mp OR “Grip Ability Test”.
mp OR “GAT”.mp OR “Jebsen Hand Function Test”.mp OR “JHFT”.mp OR “Jebsen-Taylor 
test”.mp OR “Pick-up test”.mp OR “pickup test”.mp OR “Pegboard test”.mp OR “Australian 
Canadian Osteoarthritis Hand Index”.mp OR “AUSCAN”.mp OR “Functional Index for Hand 
Osteoarthritis”.mp OR “FIHOA”.mp OR “Michigan Hand Outcomes Questionnaire”.mp OR 
“MHQ”.mp OR “Cochin hand function scale”.mp OR “Dreiser index”.mp OR “Disabilities of 
the ARM, Shoulder and Hand”.mp OR “DASH”.mp OR “Hand/Upper Extremity Function 
Scale”.mp OR “Health Assessment Questionnaire”.mp OR “HAQ”.mp OR “Arthritis Impact 
Measurement Scale”.mp OR “AIMS”.mp OR (strength AND (grip OR pinch)).mp OR dex-
terity.mp OR stiffness.mp OR “Visual Analogue Scale”.mp OR “Visual Analog Scale”.mp OR 
“VAS”.mp OR “Doyle index”.mp OR ((pain OR tenderness) AND (self report OR assessment 
OR measurement)).mp OR “hand function”.mp OR “hand functions”.mp OR “hand func-
tioning”.mp OR “hand dysfunction”.mp OR “hand dysfunctions”.mp OR “hand dysfunction-





(“hand osteoarthritis”.ti OR “osteoarthritis hand”.ti OR “thumb osteoarthritis”.ti OR “finger 
osteoarthritis”.ti OR “hand oa”.ti OR “finger oa”.ti OR ((exp *Hand/ OR exp *Hand Bone/ 
OR Hand.ti OR Carpal.ti OR Carpometacarpal.ti OR Finger.ti OR Metacarpophalangeal.ti 
OR Wrist.ti OR Intermetacarpal.ti OR Hands.ti OR Fingers.ti OR Thumb.ti OR Thumbs.ti OR 
Metacarpus.ti OR Metacarpal.ti OR Wrists.ti) AND (exp *Osteoarthritis/ OR Osteoarthritis.ti 
OR Osteoarthrit*.ti OR Osteoarthrosis.ti OR Osteoarthroses.ti OR “Degenerative Arthritis”.
ti OR “Osteoarthrosis Deformans”.ti OR OA.ti))) AND (exp “Treatment Outcome”/ OR exp 
“Outcome Assessment”/ OR outcome.mp OR outcomes.mp OR exp “Severity of Illness In-
dex”/ OR exp “Patient Acuity”/ OR exp “Health Status Indicator”/ OR exp “Pain Assessment”/ 
OR “pain measurement”.mp OR “Pain Measurements”.mp OR “Pain Assessments”.mp OR 
“Pain Assessment”.mp OR “McGill Pain Questionnaire”.mp OR “McGill Pain Scale”.mp OR 
“Visual Analog Pain Scale”.mp OR “Visual Analogue Pain Scale”.mp OR “Pain Scale”.mp OR 
“Pain Scales”.mp OR “self reported pain”.mp OR (exp “Self Report”/ AND (exp “Pain”/ OR 
pain.mp)) OR exp “Self Evaluation”/ OR “patient global”.mp OR exp “Strength”/ OR “Hand 
Strength”.mp OR “Pinch Strength”.mp OR “grip strength”.mp OR grip.mp OR grasp.mp OR 
pinch.mp OR gripping.mp OR grasping.mp OR pinching.mp OR pinches.mp OR exp “Qual-
ity of Life”/ OR “quality of life”.mp OR “qol”.mp OR “Measurements of hand function”.mp 
OR “Measurement of hand function”.mp OR “Arthritis Hand Function Test”.mp OR “AHFT”.
mp OR “Grip Ability Test”.mp OR “GAT”.mp OR “Jebsen Hand Function Test”.mp OR “JHFT”.
mp OR “Jebsen-Taylor test”.mp OR “Pick-up test”.mp OR “pickup test”.mp OR “Pegboard 
test”.mp OR “Australian Canadian Osteoarthritis Hand Index”.mp OR “AUSCAN”.mp OR 
“Functional Index for Hand Osteoarthritis”.mp OR “FIHOA”.mp OR “Michigan Hand Out-
comes Questionnaire”.mp OR “MHQ”.mp OR “Cochin hand function scale”.mp OR “Dreiser 
index”.mp OR “Disabilities of the ARM, Shoulder and Hand”.mp OR “DASH”.mp OR “Hand/
Upper Extremity Function Scale”.mp OR “Health Assessment Questionnaire”.mp OR “HAQ”.
mp OR “Arthritis Impact Measurement Scale”.mp OR “AIMS”.mp OR (strength AND (grip 
OR pinch)).mp OR dexterity.mp OR stiffness.mp OR “Visual Analogue Scale”.mp OR “Visual 
Analog Scale”.mp OR “VAS”.mp OR “Doyle index”.mp OR ((pain OR tenderness) AND (self 
report OR assessment OR measurement)).mp OR “hand function”.mp OR “hand functions”.
mp OR “hand functioning”.mp OR “hand dysfunction”.mp OR “hand dysfunctions”.mp OR 
“hand dysfunctioning”.mp OR “self report”.mp OR selfreport*.mp OR exp “Self Report”/) 
Web of Science 
TI=(“hand osteoarthritis” OR “osteoarthritis hand” OR “thumb osteoarthritis” OR “finger 
osteoarthritis” OR “hand oa” OR “finger oa” OR ((Hand OR Hand Bone OR Hand OR Carpal 
OR Carpometacarpal OR Finger OR Metacarpophalangeal OR Wrist OR Intermetacarpal OR 
Hands OR Fingers OR Thumb OR Thumbs OR Metacarpus OR Metacarpal OR Wrists) AND 
(Osteoarthritis OR Osteoarthritis OR Osteoarthrit* OR Osteoarthrosis OR Osteoarthroses 
OR “Degenerative Arthritis” OR “Osteoarthrosis Deformans” OR OA))) AND TS=(“Treatment 
Outcome” OR “Outcome Assessment” OR outcome OR outcomes OR “Severity of Illness 
Index” OR “Patient Acuity” OR “Health Status Indicator” OR “Pain Assessment” OR “pain 
measurement” OR “Pain Measurements” OR “Pain Assessments” OR “Pain Assessment” 
OR “McGill Pain Questionnaire” OR “McGill Pain Scale” OR “Visual Analog Pain Scale” OR 
“Visual Analogue Pain Scale” OR “Pain Scale” OR “Pain Scales” OR “self reported pain” OR 
(“Self Report” AND (“Pain” OR pain)) OR “Self Evaluation” OR “patient global” OR “Strength” 
502331-L-bw-Visser
139
OR “Hand Strength” OR “Pinch Strength” OR “grip strength” OR grip OR grasp OR pinch 
OR gripping OR grasping OR pinching OR pinches OR “Quality of Life” OR “quality of 
life” OR “qol” OR “Measurements of hand function” OR “Measurement of hand function” 
OR “Arthritis Hand Function Test” OR “AHFT” OR “Grip Ability Test” OR “GAT” OR “Jebsen 
Hand Function Test” OR “JHFT” OR “Jebsen-Taylor test” OR “Pick-up test” OR “pickup test” 
OR “Pegboard test” OR “Australian Canadian Osteoarthritis Hand Index” OR “AUSCAN” 
OR “Functional Index for Hand Osteoarthritis” OR “FIHOA” OR “Michigan Hand Outcomes 
Questionnaire” OR “MHQ” OR “Cochin hand function scale” OR “Dreiser index” OR “Disa-
bilities of the ARM, Shoulder and Hand” OR “DASH” OR “HandUpper Extremity Function 
Scale” OR “Health Assessment Questionnaire” OR “HAQ” OR “Arthritis Impact Measure-
ment Scale” OR “AIMS” OR (strength AND (grip OR pinch)) OR dexterity OR stiffness OR 
“Visual Analogue Scale” OR “Visual Analog Scale” OR “VAS” OR “Doyle index” OR ((pain OR 
tenderness) AND (self report OR assessment OR measurement)) OR “hand function” OR 
“hand functions” OR “hand functioning” OR “hand dysfunction” OR “hand dysfunctions” 
OR “hand dysfunctioning” OR “self report” OR selfreport* OR “Self Report”) 
Cochrane
(“hand osteoarthritis” OR “osteoarthritis hand” OR “thumb osteoarthritis” OR “finger oste-
oarthritis” OR “hand oa” OR “finger oa” OR ((Hand OR Hand Bone OR Hand OR Carpal OR 
Carpometacarpal OR Finger OR Metacarpophalangeal OR Wrist OR Intermetacarpal OR 
Hands OR Fingers OR Thumb OR Thumbs OR Metacarpus OR Metacarpal OR Wrists) AND 
(Osteoarthritis OR Osteoarthritis OR Osteoarthrit* OR Osteoarthrosis OR Osteoarthroses 
OR “Degenerative Arthritis” OR “Osteoarthrosis Deformans” OR OA))) AND (“Treatment 
Outcome” OR “Outcome Assessment” OR outcome OR outcomes OR “Severity of Illness 
Index” OR “Patient Acuity” OR “Health Status Indicator” OR “Pain Assessment” OR “pain 
measurement” OR “Pain Measurements” OR “Pain Assessments” OR “Pain Assessment” 
OR “McGill Pain Questionnaire” OR “McGill Pain Scale” OR “Visual Analog Pain Scale” OR 
“Visual Analogue Pain Scale” OR “Pain Scale” OR “Pain Scales” OR “self reported pain” OR 
(“Self Report” AND (“Pain” OR pain)) OR “Self Evaluation” OR “patient global” OR “Strength” 
OR “Hand Strength” OR “Pinch Strength” OR “grip strength” OR grip OR grasp OR pinch 
OR gripping OR grasping OR pinching OR pinches OR “Quality of Life” OR “quality of 
life” OR “qol” OR “Measurements of hand function” OR “Measurement of hand function” 
OR “Arthritis Hand Function Test” OR “AHFT” OR “Grip Ability Test” OR “GAT” OR “Jebsen 
Hand Function Test” OR “JHFT” OR “Jebsen-Taylor test” OR “Pick-up test” OR “pickup test” 
OR “Pegboard test” OR “Australian Canadian Osteoarthritis Hand Index” OR “AUSCAN” 
OR “Functional Index for Hand Osteoarthritis” OR “FIHOA” OR “Michigan Hand Outcomes 
Questionnaire” OR “MHQ” OR “Cochin hand function scale” OR “Dreiser index” OR “Disa-
bilities of the ARM, Shoulder and Hand” OR “DASH” OR “HandUpper Extremity Function 
Scale” OR “Health Assessment Questionnaire” OR “HAQ” OR “Arthritis Impact Measure-
ment Scale” OR “AIMS” OR (strength AND (grip OR pinch)) OR dexterity OR stiffness OR 
“Visual Analogue Scale” OR “Visual Analog Scale” OR “VAS” OR “Doyle index” OR ((pain OR 
tenderness) AND (self report OR assessment OR measurement)) OR “hand function” OR 
“hand functions” OR “hand functioning” OR “hand dysfunction” OR “hand dysfunctions” 





ti/maj (“hand osteoarthritis” OR “osteoarthritis hand” OR “thumb osteoarthritis” OR “finger 
osteoarthritis” OR “hand oa” OR “finger oa” OR ((Hand OR Hand Bone OR Hand OR Carpal 
OR Carpometacarpal OR Finger OR Metacarpophalangeal OR Wrist OR Intermetacarpal 
OR Hands OR Fingers OR Thumb OR Thumbs OR Metacarpus OR Metacarpal OR Wrists) 
AND (Osteoarthritis OR Osteoarthritis OR Osteoarthrit* OR Osteoarthrosis OR Osteoar-
throses OR “Degenerative Arthritis” OR “Osteoarthrosis Deformans” OR OA))) AND ti/ab/
mw  (“Treatment Outcome” OR “Outcome Assessment” OR outcome OR outcomes OR 
“Severity of Illness Index” OR “Patient Acuity” OR “Health Status Indicator” OR “Pain Assess-
ment” OR “pain measurement” OR “Pain Measurements” OR “Pain Assessments” OR “Pain 
Assessment” OR “McGill Pain Questionnaire” OR “McGill Pain Scale” OR “Visual Analog 
Pain Scale” OR “Visual Analogue Pain Scale” OR “Pain Scale” OR “Pain Scales” OR “self 
reported pain” OR (“Self Report” AND (“Pain” OR pain)) OR “Self Evaluation” OR “patient 
global” OR “Strength” OR “Hand Strength” OR “Pinch Strength” OR “grip strength” OR 
grip OR grasp OR pinch OR gripping OR grasping OR pinching OR pinches OR “Quality of 
Life” OR “quality of life” OR “qol” OR “Measurements of hand function” OR “Measurement 
of hand function” OR “Arthritis Hand Function Test” OR “AHFT” OR “Grip Ability Test” OR 
“GAT” OR “Jebsen Hand Function Test” OR “JHFT” OR “Jebsen-Taylor test” OR “Pick-up test” 
OR “pickup test” OR “Pegboard test” OR “Australian Canadian Osteoarthritis Hand Index” 
OR “AUSCAN” OR “Functional Index for Hand Osteoarthritis” OR “FIHOA” OR “Michigan 
Hand Outcomes Questionnaire” OR “MHQ” OR “Cochin hand function scale” OR “Dreiser 
index” OR “Disabilities of the ARM, Shoulder and Hand” OR “DASH” OR “HandUpper Ex-
tremity Function Scale” OR “Health Assessment Questionnaire” OR “HAQ” OR “Arthritis Im-
pact Measurement Scale” OR “AIMS” OR (strength AND (grip OR pinch)) OR dexterity OR 
stiffness OR “Visual Analogue Scale” OR “Visual Analog Scale” OR “VAS” OR “Doyle index” 
OR ((pain OR tenderness) AND (self report OR assessment OR measurement)) OR “hand 
function” OR “hand functions” OR “hand functioning” OR “hand dysfunction” OR “hand 
dysfunctions” OR “hand dysfunctioning” OR “self report” OR selfreport* OR “Self Report”) 
Academic Search Premier
ti/su/kw (“hand osteoarthritis” OR “osteoarthritis hand” OR “thumb osteoarthritis” OR 
“finger osteoarthritis” OR “hand oa” OR “finger oa” OR ((Hand OR Hand Bone OR Hand 
OR Carpal OR Carpometacarpal OR Finger OR Metacarpophalangeal OR Wrist OR Inter-
metacarpal OR Hands OR Fingers OR Thumb OR Thumbs OR Metacarpus OR Metacarpal 
OR Wrists) AND (Osteoarthritis OR Osteoarthritis OR Osteoarthrit* OR Osteoarthrosis OR 
Osteoarthroses OR “Degenerative Arthritis” OR “Osteoarthrosis Deformans” OR OA))) AND 
(“Treatment Outcome” OR “Outcome Assessment” OR outcome OR outcomes OR “Severity 
of Illness Index” OR “Patient Acuity” OR “Health Status Indicator” OR “Pain Assessment” 
OR “pain measurement” OR “Pain Measurements” OR “Pain Assessments” OR “Pain As-
sessment” OR “McGill Pain Questionnaire” OR “McGill Pain Scale” OR “Visual Analog Pain 
Scale” OR “Visual Analogue Pain Scale” OR “Pain Scale” OR “Pain Scales” OR “self reported 
pain” OR (“Self Report” AND (“Pain” OR pain)) OR “Self Evaluation” OR “patient global” 
OR “Strength” OR “Hand Strength” OR “Pinch Strength” OR “grip strength” OR grip OR 
grasp OR pinch OR gripping OR grasping OR pinching OR pinches OR “Quality of Life” OR 
“quality of life” OR “qol” OR “Measurements of hand function” OR “Measurement of hand 
function” OR “Arthritis Hand Function Test” OR “AHFT” OR “Grip Ability Test” OR “GAT” 
502331-L-bw-Visser
141
OR “Jebsen Hand Function Test” OR “JHFT” OR “Jebsen-Taylor test” OR “Pick-up test” OR 
“pickup test” OR “Pegboard test” OR “Australian Canadian Osteoarthritis Hand Index” OR 
“AUSCAN” OR “Functional Index for Hand Osteoarthritis” OR “FIHOA” OR “Michigan Hand 
Outcomes Questionnaire” OR “MHQ” OR “Cochin hand function scale” OR “Dreiser index” 
OR “Disabilities of the ARM, Shoulder and Hand” OR “DASH” OR “HandUpper Extremity 
Function Scale” OR “Health Assessment Questionnaire” OR “HAQ” OR “Arthritis Impact 
Measurement Scale” OR “AIMS” OR (strength AND (grip OR pinch)) OR dexterity OR stiff-
ness OR “Visual Analogue Scale” OR “Visual Analog Scale” OR “VAS” OR “Doyle index” 
OR ((pain OR tenderness) AND (self report OR assessment OR measurement)) OR “hand 
function” OR “hand functions” OR “hand functioning” OR “hand dysfunction” OR “hand 
dysfunctions” OR “hand dysfunctioning” OR “self report” OR selfreport* OR “Self Report”) 
ScienceDirect
title(“hand osteoarthritis” OR “osteoarthritis hand” OR “thumb osteoarthritis” OR “finger 
osteoarthritis” OR “hand oa” OR “finger oa” OR ((Hand OR Hand Bone OR Hand OR Carpal 
OR Carpometacarpal OR Finger OR Metacarpophalangeal OR Wrist OR Intermetacarpal OR 
Hands OR Fingers OR Thumb OR Thumbs OR Metacarpus OR Metacarpal OR Wrists) AND 
(Osteoarthritis OR Osteoarthritis OR Osteoarthrit* OR Osteoarthrosis OR Osteoarthroses 
OR “Degenerative Arthritis” OR “Osteoarthrosis Deformans” OR OA))) AND TITLE-AB-
STR-KEY(“Treatment Outcome” OR “Outcome Assessment” OR outcome OR outcomes 
OR “Severity of Illness Index” OR “Patient Acuity” OR “Health Status Indicator” OR “Pain 
Assessment” OR “pain measurement” OR “Pain Measurements” OR “Pain Assessments” 
OR “Pain Assessment” OR “McGill Pain Questionnaire” OR “McGill Pain Scale” OR “Visual 
Analog Pain Scale” OR “Visual Analogue Pain Scale” OR “Pain Scale” OR “Pain Scales” OR 
“self reported pain” OR (“Self Report” AND (“Pain” OR pain)) OR “Self Evaluation” OR “pa-
tient global” OR “Strength” OR “Hand Strength” OR “Pinch Strength” OR “grip strength” OR 
grip OR grasp OR pinch OR gripping OR grasping OR pinching OR pinches OR “Quality of 
Life” OR “quality of life” OR “qol” OR “Measurements of hand function” OR “Measurement 
of hand function” OR “Arthritis Hand Function Test” OR “AHFT” OR “Grip Ability Test” OR 
“GAT” OR “Jebsen Hand Function Test” OR “JHFT” OR “Jebsen-Taylor test” OR “Pick-up test” 
OR “pickup test” OR “Pegboard test” OR “Australian Canadian Osteoarthritis Hand Index” 
OR “AUSCAN” OR “Functional Index for Hand Osteoarthritis” OR “FIHOA” OR “Michigan 
Hand Outcomes Questionnaire” OR “MHQ” OR “Cochin hand function scale” OR “Dreiser 
index” OR “Disabilities of the ARM, Shoulder and Hand” OR “DASH” OR “HandUpper Ex-
tremity Function Scale” OR “Health Assessment Questionnaire” OR “HAQ” OR “Arthritis Im-
pact Measurement Scale” OR “AIMS” OR (strength AND (grip OR pinch)) OR dexterity OR 
stiffness OR “Visual Analogue Scale” OR “Visual Analog Scale” OR “VAS” OR “Doyle index” 
OR ((pain OR tenderness) AND (self report OR assessment OR measurement)) OR “hand 
function” OR “hand functions” OR “hand functioning” OR “hand dysfunction” OR “hand 
dysfunctions” OR “hand dysfunctioning” OR “self report” OR selfreport* OR “Self Report”) 
7
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  CHAPTER 8
 Radiographic scoring methods in hand osteoarthritis – a systematic 
 literature search and descriptive review
 A.W. Visser, P. Bøyesen, I.K. Haugen, J.W. Schoones, D.M. van der Heijde, F.R.  
 Rosendaal, M. Kloppenburg 
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ABSTRACT
Objective 
This systematic literature review aimed to evaluate the use of conventional radiography in 
hand osteoarthritis (OA) and to assess the metric properties of the different radiographic 
scoring methods.
Design 
Medical literature databases up to November 2013 were systematically reviewed for 
studies reporting on radiographic scoring of structural damage in hand OA. The use and 
metric properties of the scoring methods, including discrimination (reliability, sensitivity 
to change), feasibility and validity, were evaluated.
Results 
Of the 48 included studies, 10 provided data on reliability, 11 on sensitivity to change, 
four on feasibility and 36 on validity of radiographic scoring methods. Thirteen differ-
ent scoring methods have been used in studies evaluating radiographic hand OA. The 
number of examined joints differed extensively and the obtained scores were analyzed 
in various ways. The reliability of the assessed radiographic scoring methods was good 
for all evaluated scoring methods, for both cross-sectional and longitudinal radiographic 
scoring. The responsiveness to change was similar for all evaluated scoring methods. 
There were no major differences in feasibility between the evaluated scoring methods, 
although the evidence was limited. There was limited knowledge about the validity of 
radiographic OA findings compared with clinical nodules and deformities, whereas there 
was better evidence for an association between radiographic findings and symptoms and 
hand function.
Conclusions 
Several radiographic scoring methods are used in hand OA literature. To enhance com-
parability across studies in hand OA, consensus has to be reached on a preferred scoring 





Osteoarthritis (OA) is the most common musculoskeletal disorder, frequently affecting 
the hands.1,2 Hand OA is characterized by the formation of bony enlargements and de-
formities, most frequently occurring in the distal interphalangeal (DIP) joints and first 
carpometacarpal (CMC1) joints, less often in the proximal interphalangeal (PIP) joints and 
least prevalent in metacarpaphalangeal (MCP) joints.3 Currently, no structure modifying 
treatments are available. To date, few high-quality clinical trials have been performed in 
hand OA.4,5 A key problem in the lack of high-quality clinical trials in hand OA is the lack of 
standardization of outcome measures.4,6 The Outcome Measures in Rheumatoid Clinical 
Trials (OMERACT) and Osteoarthritis Research Society International (OARSI) Task Force 
on Clinical Trials Guidelines defined core domains to describe outcomes in clinical trials. 
One of these domains for structure modifying trials was imaging.7-9 
Conventional radiography is commonly used to assess structural damage in hand OA, as 
they are widely available and relatively cheap. Radiography allows visualization of oste-
ophytes, joint space narrowing (JSN), subchondral cysts, sclerosis and central erosions. 
Several standardized scoring methods are available such as the Kellgren-Lawrence (KL),10 
Kessler11 and Kallmann grading scales,12 the OARSI scoring atlas,13 the Verbruggen-Veys 
anatomical phase score,14 and the Gent University scoring system (GUSS).15 These scores 
differ in the joints that are assessed, the type of scores (composite score or individual 
feature scores), and the total score ranges. 
Most scoring methods have been shown to be reliable instruments for the assessment of 
structural damage in hand OA as well as its change.15-17 However, a systematic comparison 
of the different scoring methods that will help to decide on a recommended method has 
not been performed. 
We performed a systematic review to evaluate the use of conventional radiography in 
studies on hand OA and to assess the metric properties of the different radiographic 
scoring methods.18 To this end we made use of the OMERACT filter,19 focusing on aspects 
of discrimination (reliability and sensitivity to change), feasibility and truth (validity) of the 
radiographic scoring methods available in hand OA.
METHODS
Identification of studies
In cooperation with a medical librarian (JWS), a systemic literature search was performed 
to obtain all manuscripts reporting on any radiographic scoring methods assessing the 
nature, severity and progression of structural damage in hand OA. Medical literature da-
tabases (PubMed, Embase, Web of Science, COCHRANE and CINAHL) were searched up 
to November 2013, using all variations of the following key words ‘hand’, ‘osteoarthritis’, 
‘radiography’, ‘reliability’, ‘validity’, ‘sensitive’ and ‘feasibility’ (see Supplementary File for 
exact search strings). 
8
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Inclusion and exclusion criteria
First all retrieved titles were screened, subsequently selected abstracts were reviewed 
and finally full text articles of the remaining references were read by one reviewer (AWV). 
A random sample of 150 titles was also reviewed by a second reviewer (MK), resulting in 
a similar selection of titles. In case of uncertainties in the reviewing process by the single 
reviewer, these were discussed and solved with MK. The metric properties of the studied 
radiographic scoring methods were evaluated according to four items: reliability, sensi-
tivity to change, feasibility and validity. Inclusion criteria  required for studies to evaluate 
these items differed per item:  
Data extraction
A standardized form was used to extract information about the following data: (1) study 
population (population size, setting, age, sex), (2) applied radiographic scoring methods, 
(3) performance of the scoring (number of readers, consensus/independent reading, (4) 
assessed joints, (5) level of analyses of obtained scores ( joint, joint group or patient lev-
el) and used definition of outcome (e.g. summed scores (total or per feature), counts of 
number of affected joints, dichotomized outcome), (6) results concerning: reliability (in-
traclass correlation coefficient (ICC), kappa-value, percentage of agreement, smallest de-
tectable change (SDC)), sensitivity to change (percentage of change, amount of change, 
standardized response mean (SRM)), feasibility (time needed to perform scoring), validity 
(correlations, associations and measures of agreement between radiographic scores and 
other measures). From a random number of studies data were also extracted by MK and 
all extracted results were discussed with MK.
Reliability was evaluated in studies describing the reliability of two or more scoring 
methods performed on the same radiographs and by the same reader. Both cross-sec-
tional and longitudinal studies were included.
Sensitivity to change was evaluated in longitudinal studies of at least one year, in 
which hand OA was assessed by at least two radiographic scoring methods. Studies 
with a follow-up duration between one and three years using only one radiographic 
scoring method were also included.
Feasibility was evaluated in studies describing the feasibility of one or more scoring 
methods.
Validity was evaluated in studies comparing a radiographic scoring method with oth-
er measurements of structural damage such as magnetic resonance imaging (MRI), 
computed tomography (CT), ultrasound (US), digital photography, histology or nodes 
at physical examination. In addition, validity was evaluated in studies comparing radi-
ographic findings to clinical signs such as hand function or symptoms. Both cross-sec-
tional and longitudinal studies were included. 
Studies that fulfilled the requirements for at least one of these four items were includ-
ed in this review.
Animal studies, reviews, abstracts, letters to the editor and studies reporting on mus-









Due to the heterogeneity of the studies and the difference in outcome measures that 




After removing duplicate references, 1,873 unique references were identified (Figure 1). 
After reviewing 133 abstracts and 80 full-text articles, 48 articles were included in this 
review. Of the included studies, 10 fulfilled the inclusion criteria for evaluation of reliabili-
ty,12,16,17,20-26 11 for sensitivity to change,14,16,17,24-31 four for feasibility, 11,16,17,22 and 36 for validity 
of radiographic scoring methods.20-24,32-62
Evaluation of radiographic scoring methods was the primary aim in 10 of the included 
studies.11,12,14,16,17,22,26,27,59,60 The other studies used radiographic scoring to identify preva-
lence or progression of radiographic OA features (n = 7),20,25,28-30,33,34 or to compare ob-
tained scores with other outcome measures (other imaging methods, clinical outcomes, 
histology) (n = 31).21,23,24,31,32,35-38,40-58,61-63 
The characteristics of the evaluated or applied radiographic scoring methods (except for 
non-validated methods) are depicted in Table 1.
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Study characteristics
The characteristics of the 48 included studies are depicted in Table 2. Most studies in-
cluded more women than men and most of the studied individuals were aged >50 years. 
As shown in Table 2, a wide variety of scoring methods (n = 13) was used to assess radi-
ographic (signs of) hand OA. The KL scoring method was used most frequently (n = 24), 
followed by the OARSI scoring method (n = 18). Other scoring methods were the Kallman 
(n = 9), individual features following non-validated methods (n = 7), anatomical phases 
(n = 6), anatomical lesions (n = 2) and automatic JSW measurement (n = 3). The GUSS, 
















































































CMC1, first carpometacarpal joint; DIP, distal interphalangeal joint; GUSS, Gent University scoring system; IP1, first 
interphalangeal joint; JSN, joint space narrowing; MCP, metacarpaphalangeal joint; No., number; OARSI, Osteoar-
thritis Research Society International; PIP, proximal interphalangeal joint; STT, scaphotrapezotrapezoidal joint.
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Burnett, Kessler, Lane, Eaton and a non-validated global score were all used in only one 
study. Although the majority of studies used only one radiographic scoring method, 15 
studies used more than one method.
The examined joint groups differed between the studies: DIPs and PIPs were assessed 
most frequently (in 48 and 46 studies, respectively), followed by the CMC1s (n = 34), 
MCPs (n = 30), IP1s (n = 23) and the scaphotrapezotrapezoidal (STT) joints (n = 8). 
The way the analysis of the radiographic scores were executed was quite different across 
the studies; (1) the score of one joint (the most severely affected) from a joint group, 
hand or patient33,36,37,43,46,50, (2) sum score for all joints and features14,16,17,20-22,24-26,31,34,38,44,45, 
(3) sum scores per feature21,22,24,27-29,48, (4) sum scores per joint group16,24,47,49, (5) mean 
score per feature12,30 or per joint60, (6) scores on joint level (composite score or per fea-
ture)12,20-24,34,35,38,40-44,47,48,51-53,60,61 and (7) presence or absence of radiographic features per 
joint,21,22,54,55,57,58 joint group,32,38,39,45 or on patient level52,56. 
Table 2. Overview of included studies (n = 48)
First author, year of 
publication
Source population, 
no. of patients (% 




Joints investigated Analysis of radio-
graphic scores
Addimanda, 201220 Secondary care 






Score per joint, 
summed total
Score per joint per 
feature, summed 
per joint, summed 
total
Bagge, 199133 General population, 
217 (66), 82
KL DIP, PIP, IP, MCP, 
CMC1
Score per joint 
group (most affect-
ed joint)
Bijsterbosch, 201116 Familial polyarticu-






DIP, PIP, IP1, MCP, 
CMC1
DIP, PIP, IP1, CMC1
DIP, PIP, IP1, MCP
Summed per joint 
group, summed 
total
Summed per joint 
group, summed 
total
Summed per joint 
group, summed 
total
Botha-Scheepers, 200527 Familial polyarticu-
lar OA (GARP), 20 
(90), median age 62
OARSI DIP, PIP, IP1, MCP, 
CMC1, STT
Summed total per 
feature
Botha-Scheepers, 200729 Familial polyarticu-
lar OA (GARP), 193 
(80), 60
OARSI DIP, PIP, IP1, MCP, 
CMC1, STT
Summed total per 
feature
Botha-Scheepers, 200828 Familial polyarticu-
lar OA (GARP), 172 
(79), 61




tients), 32 (91), 62
Stereoscopic
measurement 
DIP, PIP, MCP Mean score total 
per feature, mean 
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Table 2. Continued 
First author, year of 
publication
Source population, 
no. of patients (% 




Joints investigated Analysis of radio-
graphic scores





DIP, PIP, IP1, MCP, 
CMC1
Score per joint, 
summed total
Ceceli, 201262 Secondary care, 60 
(100), 59
Kallman Not specified Summed per hand
Cicuttini, 199835 General population 








Dahaghin, 200443 General population 
(Rotterdam study), 
3906 (58), 67
Modified KL DIP, PIP, MCP, CMC1, 
STT
Score per joint, 
score per joint 
group,  score per 
patient (most 
affected joint)
Ding, 200744 Finnish dentists/
teachers, 543 (100), 
range 45-63
KL DIP, PIP, IP1, MCP Score per joint, no. 
of joints scored ≥2, 
summed total
Dominick, 200545 Familial OA (GOGO 
study), 700 (80), 69
KL DIP, PIP, IP1, MCP, 
CMC1, STT
Present/absent of 
score ≥2 per joint 
group, summed 
total
Drape, 199632 Secondary care 




DIP Present/absent per 
joint group per 
feature
El-Sherif, 200846 Secondary care, 40 
(100), 57
KL DIP, PIP, IP1, MCP, 
CMC1
Score per patient 
(most affected 
joint)




DIP, PIP Present/absent per 
joint




KL DIP, PIP, CMC1 Score per joint 
group (most affect-
ed joint)
Hart, 199437 Primary care, 976 
(100), age range 
45-65
KL DIP, PIP, CMC1 Score per joint 
group (most affect-
ed joint)
Haugen, 201221 Secondary care 
(Oslo hand OA co-





DIP, PIP, IP1, MCP, 
CMC1
DIP, PIP, IP1, MCP, 
CMC1
DIP, PIP, IP1, MCP, 
CMC1
Score per joint, 
summed total





Haugen, 201324 Secondary care 
(Oslo hand OA 
cohort), 190 (91), 62 
(longitudinal analy-
sis: 99 (92), 61)
KL
OARSI
DIP, PIP, IP1, MCP, 
CMC1
DIP, PIP, IP1, MCP, 
CMC1
Score per joint, 
summed per joint 
group, summed 
total





Table 2. Continued 
First author, year of 
publication
Source population, 
no. of patients (% 




Joints investigated Analysis of radio-
graphic scores
Huetink, 201259 22 phantom joints, 





DIP, PIP, MCP Millimeter per joint






DIP, PIP Present/absent per 
patient
Jones, 200147 Secondary care, 522 
(67), 56
OARSI DIP, CMC1 Score per joint per 
feature, summed 
per joint group
Jonsson, 201238 General population 
(AGES-Reykjavik 
study), 381 (58), 76
KL DIP, PIP, CMC1 Score per joint, 
present/absent of 
score ≥2 per joint 
group, summed 
total
Kallman, 198912 General population 
(BLSA), 50 (0), 68
KL
Kallman
DIP, PIP, IP1, CMC1
DIP, PIP, IP1, CMC1, 
STT
Score per joint, 
score per joint 
group, mean score 
total
Score per joint 
per feature, score 
per joint group 
per feature, mean 
score total per 
feature
Keen, 200857 Secondary care, 37 
(84), 57
OARSI DIP, PIP, MCP, CMC1 Present/absent per 
joint per feature
Kessler, 200011 Advanced hip/knee 
OA patients (Ulm 








No. of affected 




Kortekaas, 201148 Secondary care, 55 
(47), 61
OARSI DIP, PIP, IP1, CMC1 Score per joint per 
feature, summed 
total per feature
Kwok, 201122 Familial polyarticu-
lar OA (GARP), 235 
















Score per joint, 
summed total
Lee, 201249 General population 
(KLoSHA), 378 
(48), 75
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Table 2. Continued 
First author, year of 
publication
Source population, 
no. of patients (% 




Joints investigated Analysis of radio-
graphic scores

























Marshall, 200939 Primary care (hand 
pain), 592 (62), 64
KL DIP, PIP, IP1, MCP, 
CMC1, STT
Present/absent of 
score ≥2 per joint 
group
Mathiessen, 201240 Secondary care 
(Oslo hand OA co-
hort), 127 (91), 69
OARSI DIP, PIP, IP1, MCP Score per joint per 
feature
Olejárová, 200031 Secondary care, 
erosive OA: 28 (93), 
68; non-erosive OA: 
24 (83), 65
Kallman DIP, PIP, IP1, MCP, 
CMC1
Summed total
Ozkan, 200750 Secondary care, 100 
(87), 69
KL DIP, PIP, MCP, CMC1 Score per patient 
(most affected 
joint)
Rees, 201241 Secondary care 
(GOAL study 
participants with ≥1 
node), 1939 (54), 68
KL
OARSI
DIP, PIP, IP1, CMC1
DIP, PIP, IP1, CMC1
Score per joint
Score per joint per 
feature
Saltzherr, 201361 Secondary care, 30 
(70), median age 57
Eaton CMC1, STT Score per joint, 
score per joint per 
feature
Sonne-Holm, 200651 General population 
(Copenhagen city 
hearth study), 3355 
(61),age>20
Modified KL CMC1 Score per joint, 
score per joint per 
feature
Stern, 200442 Primary and 
secondary care 
(I-NODAL study), 71 
(80), 67
KL DIP, PIP, IP1, CMC1 Score per joint
Sunk, 201253 Post mortem IP 







Score per joint per 
feature
Verbruggen, 199614 Unclear (radio-










Verbruggen, 200226 Unclear (radi-
ographic OA, 2 











Table 2. Continued 
First author, year of 
publication
Source population, 
no. of patients (% 




Joints investigated Analysis of radio-
graphic scores
Verbruggen, 201225 Secondary care 






No. of joints in 
each phase per 
patient
Summed total
Van ‘t Klooster, 200860 Familial polyarticu-









Mean score per 
joint
Vlychou, 200958 Secondary care (OA 




DIP, PIP, IP1, MCP, 
CMC1
Present/absent per 
joint per feature 
Wittoek, 201155 Secondary care, 
erosive OA: 9 
(67), median 61; 





DIP, PIP Present/absent per 
joint per feature
Zhang, 200252 General population 
(Framingham hand 
OA study), 1032(64), 
age≥71
Modified KL DIP, PIP, IP1, MCP, 
CMC1
Score per joint, 
present/absent 
of score ≥2 per 
patient
AGES, Age, Gene/Environment Susceptibility; BLSA, Baltimore Longitudinal Study of Aging; CMC1, first carpomet-
acarpal joint; DIP, distal interphalangeal joint; GARP, Genenetics osteoArthritis and Progession; GOAL, Genetics 
of Osteoarthritis and Lifestyle; GOGO, Genetics of Generalized Osteoarthritis; I-NODAL, Investigation of Nodal 
Osteoarthritis to Detect an Association with Loci encoding IL-1; IP1, first interphalangeal joint; JSN, joint space 
narrowing; JSW, joint space width; KL, Kellgren-Lawrence; KLoSHA, Korean Longitudinal Study on Health and 
Aging; MCP, metacarpaphalangeal joint;  no., number; NVM, non-validated method; OA, osteoarthritis; OARSI, 
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Discrimination
Reliability
Ten included articles provided data on the reliability of at least two radiographic scoring 
methods, shown in Table 3. The KL scoring method was assessed in seven of these stud-
ies.12,16,17,20,21,23,24 Other assessed scoring methods were the Kallman (n = 4),12,17,20,23 OARSI 
(n = 4),16,21,22,24 anatomical phases (n = 4),16,17,25,26 anatomical lesions (n = 1),26 GUSS (n = 
1),25 global score (n = 1),17 and the semi-automated joint space width (JSW) measurement 
(n = 1).22
Eight studies provided cross-sectional data.12,16,17,20-24 The ICCs as well as kappa values 
were shown to be reliable for all assessed total scores, and no differences between the 
scoring methods were observed. The ICCs and kappa values for the individual radio-
graphic features depended on the scored feature; the lowest reliability was reported for 
the scoring of cysts and the highest for the scoring of erosions and osteophytes.12,20,21
In five of the studies readers performed the scoring independently of another reader, 
providing results on the interreader reliability.12,16,17,21,24 The interreader ICCs and kappa 
values were somewhat lower than the intrareader values, especially for the Kallman meth-
od and for sclerosis as scored using the OARSI atlas.12,17,24 Whether readers were from one 
or different centers did not seem to influence the reliability of the scoring methods.
Six studies provided data on the reliability of change of at least two radiographic scor-
ing methods.12,16,17,24-26 The reliability of change of KL, OARSI, Kallman, global, anatomical 
phases and GUSS scores was reported to be good for all methods.12,16,17,24-26 Bijsterbosch 
et al. compared the SDC of three scoring methods on patient level, showing a small dif-
ference in favor of the KL score, followed by the anatomical phases and OARSI scores. 
Reported SDCs were a little higher over a six year interval than over a two year interval.16 
Haugen et al. assessed reliability of change in KL and OARSI scores, showing a good reli-
ability for the KL score and most of the OARSI features. ICC and kappa values were some-
what lower for change scores than for baseline KL and OARSI scores. Except for change 
of sclerosis (OARSI), moderate to good reliability was reported for the scoring of change 
in KL and OARSI scores.24 Kallman et al. evaluated agreement on progression in KL and 
Kallman scores on joint group level, showing that agreement was more often present in 
DIP joints than PIP joints and that agreement was lowest on the progression of cysts.12 
Sensitivity to change
Table 4 shows the characteristics of the included studies describing data on sensitivity 
to change of radiographic scoring methods. Nine studies reported data on short-term 
follow-up (≤3 years), most of them on patient level.16,17,25-31 Two studies evaluated change 
of summed KL, Kallman and anatomical phases scores, of which one study also evaluated 
the global score.16,17 Maheu et al. reported SRMs over a 1 year interval of the global, KL, 
Kallman, anatomical phases and OARSI scores; all below 0.50, indicating that the respon-
siveness to change was small.17 Bijsterbosch et al. detected somewhat more progression 
over a two year interval when scored following the KL or anatomical phases score as 
compared with the OARSI atlas.16 The anatomical phases score was evaluated in two oth-
er studies,25,26 one of these studies (a randomized controlled trial) also assessed change 
of GUSS.  Progression over a one year interval was detected by both scoring methods, 
although no difference between treatment and placebo group was observed.25
502331-L-bw-Visser
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Table 3. Studies providing data on reliability of scoring methods (n = 10)
First author No. of readers, centers Intrareader reliability* Interreader reliability*
Cross-sectional studies
Addimanda20 2 (consensus), 1 KL: ICC 0.994
Kallman: ICC 0.987, κ range per 
feature 0.42-0.81
N/A
Bijsterbosch16 3 (independent), 3 KL: ICC range per reader 0.90-0.96
OARSI: ICC range per reader 
0.77-0.97
Anatomical phases: ICC range per 
reader 0.88-0.97
KL: ICC range per 2 readers 
0.84-0.91
OARSI: ICC range per 2 
readers 0.80-0.95
Anatomical phases: ICC 
range per 2 readers 0.81-
0.95
Haugen21 2 (independent), 2 KL: ICC 0.97, κ 0.86 (one reader)
OARSI (including marginal ero-
sions):
ICC range per feature 0.70-0.97, κ 
range per feature 0.75-0.88 (one 
reader)
KL: ICC 0.96, κ 0.79
OARSI (including marginal 
erosions):
ICC range per feature 0.56-
0.95, κ range per feature 
0.62-0.81
Haugen24 2 (independent), 2 KL: ICC 0.97, κ 0.82 (one reader)
OARSI: ICC range per feature 0.62-
0.96, κ range per feature 0.64-0.81 
(one reader)
KL: ICC  0.95, κ 0.70
OARSI: ICC range per feature 
-0.07-0.94, κ range per 
feature 0.00.-0.77
Kallman12 4 independent, 2 KL mean score: ICC 0.80, range per 
joint group 0.68-0.87
Kallman mean score: ICC per fea-
ture range 0.74-0.84, per feature 
per joint group range 0.62-0.93
KL mean score: ICC 0.74, 
range per joint group 0.74-
0.81
Kallman mean score: ICC per 
feature range 0.29-0.71, per 
feature per joint group range 
0.33-0.82
Kwok22 2 (consensus), 1 OARSI (JSN): ICC 0.92
Semi-automated JSW: ICC 0.99, 
mean difference 0.017 mm (SD 
0.04), SDD 0.055 mm
N/A
Maheu17 2 (independent), 2 KL: ICC range per reader 0.988-
0.991
Kallman: ICC range per reader 
0.962-0.999
Global: ICC range per reader 0.922-
0.961





Anatomical phases: ICC 0.996
Mancarella23 2, not specified KL: ICC score per joint 0.99
Kallman: ICC score per joint 0.99
8
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Table 3. Continued
First author No. of readers, centers Intrareader reliability* Interreader reliability*
Longitudinal studies
Bijsterbosch16 3 (independent), 3 
Mean follow-up 2 years 
Mean follow-up 6 years
KL: SDC range per reader 2.1-7.1
OARSI: SDC range per reader 
1.2-10.2
Anatomical phases: SDC range per 
reader 1.4-7.8
KL: SDC range per reader 3.7-8.1
OARSI: SDC range per reader 
3.0-11.1
Anatomical phases: SDC range per 
reader 3.5-9.9
KL: SDC 2.9
OARSI:  SDC 4.1
Anatomical phases:  SDC 2.7
KL: SDC 3.8
OARSI:  SDC 4.6
Anatomical phases:  SDC 4.0
Haugen24 2(independent), 2 Mean 
follow-up 7 years
KL: ICC 0.93, κ 0.83 (one reader)
OARSI: ICC range per feature -0.02-
0.96, κ range per feature 0.00-0.90 
(one reader)
KL: ICC  0.83, κ 0.53
OARSI: ICC range per feature 
-0.03-0.90, κ range per 
feature -0.03-0.71
Kallman12 4 (independent), 2 
Mean follow-up 23 
years






Maheu17 2 (independent), 2 
Mean follow-up 1 year
KL: ICC range per reader 0.990-
0.998
Kallman: ICC range per reader 
0.986-0.959
Global: ICC range per reader 0.939-
0.956





Anatomical phases: ICC 0.998
Verbruggen26 2 (independent), 1 
Mean follow-up 3 year
Anatomical phases: agreement for 
2 RCTs 84-93%, κ 0.6-0.8
Anatomical lesions: correlation for 
2 RCTs r 0.7-0.9, R2 44-87%
Anatomical phases: agree-
ment for 2 RCTs 81-85%, κ 
0.6-0.7
Anatomical lesions: correla-
tion for 2 RCTs r 0.7-0.8, R2 
55-66%
Verbruggen25 2 (independent), 1 
Mean follow-up 1 year
Anatomical phases: 96% agree-
ment, κ 0.95 
GUSS: ICC 0.97
Anatomical phases: 94% 
agreement, κ 0.92
GUSS: ICC 0.86, SDC 18
 *Unless stated otherwise ICCs are for summed total scores on patient level, κ’s on joint level.
GUSS, Ghent University Score System; ICC, intraclass correlation coefficient; κ, kappa; KL, Kellgren-Lawrence; OARSI, 
Osteoarthritis Research Society International; JSN, joint space narrowing; JSW, joint space width; N/A, not applica-
ble; r, correlation coefficient; R2, explained variance; RCT, randomized controlled trial; SD, standard deviation; SDC, 
smallest detectable change; SDD, smallest detectable difference.
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Five studies reported follow-up data of only one scoring method.27-31 Botha-Scheepers 
et al. reported change of JSN and osteophytes as scored following the OARSI atlas over 
a two year interval.27-29 Scoring of these features tended to be more sensitive to change 
when scoring radiographs in chronological order as compared with paired reading.27 
Buckland-Wright et al. evaluated stereoscopic measurement of individual OA features 
during a 1.5 year interval, reporting change of most features.64 Olejárová et al. evaluated 
change of hand OA over a two year interval using the Kallman scoring method, reporting 
no significant difference in total score.31
In the three studies investigating long term follow-up data (>3 years), change in KL (n 
= 2), OARSI (n = 2), anatomical phases (n = 2) and anatomical lesions (n = 1) score was 
evaluated.12,14,16,24 Studies with a longer follow-up duration detected higher occurrence of 
progression of OA features as well as higher mean radiographic change scores.16 
Table 4. Studies providing data on sensitivity to change of radiographic scoring methods in hand osteoarthritis (n = 11)








Results relevant for evaluation of sensi-
tivity to change
Short-term




- Anatomical phases: 13-52%
Botha-Scheep-
ers27
2 ≥1 score Known/ un-
known
Progression of JSN/osteophytes:
- chronological reading: 1/15% (SRM 
0.38/0.41)
- paired reading: 5/15% (SRM 0.00/0.39)
Botha-Scheep-
ers28
2 ≥1 score Unknown JSN: 19% progression, mean change 0.3, 
SRM 0.34
Osteophytes: 22% progression, mean 
change 0.4, SRM 0.35
Botha-Scheep-
ers29
2 ≥1 score Unknown JSN: 24% progression (≥2/≥3/≥4 score: 
10/4/3%)




1.5 Change > 
variations in 
precision
Not specified JSW: 62% narrowing (P < 0.02)
Subchondral sclerosis: 60% increase, 34% 
decrease
Osteophytes: increase in size and no. (P 
< 0.005)
Juxta-articular radiolucencies: increase in 
size (P < 0.002), not in no.
Maheu17 1 Change in 
summed score




- Anatomical phases: 0.18/0.27
8
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Table 4. Continued 








Results relevant for evaluation of sensi-
tivity to change
Olejárová31 2 Change in 
summed score
Unknown Erosive OA: change 5.0, P > 0.05
Non-erosive OA: change 4.3, P > 0.05





Known Anatomical lesions showed different pro-
gression between trial arms, anatomical 
phases did not.
Verbruggen25 1 Change in ana-
to-mical N/S/J 




Unknown No. (%) joints with progression to E phase:
- Total group: 24 (2.8%) of 848 N/S/J joints
- Placebo treated: 15 (3.6%) of 429 N/S/J 
joints
- Adalimumab treated: 9 (2.1%) of 419 
N/S/J joints









- Anatomical phases: 27-66%
Haugen24 7.3 Change in 
score
Known Progression (percentage of joints):
- KL: 29%
- OARSI: osteophytes 19%, JSN 13%, 
erosions 9%, malalignment 4%, cysts 2%, 
sclerosis 1%





Known Progression of anatomical lesions more 
frequent in PIP/DIP than MCP. Progression 
of anatomical phases in 43%. Progres-
sion according anatomical phases and 
anatomical lesions yielded comparable 
results.
DIP, distal interphalangeal joint; GUSS, Ghent University Score System; JSN, joint space narrowing; JSW, joint space 
width; KL, Kellgren-Lawrence; MCP, metacarpaphalangeal joint; no., number; OARSI, Osteoarthritis Research Society 





Four studies reported data regarding feasibility of radiographic scoring methods (Ta-
ble 5).11,16,17,22 The KL, anatomical phases and Kallman scoring methods were assessed in 
two studies.16,17 The OARSI, Kessler and Lane scoring methods, as well as a non-validat-
ed global score and semi-automated JSW measurement, were all examined in only one 
study.11,16,17,22
The mean time to perform scoring ranged from 1.5 to 10-15 minutes per hand radio-
graph. The KL, anatomical phases and Kessler scoring methods seemed to be least time 
consuming while scoring according Kallman, Lane and the OARSI atlas needed more time 
to perform.11,16,17 However, the time needed to perform the scoring differed per study.11,16,17 
Bijsterbosch et al. showed that the performance time increased in patients with higher 
levels of structural abnormalities; one minute increment in performance time was asso-
ciated with 3.9 points in KL score (95% confidence interval (CI) 1.0 to 6.8), 8.0 (5.3 to 10.7) 
points in OARSI score, and 21.1 (12.9 to 29.2) points in the anatomical phases scoring 
method.16
Validity
The 36 studies providing data regarding validity of radiographic scoring methods are list-
ed in Table 6. Analyses on individual joint level were performed in 18 of these studies, and 
analyses on joint group or patient level were performed in 13 and 14 studies, respectively.
Thirteen studies focused on structural findings at physical examination in comparison 
to radiographic OA findings.20,22,33-42 Four studies presented correlation coefficients and 
kappa values, reporting that nodes at physical examination were weakly to moderately 
associated with radiographic hand OA.34,35,37,38 The lowest agreement was reported in a 
study on clinical Heberden nodes and radiographic DIP osteophytes scored following the 
Burnett scoring method, performed on joint level (k = 0.36).35 The highest correlation was 
reported in a study examining a clinical score consisting of nodes and deformity and the 
radiographic KL score, analyzed on joint group level (males r = 0.47, females r = 0.66).38
Two studies reported the association between two radiographic scoring methods and 
clinical nodes, both analyzed on a joint level.20,41 Addimanda et al., examining KL and Kall-
man scores, reported the erosion and osteophyte features of the Kallman method to be 
Table 5. Studies providing data on feasibility of radiographic scoring methods in hand osteoarthritis (n = 4)
First author No. of radiographs Mean (SD) time to perform scoring
Bijsterbosch16 3 KL: 4.3 (2.5) min
OARSI: 9.3 (6.0) min
Anatomical phases: 2.8 (1.5) min
Kessler11 1 Kessler: 5 min per hand
Kallman: 10-15 min per hand
Lane: 10-15 min per hand
Kwok22 1 Semi-automated JSW measurement: 5.1 (2.8) min
Maheu17 1 KL: 1.9 (0.6) min
Kallman: 3.5 (0.7) min
Global score: 1.5 (0.5) min
Anatomical phases: 1.6 (0.5) min
 KL, Kellgren-Lawrence; OARSI, Osteoarthritis Research Society International; SD, standard deviation; min, minutes. 8
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associated most strongly with nodes (OR 7.4 and 3.2 respectively).20 Rees et al. examined 
the association between KL and OARSI scores and clinical nodes, reporting ORs only for 
the KL method (range per joint 2.3-21.2). Regarding the OARSI atlas, JSN was mentioned 
to be more strongly associated with clinical nodes than osteophytes.41
Seventeen studies assessed clinical symptoms and hand function in comparison to ra-
diographic scoring methods (KL: n = 14, OARSI: n = 3, Kallman: n = 1, JWS/JSN: n = 
1).22,24,33,36,37,39,43-52,62 All studies reported significant associations between radiographic OA 
features and pain and disability, of which four showed a dose-dependent association be-
tween KL and OARSI scores and pain.24,43,44,48 Of the nine studies assessing grip or pinch 
strength, only two did not find an association with radiographic OA (1x KL, 1x JSW/JSN, 
analyzed on patient level).22,50 
Only one study assessed longitudinal data, showing incident or progressive KL or OARSI 
scores to be associated with incident pain on joint level and with change in Australian/
Canadian Hand Osteoarthritis Index (AUSCAN) pain/function and grip strength.24
One study examined the association between the KL and OARSI scoring methods and 
histological findings on joint group level, showing a good correlation (r ≥ 0.7) as well as 
a high sensitivity and specificity.53
Four studies assessed individual features of hand OA by both radiography and MRI.21,32,54,55 
The agreement between the two methods was lowest for the presence of cysts and high-
est for central erosions.21 Three of the studies showed that MRI detected more osteo-
phytes, cysts and erosions as compared to radiography.32,54,55 
One study assessed individual features of CMC1 and STT OA by both radiography and 
CT, reporting the latter to detect more JSN, osteophytes, subchondral sclerosis, cysts, 
erosions and subluxation.61
even studies used both US and radiography to assess hand OA signs.23,40,48,55-58 Six of the 
studies examined individual radiographic features and reported US to detect more os-
teophytes and erosions than radiography. A study on KL and Kallman scores reported a 
negative correlation between radiographic JSN and US-detected cartilage thickness on 
joint level.23 
Three studies examined hand OA using digital photography and radiography.38,42,47 Two 
studies, performed on joint group level, reported a good correlation between OARSI 
scores and Heberden nodes on digital photography (r = 0.74), and a weak to moderate 
correlation between summed KL scores and summed digital photograph score (com-
prising enlargement and deformity) on digital photography (males r = 0.35, females r = 
0.53).38,47
Finally, two studies examined quantitative measures of JSW, both on individual joint lev-
el.59,60 Van ‘t Klooster et al. showed that automatic JSW quantification was associated with 
JSN scored according to the OARSI atlas.60 Huetink et al. reported that automatic JSW 
quantification has a high accuracy in measuring the true JSW (assessed by micrometer).59 
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Table 6. Studies providing data on validity of scoring methods (n = 37)
First 
author
Validation method Results relevant for evaluation of validity





OR (95%CI) for nodes on joint level, adjusted for disease duration, 
BMI:
- KL: 2.20 (2.09, 2.31)
- Kallman: 1.17 (1.62, 1.72)
- Kallman JSN: 2.57 (2.40, 2.75)
- Kallman osteophytes: 3.19 (2.97, 3.42)
- Kallman central erosions: 7.4 (6.0, 10.1)
Bagge33 Nodes/periarticular 
enlarge-ment, instability, 
squaring (yes/no ≥1 fea-
ture per joint)
Correlated with KL score in all joint groups (correlation coefficient 
not provided), test for linear trend: P < 0.01.
Clinical features also present in KL 0 joint groups.
Caspi34 Nodes, malalignment DIP/
PIP (summed)
Correlation with OARSI: 
- summed total: r 0.4 (P 0.001)
- DIP/PIP: range per joint r 0.18-0.52 (P 0.004-0.0001)
Cicuttini35 Heberden nodes (yes/no) κ with DIP osteophytes (Burnett): 0.36 (95%CI 0.33, 0.39)
Hart36 Nodes (yes/no) Sensitivity for KL ≥2: range per joint group 19-49%
Specificity for KL ≥2: range per joint group 87-98%
Hart37 Nodes IP (graded 0-4), 
squaring CMC1 (grade 0-1)
Prevalence node ≥2: KL0: 3%, KL1: 19%, KL2: 48%, KL3: 74%, KL4: 
82%
Prevalence squaring: KL0: 5%, KL1: 11%, KL2: 25%, KL3: 41%, KL4: 
70%
(correlation coefficient not specified)
Jonsson38 Nodes, deformity 
(graded 0-3, summed)
Correlation summed score with summed total KL: males r 0.47, 
females r 0.66
Prevalence KL ≥2 (DIP 67%, PIP 32%, CMC1 20%) higher as com-
pared
to clinical grade ≥2 (DIP 54%, PIP 19%, CMC1 10%)
Kwok22 Nodes (yes/no) β (95%CI) for nodes on joint level, adjusted for age, sex, BMI, family 
effect, mean phalanx width:
- JSW: -0.37 (-0.40, -0.34)
- JSN: 0.48 (0.42, 0.55)
Marshall39 Nodes, deformity, enlarge-
ment (yes/no)
OR (95%CI) of presence of ≥1 feature for:
- KL ≥2 in CMC1: 2.2 (1.5, 3.3)
- KL ≥2 in any thumb joint: 3.1 (2.1, 4.5)
Mathies-
sen40
Nodes (yes/no) Osteophytes (OARSI) in 30% of joints, nodes in 37% of joints
Rees41 Nodes (yes/no) KL ≥2 associated with any node on patient level: OR range per 
joint 2.26-21.23 (adjusted for age, sex, BMI, hand dominance, 
trauma, occupation, sports).
JSN/osteophytes  (OARSI) also associated with nodes (P < 0.001); 
ORs of JSN greater than ORs of osteophytes in all joints except for 
IP1/CMC1.
Stern42 Nodes (yes/no) Sensitivity for KL ≥2: range per joint group 42-100%




Correlated with KL score in all joint groups (correlation coefficient 
not provided), test for linear trend: P < 0.01.
8
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Validation method Results relevant for evaluation of validity
Ceceli62 Pain (VAS), disability (DASH 
questionnaire), dexterity 
(Purdue pegboard test), 
grip/pinch strength
Correlation with summed Kallman score right/left hand:
- Pain: r 0.17 / 0.18 (P > 0.05)
- Disability: r 0.29 / 0.30 (P < 0.05)
- Dexterity: r -0.26 / -0.30 (P < 0.05)
- Grip strength: r -0.37 / -0.40 (P < 0.05)
- Pinch strength: r range per test -0.31 to -0.25 / -0.35 to -0.27 (P 
< 0.05)
Dahaghin43 Pain (interview, yes/no)/ 
disability (HAQ)
OR (95%CI) for KL ≥2/≥3/4 on patient level, adjusted for age, sex:
- pain: 1.9 (1.5, 2.4) / 1.8 (1.3, 2.5) / 3.6 (2.2, 5.8)
- disability: 1.5 (1.1, 2.1) / 1.6 (1.1, 2.5) / 1.6 (0.9, 2.9)
Pain associated with KL ≥2 in PIP/CMC1/STT, disability with KL ≥2 
in MCP.
Adjusted OR (95%CI) for KL ≥2 in all joint groups: pain 2.7 (1.4, 
5.2), disability 2.7 (1.3, 6.0).
Ding44 Pain (questionnaire, yes/no 
per joint, summed)
Correlation with summed total KL: r 0.26 (P 0.0005)
Correlation with no. KL≥2 joints: r 0.28 (P 0.0005)
PR (95%CI) for pain on joint level, adjusted for age, occupation:
- KL 2: 1.70 (1.44, 2.01)
- KL ≥3: 5.17 (4.34, 6.16)
Adjusted PR (95%CI) for mild / moderate pain on joint level:
- KL 2: 1.93 (1.54, 2.41) / 2.21 (1.58, 3.10)
- KL ≥3: 4.92 (3.77, 6.43) / 11.73 (8.95, 15.38)
Dominick45 Grip/pinch strength β (P-value) for grip / pinch strength, adjusted for age, sex, pain, 
chondro-calcinosis, hand hypermobility:
- Summed total KL: -0.67 (<0.001) / -0.16 (<0.001)
- KL ≥2 PIP: -6.67 (0.003) / -1.17 (0.070)
- KL ≥2 MCP: -3.32 (0.114) / -1.78 (0.003)
- KL ≥2 CMC: -9.06 (<0.001) / -1.03 (0.049)
- KL ≥2 per finger: range -1.81 to -11.08 (p<0.05)
El-Sherif46 AUSCAN, morning stiffness 
(minutes), grip strength, 
Ritchie index
AUSCAN pain/function higher in KL4 than KL2 (P < 0.05)
Correlation with KL score:
- AUSCAN pain: r 0.459 (p 0.003), function: r 0.394 (P 0.012)
- Grip strength right hand: r -0.322 (P 0.043)
Other measures not significantly correlated with KL.
Hart36 Tenderness, pain on move-
ment (physical examina-
tion, yes/no)
Comparison tenderness / pain on movement with KL ≥2:
- sensitivity: range per joint group 7-26% / 1-22%
- specificity: range per joint group 92-99% / 96-99%
Hart37 Pain, stiffness 
(interview, yes/no)
Prevalence symptoms  in patients with KL <2: 15%, KL2: 49%, KL3-
4: 81%;






Validation method Results relevant for evaluation of validity
Haugen24 Tenderness on palpation 
(yes/no), grip strength, 
AUSCAN
Cross-sectional OR (95%CI) for tenderness on joint level, adjusted 
for age, sex:
- KL score 1/2/3/4: 1.4 (1.2, 1.7) / 3.0 (2.4, 3.7) / 6.8 (4.5, 10) / 5.3 
(3.3, 8.6)
- OARSI osteophytes score 1/2/3: 2.8 (2.3, 3.4) / 4.3 (3.0, 6.3) / 4.5 
(2.9, 7.0)
- OARSI JSN score 1/2/3: 0.9 (0.7, 1.2) / 1.9 (1.4, 2.5) / 2.5 (1.7, 3.7)
- OARSI erosions: 3.3 (2.3, 4.9), malalignment: 2.8 (2.0, 3.9), cysts: 
2.2 (1.4,3.3), sclerosis: 2.6 (1.1, 6.0)
AUSCAN pain associated with summed KL and OARSI osteophytes/
JSN. AUSCAN function associated with summed KL and OARSI 
osteophytes, JSN, erosions, cysts. Grip strength associated with 
summed KL and all OARSI features except for sclerosis.
Summed KL per joint group only associated with grip strength 
(CMC1 strongest).
Adjusted OR (95%CI) of progressive/incident scores for incident 
tenderness:
- KL score 1/2/3/4: 1.2 (0.7, 2.0) / 1.5 (0.9, 2.4) / 5.7 (3.0, 11) / 11 
(4.0, 33)
- OARSI osteophytes: 3.0 (2.0, 4.4), JSN: 2.8 (1.7, 4.7), erosions: 8.4 
(4.7, 15), malalignment: 3.8 (1.9, 7.4), cysts: 2.2 (0.9, 5.0), sclerosis: 
2.4 (0.8, 8.0)
Increasing summed KL and OARSI JSN/malalignment associated 
with increased AUSCAN function. More malalignment associated 
with less grip strength.
Change summed KL per joint group not associated with AUSCAN/
grip strength.
Jones47 AUSCAN, grip strength Association with summed OARSI per joint group, adjusted for age/
sex/other joints/Heberden nodes: 
- AUSCAN pain: PIP β 0.17, CMC1 β 0.14 (P < 0.05)
- AUSCAN function: PIP β 0.15, CMC1 β 0.19 (P < 0.05)
- grip strength: PIP β -0.12, CMC1 β -0.09 (P < 0.05)
Korteka-
as48
AUSCAN, pain (VAS), Doyle 
index of hands
OR (95%CI) for pain on palpation on joint level, adjusted for age, 
sex, BMI:
- osteophytes score 1/2/3: 2.2 (1.7, 2.9) / 3.9 (2.6, 5.9) / 4.8 (2.7, 8.4)
- JSN score 1/2/3: 2.0 (1.4, 2.8) / 5.3 (3.1, 9.1) / 6.4 (2.7, 14.8)
Summed osteophytes/JSN not associated with AUSCAN pain, VAS, 
Doyle.
Kwok22 AUSCAN, pain on palpation 
(yes/no), grip strength, 
mobility
β (95%CI) for JSW / JSN on joint level, adjusted for age, sex, BMI, 
family effect, mean phalanx width:
- self-reported pain: -0.21 (-0.27, -0.16) / 0.39 (0.30, 0.48)
- pain on palpation: -0.25 (-0.29, -0.21) / 0.37 (0.29, 0.44)
No. joints with self-reported pain/pain on palpation, AUSCAN 
pain/function and mobility associated with summed JSW/JSN. Grip 
strength not associated.
Lee49 Grip/pinch strength, disa-
bility (DASH questionnaire)
Associations with summed KL, adjusted for age/sex (P < 0.05):
- grip strength: thumb β -1.05, 3rd finger β -2.17
- pinch strength: thumb β -0.28, 2nd finger β -0.26
- disability: thumb β 1.53, 2nd finger β 0.63, 3rd finger β 3.97
8
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Validation method Results relevant for evaluation of validity
Marshall39 AUSCAN, pain during 
activity/pain in past month 
(questionnaire, yes/ no), 
grip/ pinch strength, grind 
test, Finkelstein’s test
OR (95%CI) for KL ≥2 in CMC1 / any thumb joint:
- Pain during activity: 2.1 (1.5, 2.9) / 2.2 (1.6, 3.2)
- Pain in past month: 1.5 (1.0, 2.1) / 1.4 (1.0, 2.0)
- Grind test: 1.8 (1.1, 2.9) / 1.7 (1.0, 2.9), Finkelstein’s test not 
associated.
Ozkan50 Grip/pinch strength, 
Dreiser’s functional index, 
disability (HAQ)
Disability KL score <2/2/3-4: 2.40 / 2.10 / 6.45 (KL3-4 vs KL<2/2 P 
< 0.05)
Dreiser’s index KL score <2/2/3-4: 2.73 / 2.10 / 9.25 (KL3-4 vs 
KL<2/2 P <0.05)
Grip/pinch strength not different between KL scores.
Sonne-
Holm51
Pain CMC1 (interview, yes/
no)
OR (95%CI) for pain, adjusted for age, sex, BMI:
- KL: 1.48 (1.33, 1.65)
- Sclerosis / cyst: 1.48 (1.23, 1.77) / 1.23 (1.03, 1.47)
JSW and osteophytes not associated.
Zhang52 Functional limitations 
(questionnaire), grip 
strength
Patients with KL ≥2 and joint pain/aching/stiffness had more func-
tional limitations and lower grip strength; age adjusted difference 
(95%CI) men 3.1 kg (1.8, 4.4), women 1.9 kg (1.4, 2.4)
Histological
Sunk53,69 Modified Mankin score 
(range 0-14; >5 = OA)
Correlation with KL score (DIP/PIP): r 0.87/0.79 (P < 0.0001)
Correlation with OARSI JSN: r 0.77/0.76, osteophytes: r 0.89/0.69 (P 
< 0.0001)
Sensitivity KL ≥2 for Mankin >5 (DIP/PIP): 84.6/54.2%, specificity: 
100/100%
Drape32 Pedicled cysts DIP (yes/no) 19 pedicled cysts: 16 associated with osteophytes/JSN on CR, 3 no 
osteophytes/JSN on CR 
Grainger54 Erosions (central/marginal, 
yes/no)
37 MRI erosions: 24% also on CR (44% of central, 5% of marginal 
erosions) 
All CR erosions also on MRI
Haugen21 Oslo hand OA score 
(graded per feature)
Agreement with osteophytes κ 0.41, JSN κ 0.50, central erosions κ 
0.75, central/marginal erosions κ 0.43, cysts κ 0.11, malalignment 
κ 0.50
MRI
Wittoek55 Erosions, osteophytes (yes/
no)
Prevalence erosions: MRI PIP 29%, DIP 68%, CR PIP 11%, DIP 38%.
PIP osteophytes (erosive/non-erosive) hand OA MRI 25/50%, CR 
42/40%.
DIP osteophytes: MRI and CR >80%. 
CT
Saltzherr61 JSN, osteophytes, subchon-
dral sclerosis, cyst, erosion, 
subluxation (OA defined on 
no. of features)
Prevalence of individual features and OA higher according to CT 
than CR
US
Iagnocco56 Erosions (yes/no) US erosions in 16 (72.7%) of 22 CR erosive hand OA patients.
No US erosions in CR classical hand OA patients (n = 88).
Keen57 JSN, osteophytes (yes/no) Osteophytes: κ 0.54 (77.8% agreement)
JSN: κ 0.436 (74.6% agreement)
Kortekaas48 Osteophytes (yes/no) US osteophytes 69%, OARSI osteophytes 46% 
Mancar-
ella23






Validation method Results relevant for evaluation of validity
Mathies-
sen40
Osteophytes (yes/no) OARSI osteophytes in 30% of joints, US osteophytes in 53% of 
joints.
CR and US: 57.3% exact agreement, 88.3% close agreement.
Vlychou58 Central erosions, osteo-
phytes (yes/no)
CR detected less erosions/osteophytes (17/47%) than US (35/55%), 
P < 0.05. 
Difference most apparent in DIP and PIP.
Wittoek55 Erosions, osteophytes (yes/
no)
CR detected less erosions (PIP 11%, DIP 38%) than US (21, 52%) in 
erosive and non-erosive hand OA.
CR detected less PIP osteophytes (41%) than US (54%).
CR and US both detected >80% DIP osteophytes.
Digital photography
Jones47 Heberden nodes (yes/no) Correlation with OARSI score ≥1 in DIP joints: r 0.74 (P < 0.001) 
Jonsson38 Tissue enlargement/ 
deformity (graded 0-3 per 
joint, summed)
Prevalence OA higher according to KL ≥2 (DIP 67%, PIP 32%, CMC1 
20%) as compared to digital photograph ≥2 (DIP 33%, PIP 20%, 
CMC1 3%). 
Correlation summed score with summed total KL: males r 0.35, 
females r 0.53
Stern42 Hard tissue enlargement 
(yes/no)
Sensitivity for KL ≥2: range per joint 17-74%
Specificity for KL ≥2: range per joint 67-92%
Other measures of JSW
Huetink59 True JSW by micrometer Compared to automatic JSN quantification:
Mean difference (SD): phantom joints: 0.052 (0.014) mm, cadaver 
joints:
0.210 (0.115) mm





Association with OARSI JSN: R2 0.54, P < 0.01
AUSCAN, Australian/Canadian Hand Osteoarthritis Index; β, beta coefficient; BMI, body mass index; CI, confidence 
interval; CMC1, first carpometacarpal joint; CR, conventional radiography; CT, computed tomography; DASH, Dis-
abilities of the Arm Shoulder and Hand; DIP, distal interphalangeal joint; HAQ, Health Assessment Questionnaire; 
IP1, first interphalangeal joint; JSN, joint space narrowing; JSW, joint space width; κ, kappa; KL, Kellgren-Lawrence; 
kg, kilogram; MCP, metacarpaphalangeal joint; mm, millimeter; MRI, magnetic resonance imaging; no., number; 
OA, osteoarthritis; OARSI, Osteoarthritis Research Society International;, OR, odds ratio; PIP, proximal interphalan-
geal joint; PR, prevalence ratio; r, correlation coefficient; R2, explained variance; STT, scaphotrapezotrapezoidal 
joint; US, ultrasound; VAS, visual analogue scale. 
8
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DISCUSSION
This review aimed at evaluating the radiographic scoring methods used in hand OA re-
search and to assess their metric properties. We noticed that a wide variety of scoring 
methods has been used in studies evaluating radiographic hand OA. Furthermore, the 
joints that were examined and the analysis of the obtained scores differed extensively 
across studies. Evaluation of metric properties of the evaluated scoring methods regard-
ing reliability, sensitivity to change, feasibility and validity did not reveal major differenc-
es.  
Both intra- and interreader reliability of all evaluated radiographic scoring methods were 
good for summed scores and global scores, for both cross-sectional and longitudinal ra-
diographic scoring. When grading individual radiographic features, the highest reliability 
was reported for the scoring of erosions and osteophytes and the lowest for the scoring 
of cysts. 
When evaluating sensitivity to change, only one study evaluated this in different groups 
of patients (trial arms) using different scoring methods. Although such comparative stud-
ies may provide the best insights in sensitivity to change, the  included observational fol-
low-up studies showed the ability to detect change in structural damage over time with 
conventional radiography. Change over time was observed even in short term follow-up 
studies (<3 years). Reported SRMs were similar for all evaluated scoring methods. 
The feasibility of scoring methods has been described in a limited number of studies. The 
performance time of the scoring differed not only across the evaluated scoring method 
but also across studies, and was shown to increase with the amount of structural damage. 
A large number of studies investigated the validity of radiographic OA findings in com-
parison with clinical findings at physical examination (such as nodes and deformities) and 
symptoms and function; there was large variation between these studies. This could be 
due to the various analyses of radiographic and clinical findings, e.g., joint level versus 
patient level, and individual features versus summed scores. Furthermore, studies were 
difficult to compare because of the use of different effect measures, such as odds ratios, 
correlation coefficients, sensitivity and specificity. In general we can say that there was 
moderate agreement between radiographic features and structural findings at physical 
examination. The association of radiographic findings with hand function and symptoms 
was reported to be stronger than the association with findings at physical examination. 
All evaluated radiographic scores were associated with grip strength and pain, the re-
lation with pain was observed on joint level as well as on patient level, and was shown 
to be dependent on the radiographic severity. No differences between the evaluated 
radiographic scoring methods were observed. Only few studies assessed longitudinal 
associations between radiography and pain or function, requiring further validation.
In comparison with other imaging methods, radiography appeared to detect fewer struc-
tural damage than MRI, CT and US, and more structural damage than digital photogra-
phy. However, the findings on MRI, CT and digital photography require further confirma-
tion because of limited evidence. Agreement between radiography and other imaging 
methods was assessed most often on joint level and differed per feature. 
Although no major differences regarding the metric properties of the evaluated radi-
ographic scoring methods were observed in this review, the examined joints and anal-
ysis of the obtained scores were shown to differ extensively across studies. All kinds 
502331-L-bw-Visser
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of presentation of radiographic outcome measures were used, such as scores per joint, 
summed scores, presence/absence of radiographic OA features, or the highest scored 
joint. Summed scores were used most frequently for evaluation of the reliability of radio-
graphic scoring methods and change of structural damage over time, analyzed on patient 
level. When evaluating the validity of scoring methods, analyses on individual joint level 
or on joint group level were performed most often. 
The various examined joints within hand OA research has been described before in a 
review by Marshall et al. In addition, they evaluated the use of definitions of hand OA, 
reporting some agreement in the definition of individual joint OA but a wide variation in 
defining overall hand OA.65 Kerkhof et al. showed that the use of varying definitions of 
radiographic OA within the same study leads to different results.66 Therefore, as stated 
before by Haugen et al., standardization of the evaluation and definition of radiographic 
hand OA with respect to scoring methods, examined joints and required number of af-
fected joints could reduce the variation across studies.67
Based on this review, it is not possible to decide on what radiographic scoring method 
should be recommended in hand OA research. Although no major differences regarding 
metric properties of the scoring methods were observed, the amount of supporting ev-
idence differed for the evaluated methods, which may provide an argument for recom-
mendation of specific scoring methods. Most evidence across all evaluated domains is 
available for the KL and OARSI scoring methods. Although global scoring methods may 
be more reliable than the scoring of individual radiographic features, individual features 
may be more suitable for evaluation of specific study objectives. Therefore, the OARSI 
scoring method may be recommended for evaluation of individual radiographic features 
in addition to use of the KL scoring method for global radiographic assessment. The 
OARSI Task Force recommendations for the design and conduct of clinical trials in hand 
OA already stated that the use of either aggregate radiographic scores or grading of indi-
vidual features depends on the aim of study.9 However, consensus should be reached on 
a more specific definition; when should a global or individual feature score be used and 
what specific scoring method should be recommended. Furthermore, consensus on the 
evaluated joints, presentation of the radiographic outcome measures and the definition 
of hand OA will help to enhance the comparability of studies in hand OA. 
A limitation of this study is that the methodological quality of the included studies was 
not assessed, due to the heterogeneity across studies regarding their purpose. The het-
erogeneity regarding examined joints and analyses of obtained radiographic scores did 
not enable performance of a meta-analysis. Furthermore, publication bias was not ad-
dressed.
Although we aimed to provide a comprehensive overview of available literature, the for-
mulated inclusion and exclusion criteria resulted in a specific selection of studies.
Consequently, some radiographic scoring methods were not included in this review, be-
ing the Eaton-Littler classification system and the recently developed interphalangeal 
OA radiographic simplified (iOARS) score. These methods have not been evaluated for 
reliability together with another method.68,69
Since sensitivity to change was evaluated in follow-up studies assessing hand OA by at 
least two radiographic scoring methods in case of long-term follow-up studies (>3 year), 
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In the evaluation of the feasibility of the available radiographic scoring methods in hand 
OA, we did not focus on the importance of radiographic techniques. Dela Rosa et al. 
evaluated the reliability of scoring OA of the CMC1s according to the Eaton method when 
using different X-ray views, showing that a combination of the posterior-anterior, lateral 
and Bett’s view showed a higher reliability than using only one or two views.73 Stand-
ardization of radiographic techniques might further enhance comparability of studies in 
hand OA. 
In conclusion, this systematic review provides an overview of the radiographic scoring 
methods used in the assessment of structural damage in hand OA. We showed that sev-
eral scoring methods are available, evaluation of their metric properties regarding reli-
ability, sensitivity to change, feasibility and validity did not reveal major differences. The 
examined joints and analysis of the obtained radiographic scores differed extensively 
across all studies. To enhance comparability across studies in hand OA, consensus has 
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Overview of literature search per database
Total d.d. 21-11-2013:  1873 references, extracted from the following databases:
• PubMed:  963
• Embase:   1234, of which 506 unique
• Web of Science:  830, of which 274 unique
• CINAHL:  205, of which 108 unique
• COCHRANE:  60, of which 22 unique
PubMed
(((x-ray[ti] OR x-rays[ti] OR xray[ti] OR xrays[ti] OR radiograph[ti] OR radiographs[ti] OR 
radiography[ti] OR “Radiography”[majr] OR radiographic[ti] OR radiograph*[ti] OR ron-
tgen[tiab] OR roentgen[ti] OR radiological[ti] OR radiologic[ti] OR imaging[ti] OR radi-
ology[ti]) AND (“hand osteoarthritis”[ti] OR ((“Hand Joints”[majr] OR “Hand”[majr] OR 
“Hand Bones”[majr] OR Hand[ti] OR Carpal[ti] OR Carpometacarpal[ti] OR Finger[ti] OR 
Metacarpophalangeal[ti] OR Wrist[ti] OR Intermetacarpal[ti] OR Hands[ti] OR Fingers[-
ti] OR Thumb[ti] OR Thumbs[ti] OR Metacarpus[ti] OR Metacarpal[ti] OR Wrists[ti]) AND 
(“Osteoarthritis”[Majr] OR Osteoarthritis[ti] OR Osteoarthrit*[ti] OR Osteoarthrosis[ti] OR 
Osteoarthroses[ti] OR “Degenerative Arthritis”[ti] OR “Osteoarthrosis Deformans”[ti] OR 
OA[ti])))) OR ((“radiographic osteoarthritis” OR “radiographic disease” OR “radiographic 
damage” OR “radiological osteoarthritis” OR “radiological disease” OR “radiological dam-
age”) AND (“hand osteoarthritis” OR ((“Hand Joints”[mesh] OR “Hand”[mesh] OR “Hand 
Bones”[mesh] OR “Hand Joints” OR “Hand Joint” OR “Carpal Joints” OR “Carpal Joint” 
OR “Carpometacarpal Joints” OR “Carpometacarpal Joint” OR “Finger Joint” OR “Finger 
Joints” OR “Metacarpophalangeal Joint” OR “Metacarpophalangeal Joints” OR “Volar 
Plate” OR “Wrist Joint” OR “Wrist Joints” OR “Triangular Fibrocartilage” OR “Intermetacar-
pal Joints” OR Hand OR Hands OR Finger OR Fingers OR Thumb OR Thumbs OR Meta-
carpus OR Metacarpal OR Wrist OR Wrists OR “Metacarpal Bones” OR “Metacarpal Bone”) 
AND (“Osteoarthritis”[Mesh] OR Osteoarthritis OR Osteoarthrit* OR Osteoarthritides OR 
Osteoarthrosis[tiab] OR Osteoarthroses OR “Degenerative Arthritis” OR “Osteoarthrosis 
Deformans” OR OA[tiab])))) OR ((score OR scores OR scored OR scoring OR kellgren[tiab] 
OR lawrence[tiab] OR kessler[tiab] OR kallman[tiab] OR OARSI[tiab] OR verbruggen[tiab] 
OR veys[tiab] OR GUSS[tiab] OR osteophytes OR osteophyte OR “joint space narrowing” 
OR erosion OR erosions OR sclerosis OR cyst OR cysts OR deformity OR deformities OR 
malalignment OR damage OR “joint space” OR “joint spaces” OR ((joint[ti] OR joints[-
ti]) AND (space[ti] OR spaces[ti]))) AND (x-ray[tw] OR x-rays[tw] OR xray[tw] OR xrays[tw] 
OR radiograph[tw] OR radiographs[tw] OR radiography[tw] OR “radiography”[Subhead-
ing] OR “Radiography”[mesh] OR radiographic[tw] OR radiograph*[tw] OR rontgen[tiab] 
OR roentgen[tiab] OR radiological[tw] OR radiologic[tw]) AND (“hand osteoarthritis” OR 
((“Hand Joints”[mesh] OR “Hand”[mesh] OR “Hand Bones”[mesh] OR “Hand Joints” OR 
“Hand Joint” OR “Carpal Joints” OR “Carpal Joint” OR “Carpometacarpal Joints” OR “Car-
pometacarpal Joint” OR “Finger Joint” OR “Finger Joints” OR “Metacarpophalangeal Joint” 
OR “Metacarpophalangeal Joints” OR “Volar Plate” OR “Wrist Joint” OR “Wrist Joints” OR 
“Triangular Fibrocartilage” OR “Intermetacarpal Joints” OR Hand OR Hands OR Finger OR 
Fingers OR Thumb OR Thumbs OR Metacarpus OR Metacarpal OR Wrist OR Wrists OR 
“Metacarpal Bones” OR “Metacarpal Bone”) AND (“Osteoarthritis”[Mesh] OR Osteoarthri-
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tis OR Osteoarthrit* OR Osteoarthritides OR Osteoarthrosis[tiab] OR Osteoarthroses OR 
“Degenerative Arthritis” OR “Osteoarthrosis Deformans” OR OA[tiab]))))) AND english[la]
Embase
(((x-ray.ti OR x-rays.ti OR xray.ti OR xrays.ti OR radiograph.ti OR radiographs.ti OR radiog-
raphy.ti OR exp *Radiography/ OR radiographic.ti OR radiograph*.ti OR rontgen.ti,ab OR 
roentgen.ti OR radiological.ti OR radiologic.ti OR imaging.ti OR radiology.ti) AND (“hand 
osteoarthritis”.ti OR “osteoarthritis hand”.ti OR “thumb osteoarthritis”.ti OR “finger osteoar-
thritis”.ti OR “hand oa”.ti OR “finger oa”.ti OR ((exp *Hand/ OR exp *Hand Bone/ OR Hand.
ti OR Carpal.ti OR Carpometacarpal.ti OR Finger.ti OR Metacarpophalangeal.ti OR Wrist.ti 
OR Intermetacarpal.ti OR Hands.ti OR Fingers.ti OR Thumb.ti OR Thumbs.ti OR Metacarpus.
ti OR Metacarpal.ti OR Wrists.ti) AND (exp *Osteoarthritis/ OR Osteoarthritis.ti OR Osteo-
arthrit*.ti OR Osteoarthrosis.ti OR Osteoarthroses.ti OR “Degenerative Arthritis”.ti OR “Os-
teoarthrosis Deformans”.ti OR OA.ti)))) OR ((“radiographic osteoarthritis” OR “radiograph-
ic disease” OR “radiographic damage” OR “radiological osteoarthritis” OR “radiological 
disease” OR “radiological damage”).mp AND (“hand osteoarthritis”.mp OR “osteoarthritis 
hand”.mp OR “thumb osteoarthritis”.mp OR “finger osteoarthritis”.mp OR “hand oa”.mp 
OR “finger oa”.mp OR ((exp Hand/ OR exp Hand Bone/ OR (“Hand Joints” OR “Hand Joint” 
OR “Carpal Joints” OR “Carpal Joint” OR “Carpometacarpal Joints” OR “Carpometacarpal 
Joint” OR “Finger Joint” OR “Finger Joints” OR “Metacarpophalangeal Joint” OR “Metacar-
pophalangeal Joints” OR “Volar Plate” OR “Wrist Joint” OR “Wrist Joints” OR “Triangular 
Fibrocartilage” OR “Intermetacarpal Joints” OR Hand OR Hands OR Finger OR Fingers OR 
Thumb OR Thumbs OR Metacarpus OR Metacarpal OR Wrist OR Wrists OR “Metacarpal 
Bones” OR “Metacarpal Bone”).mp) AND (exp Osteoarthritis/ OR (Osteoarthritis OR Osteo-
arthrit* OR Osteoarthritides OR Osteoarthrosis.ti,ab OR Osteoarthroses OR “Degenerative 
Arthritis” OR “Osteoarthrosis Deformans”).mp OR OA.ti,ab)))) OR ((score*.mp OR scoring.
mp OR scoring system/ OR kellgren.mp OR lawrence.mp OR kessler.mp OR kallman.mp 
OR OARSI.mp OR verbruggen.mp OR veys.mp OR GUSS.mp OR osteophyte*.mp OR os-
teophyte/ OR “joint space narrowing”.mp OR bone erosion/ OR erosion*.mp OR sclerosis.
mp OR exp sclerosis/ OR cyst.mp OR cysts.mp OR deformit*.mp OR malalignment.mp OR 
damage.mp OR “joint space”.mp OR “joint spaces”.mp OR ((joint.ti OR joints.ti) AND (space.
ti OR spaces.ti))) AND (x-ray.mp OR x-rays.mp OR xray.mp OR xrays.mp OR radiograph.
mp OR radiographs.mp OR radiography.mp OR exp radiography/ OR radiographic.mp OR 
radiograph*.mp OR rontgen.ti,ab OR roentgen.ti,ab OR radiological.mp OR radiologic.mp) 
AND (“hand osteoarthritis”.mp OR “osteoarthritis hand”.mp OR “thumb osteoarthritis”.mp 
OR “finger osteoarthritis”.mp OR “hand oa”.mp OR “finger oa”.mp OR ((exp Hand/ OR exp 
Hand Bone/ OR (“Hand Joints” OR “Hand Joint” OR “Carpal Joints” OR “Carpal Joint” OR 
“Carpometacarpal Joints” OR “Carpometacarpal Joint” OR “Finger Joint” OR “Finger Joints” 
OR “Metacarpophalangeal Joint” OR “Metacarpophalangeal Joints” OR “Volar Plate” OR 
“Wrist Joint” OR “Wrist Joints” OR “Triangular Fibrocartilage” OR “Intermetacarpal Joints” 
OR Hand OR Hands OR Finger OR Fingers OR Thumb OR Thumbs OR Metacarpus OR Met-
acarpal OR Wrist OR Wrists OR “Metacarpal Bones” OR “Metacarpal Bone”).mp) AND (exp 
Osteoarthritis/ OR (Osteoarthritis OR Osteoarthrit* OR Osteoarthritides OR Osteoarthrosis.
ti,ab OR Osteoarthroses OR “Degenerative Arthritis” OR “Osteoarthrosis Deformans”).mp 




((TI=(x-ray OR x-rays OR xray OR xrays OR radiograph OR radiographs OR radiography OR 
Radiography OR radiographic OR radiograph* OR rontgen OR roentgen OR radiological 
OR radiologic OR imaging OR radiology) AND TI=(“hand osteoarthritis” OR “osteoarthritis 
hand” OR “thumb osteoarthritis” OR “finger osteoarthritis” OR “hand oa” OR “finger oa” OR 
((Hand OR Hand Bone OR Hand OR Carpal OR Carpometacarpal OR Finger OR Metacar-
pophalangeal OR Wrist OR Intermetacarpal OR Hands OR Fingers OR Thumb OR Thumbs 
OR Metacarpus OR Metacarpal OR Wrists) AND (Osteoarthritis OR Osteoarthritis OR Os-
teoarthrit* OR Osteoarthrosis OR Osteoarthroses OR “Degenerative Arthritis” OR “Oste-
oarthrosis Deformans” OR OA)))) OR TS=((“radiographic osteoarthritis” OR “radiographic 
disease” OR “radiographic damage” OR “radiological osteoarthritis” OR “radiological dis-
ease” OR “radiological damage”) AND (“hand osteoarthritis” OR “osteoarthritis hand” OR 
“thumb osteoarthritis” OR “finger osteoarthritis” OR “hand oa” OR “finger oa” OR ((Hand 
OR Hand Bone OR (“Hand Joints” OR “Hand Joint” OR “Carpal Joints” OR “Carpal Joint” OR 
“Carpometacarpal Joints” OR “Carpometacarpal Joint” OR “Finger Joint” OR “Finger Joints” 
OR “Metacarpophalangeal Joint” OR “Metacarpophalangeal Joints” OR “Volar Plate” OR 
“Wrist Joint” OR “Wrist Joints” OR “Triangular Fibrocartilage” OR “Intermetacarpal Joints” 
OR Hand OR Hands OR Finger OR Fingers OR Thumb OR Thumbs OR Metacarpus OR 
Metacarpal OR Wrist OR Wrists OR “Metacarpal Bones” OR “Metacarpal Bone”)) AND (Os-
teoarthritis OR (Osteoarthritis OR Osteoarthrit* OR Osteoarthritides OR Osteoarthrosis OR 
Osteoarthroses OR “Degenerative Arthritis” OR “Osteoarthrosis Deformans”) OR OA)))) OR 
TS=((score* OR scoring OR scoring system OR kellgren OR lawrence OR kessler OR kallman 
OR OARSI OR verbruggen OR veys OR GUSS OR osteophyte* OR osteophyte OR “joint 
space narrowing” OR bone erosion OR erosion* OR sclerosis OR sclerosis OR cyst OR cysts 
OR deformit* OR malalignment OR damage OR “joint space” OR “joint spaces” OR ((joint 
OR joints) AND (space OR spaces))) AND (x-ray OR x-rays OR xray OR xrays OR radiograph 
OR radiographs OR radiography OR radiography OR radiographic OR radiograph* OR ron-
tgen OR roentgen OR radiological OR radiologic) AND (“hand osteoarthritis” OR “osteoar-
thritis hand” OR “thumb osteoarthritis” OR “finger osteoarthritis” OR “hand oa” OR “finger 
oa” OR ((Hand OR Hand Bone OR (“Hand Joints” OR “Hand Joint” OR “Carpal Joints” OR 
“Carpal Joint” OR “Carpometacarpal Joints” OR “Carpometacarpal Joint” OR “Finger Joint” 
OR “Finger Joints” OR “Metacarpophalangeal Joint” OR “Metacarpophalangeal Joints” OR 
“Volar Plate” OR “Wrist Joint” OR “Wrist Joints” OR “Triangular Fibrocartilage” OR “Inter-
metacarpal Joints” OR Hand OR Hands OR Finger OR Fingers OR Thumb OR Thumbs OR 
Metacarpus OR Metacarpal OR Wrist OR Wrists OR “Metacarpal Bones” OR “Metacarpal 
Bone”)) AND (Osteoarthritis OR (Osteoarthritis OR Osteoarthrit* OR Osteoarthritides OR 
Osteoarthrosis OR Osteoarthroses OR “Degenerative Arthritis” OR “Osteoarthrosis Defor-
mans”) OR OA))))) AND la=english
CINAHL
((((x-ray OR x-rays OR xray OR xrays OR radiograph OR radiographs OR radiography OR 
Radiography OR radiographic OR radiograph* OR rontgen OR roentgen OR radiologi-
cal OR radiologic OR imaging OR radiology) AND (“hand osteoarthritis” OR “osteoarthri-
tis hand” OR “thumb osteoarthritis” OR “finger osteoarthritis” OR “hand oa” OR “finger 
oa” OR ((Hand OR Hand Bone OR Hand OR Carpal OR Carpometacarpal OR Finger OR 
Metacarpophalangeal OR Wrist OR Intermetacarpal OR Hands OR Fingers OR Thumb OR 
8
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Thumbs OR Metacarpus OR Metacarpal OR Wrists) AND (Osteoarthritis OR Osteoarthritis 
OR Osteoarthrit* OR Osteoarthrosis OR Osteoarthroses OR “Degenerative Arthritis” OR 
“Osteoarthrosis Deformans” OR OA)))) OR ((“radiographic osteoarthritis” OR “radiographic 
disease” OR “radiographic damage” OR “radiological osteoarthritis” OR “radiological dis-
ease” OR “radiological damage”) AND (“hand osteoarthritis” OR “osteoarthritis hand” OR 
“thumb osteoarthritis” OR “finger osteoarthritis” OR “hand oa” OR “finger oa” OR ((Hand 
OR Hand Bone OR (“Hand Joints” OR “Hand Joint” OR “Carpal Joints” OR “Carpal Joint” OR 
“Carpometacarpal Joints” OR “Carpometacarpal Joint” OR “Finger Joint” OR “Finger Joints” 
OR “Metacarpophalangeal Joint” OR “Metacarpophalangeal Joints” OR “Volar Plate” OR 
“Wrist Joint” OR “Wrist Joints” OR “Triangular Fibrocartilage” OR “Intermetacarpal Joints” 
OR Hand OR Hands OR Finger OR Fingers OR Thumb OR Thumbs OR Metacarpus OR 
Metacarpal OR Wrist OR Wrists OR “Metacarpal Bones” OR “Metacarpal Bone”)) AND (Os-
teoarthritis OR (Osteoarthritis OR Osteoarthrit* OR Osteoarthritides OR Osteoarthrosis OR 
Osteoarthroses OR “Degenerative Arthritis” OR “Osteoarthrosis Deformans”) OR OA)))) OR 
((score* OR scoring OR scoring system OR kellgren OR lawrence OR kessler OR kallman OR 
OARSI OR verbruggen OR veys OR GUSS OR osteophyte* OR osteophyte OR “joint space 
narrowing” OR bone erosion OR erosion* OR sclerosis OR sclerosis OR cyst OR cysts OR 
deformit* OR malalignment OR damage OR “joint space” OR “joint spaces” OR ((joint OR 
joints) AND (space OR spaces))) AND (x-ray OR x-rays OR xray OR xrays OR radiograph OR 
radiographs OR radiography OR radiography OR radiographic OR radiograph* OR rontgen 
OR roentgen OR radiological OR radiologic) AND (“hand osteoarthritis” OR “osteoarthri-
tis hand” OR “thumb osteoarthritis” OR “finger osteoarthritis” OR “hand oa” OR “finger 
oa” OR ((Hand OR Hand Bone OR (“Hand Joints” OR “Hand Joint” OR “Carpal Joints” OR 
“Carpal Joint” OR “Carpometacarpal Joints” OR “Carpometacarpal Joint” OR “Finger Joint” 
OR “Finger Joints” OR “Metacarpophalangeal Joint” OR “Metacarpophalangeal Joints” OR 
“Volar Plate” OR “Wrist Joint” OR “Wrist Joints” OR “Triangular Fibrocartilage” OR “Inter-
metacarpal Joints” OR Hand OR Hands OR Finger OR Fingers OR Thumb OR Thumbs OR 
Metacarpus OR Metacarpal OR Wrist OR Wrists OR “Metacarpal Bones” OR “Metacarpal 
Bone”)) AND (Osteoarthritis OR (Osteoarthritis OR Osteoarthrit* OR Osteoarthritides OR 
Osteoarthrosis OR Osteoarthroses OR “Degenerative Arthritis” OR “Osteoarthrosis Defor-
mans”) OR OA)))))) AND la=english
COCHRANE
all text (reliability OR validity OR responsiveness OR reliab* OR valid OR sensitivity OR sen-
sitive OR feasibility OR  accuracy OR accurate OR truth OR discrimination) 
TI/ab/kw (x-ray OR x-rays OR xray OR xrays OR radiograph OR radiographs OR radiog-
raphy OR Radiography OR radiographic OR radiograph* OR rontgen OR roentgen OR 
radiological OR radiologic OR imaging OR radiology) AND (“hand osteoarthritis” OR “os-
teoarthritis hand” OR “thumb osteoarthritis” OR “finger osteoarthritis” OR “hand oa” OR 
“finger oa” OR ((Hand OR Hand Bone OR Hand OR Carpal OR Carpometacarpal OR Finger 
OR Metacarpophalangeal OR Wrist OR Intermetacarpal OR Hands OR Fingers OR Thumb 
OR Thumbs OR Metacarpus OR Metacarpal OR Wrists) AND (Osteoarthritis OR Osteoar-
thritis OR Osteoarthrit* OR Osteoarthrosis OR Osteoarthroses OR “Degenerative Arthritis” 
OR “Osteoarthrosis Deformans” OR OA)))
ti/ab/kw ((“radiographic osteoarthritis” OR “radiographic disease” OR “radiographic dam-
age” OR “radiological osteoarthritis” OR “radiological disease” OR “radiological damage”) 
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AND (“hand osteoarthritis” OR “osteoarthritis hand” OR “thumb osteoarthritis” OR “finger 
osteoarthritis” OR “hand oa” OR “finger oa” OR ((Hand OR Hand Bone OR (“Hand Joints” 
OR “Hand Joint” OR “Carpal Joints” OR “Carpal Joint” OR “Carpometacarpal Joints” OR 
“Carpometacarpal Joint” OR “Finger Joint” OR “Finger Joints” OR “Metacarpophalangeal 
Joint” OR “Metacarpophalangeal Joints” OR “Volar Plate” OR “Wrist Joint” OR “Wrist Joints” 
OR “Triangular Fibrocartilage” OR “Intermetacarpal Joints” OR Hand OR Hands OR Finger 
OR Fingers OR Thumb OR Thumbs OR Metacarpus OR Metacarpal OR Wrist OR Wrists OR 
“Metacarpal Bones” OR “Metacarpal Bone”)) AND (Osteoarthritis OR (Osteoarthritis OR 
Osteoarthrit* OR Osteoarthritides OR Osteoarthrosis OR Osteoarthroses OR “Degenerative 
Arthritis” OR “Osteoarthrosis Deformans”) OR OA)))) 
ti/ab/kw ((score* OR scoring OR scoring system OR kellgren OR lawrence OR kessler OR 
kallman OR OARSI OR verbruggen OR veys OR GUSS OR osteophyte* OR osteophyte OR 
“joint space narrowing” OR bone erosion OR erosion* OR sclerosis OR sclerosis OR cyst 
OR cysts OR deformit* OR malalignment OR damage OR “joint space” OR “joint spaces” 
OR ((joint OR joints) AND (space OR spaces))) AND (x-ray OR x-rays OR xray OR xrays OR 
radiograph OR radiographs OR radiography OR radiography OR radiographic OR radi-
ograph* OR rontgen OR roentgen OR radiological OR radiologic) AND (“hand osteoar-
thritis” OR “osteoarthritis hand” OR “thumb osteoarthritis” OR “finger osteoarthritis” OR 
“hand oa” OR “finger oa” OR ((Hand OR Hand Bone OR (“Hand Joints” OR “Hand Joint” 
OR “Carpal Joints” OR “Carpal Joint” OR “Carpometacarpal Joints” OR “Carpometacarpal 
Joint” OR “Finger Joint” OR “Finger Joints” OR “Metacarpophalangeal Joint” OR “Metacar-
pophalangeal Joints” OR “Volar Plate” OR “Wrist Joint” OR “Wrist Joints” OR “Triangular 
Fibrocartilage” OR “Intermetacarpal Joints” OR Hand OR Hands OR Finger OR Fingers OR 
Thumb OR Thumbs OR Metacarpus OR Metacarpal OR Wrist OR Wrists OR “Metacarpal 
Bones” OR “Metacarpal Bone”)) AND (Osteoarthritis OR (Osteoarthritis OR Osteoarthrit* 
OR Osteoarthritides OR Osteoarthrosis OR Osteoarthroses OR “Degenerative Arthritis” OR 
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 Summary and discussion
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Osteoarthritis (OA) is a highly prevalent disease and a major cause of disability.1 The 
pathogenesis of OA is largely unknown; however, several risk factors are known to con-
tribute to disease development. Although the clinical burden of OA is high, treatment 
modalities are currently limited to alleviation of symptoms.2,3 The lack of disease-modi-
fying treatment is not only due to the incomplete understanding of the pathogenesis of 
OA but also to the lack of high-quality studies on OA treatment. In order to develop bet-
ter treatment modalities, increase of the understanding of the underlying mechanisms 
leading to OA development may provide targets for disease modification. Furthermore, 
knowledge regarding appropriate outcome measures that can be applied in OA research 
has to be increased for adequate assessment of potential treatment effects. 
Therefore, part I of this thesis describes studies aiming to increase the understanding of 
the mechanisms underlying the association between known risk factors such as obesity 
and OA. In addition, part II of this thesis focuses on appropriate outcome measures that 
can be applied in hand OA research.
Part I. Mechanisms underlying the association between risk 
factors and OA
Part I of this thesis focuses on the mechanisms underlying the association between known 
risk factors and OA, especially on obesity in association to OA of both weight-bearing and 
non-weight-bearing joints. Since obesity acts as a risk factor for OA in both weight-bear-
ing and non-weight-bearing joints, obesity-associated systemic factors could play an 
important role in OA, in addition to mechanical overload.4,5 Data of the Netherlands Epi-
demiology of Obesity (NEO) study has been used for this part of the thesis.6
Mechanical stress and systemic processes in different types of OA
In chapter 2 we investigated the relative contribution of surrogates for mechanical 
stress and systemic processes in OA of weight-bearing and non-weight-bearing joints. 
Surrogates for mechanical stress were weight and fat free mass whereas the metabolic 
syndrome was a surrogate for systemic processes. Fat mass could act as surrogate for 
both mechanical stress and systemic processes by adjusting for either the metabolic syn-
drome or weight. Analyses on the association of these measures with clinical OA of the 
weight-bearing knee joints alone, non-weight-bearing hand joints alone or with OA of 
both knees and hands suggested that in knee OA, whether or not in co-occurrence with 
hand OA, surrogates for mechanical stress are the most important risk factors. In hand 
OA alone on the contrary, surrogates for systemic processes seem the most important 
risk factors.
The association of surrogates for mechanical stress with knee OA is in accordance with 
the current literature and supports the hypotheses of damaged joint tissue due to ex-
cessive mechanical stress on the joint surface of obese individuals.7-11 The contribution of 
mechanical and systemic processes to presence of both knee and hand OA has not been 
assessed before. Although our hypothesis was that this type of polyarticular OA might be 
driven by systemic processes, presence of both knee and hand OA was associated with 
surrogates for mechanical stress, even after adjustment for metabolic factors, just as the 
presence of knee OA alone was associated to these factors. This suggests that co-occur-
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rence of knee and hand OA may represent presence of two different types of OA instead 
of being driven by a common underlying pathogenic mechanism. The relatively strong 
association between mechanical stress and knee OA may dominate the association be-
tween the metabolic syndrome and hand OA when assessing their associations with OA 
co-occurring in knees and hands. The association between the metabolic syndrome and 
presence of hand OA alone might be explained by systemic inflammation. As further 
investigated and discussed in chapter 3, adipose tissue is known as a source of pro- and 
anti-inflammatory cytokines which have been related to the metabolic syndrome12 and 
have been suggested to affect joint tissues.13-15 
Adiposity and OA in non-weight-bearing joints
In chapter 3, the association between adiposity and OA was investigated by analyzing 
the association of adipose tissue and its abdominal distribution with presence of OA in 
the non-weight-bearing hand joints. Fat percentage and fat mass were estimated using 
bioelectrical impedance analysis and the waist-to-hip ratio was calculated. Visceral adi-
pose tissue and subcutaneous adipose tissue were assessed using abdominal magnetic 
resonance (MR) imaging. Associations between these measures of adiposity and clinical 
hand OA were analyzed in men and women separately because of the anthropomor-
phic differences between the sexes. Fat percentage, fat mass and the waist-to-hip ratio 
were associated with hand OA in both men and women. In addition, in contrast with the 
amount of subcutaneous adipose tissue, the amount of visceral adipose tissue was asso-
ciated with hand OA in men. 
This suggests that both the adipose tissue mass and its distribution are of importance 
in the pathogenesis of hand OA. Especially visceral fat seems involved. Although this is 
the first study showing this association, visceral fat has previously been associated with 
other obesity-related comorbidities as diabetes mellitus, atherosclerosis and metabolic 
risk factors.16-20 
As described above, adipose tissue secretes cytokines which seem to act locally in joint 
tissues. Especially visceral fat has been suggested to secrete these bioactive cytokines,21 
acting as a pathogenic fat depot involved in the pathogenesis of hand OA. 
The association between visceral adipose tissue and hand OA was not significant in wom-
en, this may be explained by the greater overall mass of fat and reduced susceptibility to 
accumulate visceral fat in women as compared with men. Other explanations could be 
a role of unmeasured or unknown factors such as hormonal status or genetic effects in 
hand OA in women, overshadowing a possible effect of visceral fat. 
Obesity and OA in weight-bearing joints
In chapter 4, the association of fat mass and skeletal muscle mass with OA of the knees 
was assessed in order to enhance the understanding of the role of obesity in knee OA. 
The amounts of fat mass and skeletal muscle mass were assessed both as absolute mass 
in kilograms and as percentage of the total body mass. Again, associations were investi-
gated separately in men and women. Fat mass, fat percentage and skeletal muscle mass 
were all positively associated with knee OA, while the percentage of skeletal muscle was 
negatively associated with knee OA. Especially a high fat mass relative to a low skeletal 
muscle mass ratio was unfavourable. 
The positive association between skeletal muscle mass and OA could be explained by 
9
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differences in physical activity or joint loading. In obese individuals, the amount of skel-
etal muscle increases due to increased loading. However, this increase in skeletal muscle 
mass is not sufficient in relation to the total weight gain since fat mass increases more 
with increasing weight, resulting in a lower skeletal muscle percentage in obese individ-
uals. This explains the opposite associations of the skeletal muscle as absolute amount 
and as percentage of the total body mass with OA. The metabolic syndrome, frequently 
occurring in obese individuals, may provide an alternative explanation for the negative 
association between skeletal muscle percentage and knee OA. In individuals with the 
metabolic syndrome, insulin resistance and systemic inflammation can result in changes 
in striated muscle, causing loss of muscle mass and muscle weakness.22 
The sex-stratified analyses suggested that in men skeletal muscle mass was most impor-
tant in knee OA whereas in women fat mass was most important. This suggests that the 
pathogenesis of knee OA in men might be mainly biomechanical whereas the aetiology 
in women is mainly systemic. Since a low fat mass relative to high skeletal muscle mass 
was beneficial in both men and women, interventions aiming at improvement of skeletal 
muscle in addition to weight reduction might be useful in the prevention and treatment 
of knee OA in both sexes. 
The different measures of skeletal muscle mass and fat mass were associated both with 
clinical and structural knee OA, showing that all parameters associated with clinical OA 
were associated even stronger with structural OA, especially in women. The use of both 
clinical and structural classified OA revealed a large discrepancy between these two defi-
nitions; about one third of the individuals with clinical or structural OA met both defini-
tions. This discrepancy underscores the difference between the definitions; whereas in 
clinical OA objective symptoms as pain are of great importance, structural OA diagnosis 
was based only on structural abnormalities assessed by MR imaging. 
Structural abnormalities identifying symptomatic OA
Although OA is characterized by degenerative changes of joint structures, not all structur-
al abnormalities are specific for OA since they can also be present in individuals without 
OA.23-26 In chapter 5, we investigated which specific structural abnormalities on specific 
locations within the knee joint could best discriminate presence of symptomatic OA in 
the same knee to increase the understanding of the disease processes leading to symp-
tomatic OA. Structural abnormalities on different locations within the joint (osteophytes, 
cartilage loss, bone marrow lesions, cysts, meniscal abnormalities, effusion, Baker’s cyst) 
were assessed by MR imaging. The association between all structural abnormalities on 
different locations within the joint and symptomatic knee OA was assessed taking co-oc-
currence of all structural abnormalities into account. In the entire study population, com-
prising individuals with and without symptomatic knee OA, structural abnormalities were 
highly frequent in both the tibiofemoral and patellofemoral compartments of the knee. 
When assessing what structural abnormalities could best distinguish between individuals 
with and without symptomatic knee OA, Baker’s cysts showed the strongest regression 
coefficient for presence of symptomatic knee OA, followed by effusion and structural ab-
normalities as osteophytes and bone marrow lesions, most prominent in the medial side 
of the tibiofemoral compartment of the knee. 
Although this is not the first study assessing structural abnormalities in relation to pres-
ence of symptomatic knee OA or knee pain, it is innovative because of the analyses taking 
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co-occurrence of all assessed structural abnormalities in all locations within the knee 
into account. This may explain the differences observed in this study as compared with 
available literature as well as the conflicting results within available literature. A system-
atic review on structural abnormalities in relation to knee pain in OA reports supporting 
evidence for the role of effusion and bone marrow lesions in symptomatic knee OA; how-
ever the role of osteophytes and cartilage defects was not clear because of conflicting 
results.27 Our study showed a clear association of osteophytes, especially in the medial 
side of the tibiofemoral joint, with symptomatic knee OA. Although we observed a high 
prevalence of cartilage defects, they were found to be of less importance in symptomat-
ic knee OA than osteophytes. This may be explained by the frequent co-occurrence of 
cartilage defects and osteophytes that was observed within the study population. When 
taking this co-occurrence into account, only one of these abnormalities will be associated 
with presence of symptomatic OA. 
Baker’s cysts co-occurred with other structural abnormalities in the knee joint less fre-
quently than cartilage defects and osteophytes and were found to be a good marker to 
distinguish individuals with symptomatic knee OA from those without. Development of 
Baker’s cysts has been suggested to be caused by inflammation since synovial inflamma-
tion in the knee has been associated with Baker’s cysts.28 Perhaps treatment of knee OA 
has to focus on prevention of development of Baker’s cysts by treatment of inflammation.
OA and risk factors in relation to health-related quality of life
OA is the second largest contributor to disability of all musculoskeletal disorders and has 
negative impact on health-related quality of life (HRQOL).1,29-31 Some of the known risk 
factors for OA have not only been associated with development of OA but also with a 
decreased HRQOL. It could be that presence of OA together with such a risk factor that 
also has impact on HRQOL results in strengthening of both adverse associations with 
HRQOL. To gain insight into possible targets for improvement or prevention of decline 
in HRQOL in knee OA patients, in chapter 6 we evaluated the impact of knee OA and its 
modifiable or preventable risk factors obesity, fat free mass (as proxy for muscle mass) 
and comorbidities. In addition, the interaction between knee OA and these risk factors in 
relation to HRQOL was examined. HRQOL was assessed using the Short Form 36 Physical 
Component Summary score. Knee OA was associated with a clinically relevant reduced 
HRQOL, as were its risk factors, obesity, comorbidities, and low fat free mass. In men, fat 
free mass interacted with knee OA, leading to an additional decrease of HRQOL in the 
case of co-occurrence of low fat free mass and knee OA. No such interactions with obe-
sity or comorbidities were observed. 
In accordance with the previous discussed chapters also this study showed different re-
sults for men and women. While in men a low percentage of fat free mass was associated 
with impaired HRQOL, the most impaired HRQOL for women was observed in individuals 
with knee OA in the highest tertile of fat free mass. It may well be that the amount and 
intensity of physical activity, probably related to both the amount of muscle mass and to 
HRQOL, is higher in men than in women. Although the exact underlying mechanism for 
the observed difference is not clear, our findings supports the hypothesis of differences 
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Although disease-modifying treatment is not yet available for knee OA, this study sug-
gests that especially improvement of fat free mass may improve HRQOL in knee OA 
patients. This is supported by a study that reported weight reduction and performance 
of exercises to improve HRQOL in knee OA patients.32 Although to a lesser extent inter-
ventions aiming at obesity and prevention or strict control and treatment of comorbid-
ities may also maintain or improve HRQOL in knee OA patients. This has not yet been 
evaluated in a longitudinal study.
Discussion and future perspectives
This thesis increases the understanding of the mechanisms underlying the association 
between known risk factors and OA in different joints, focusing especially on obesi-
ty. In the association between obesity and OA both mechanical and systemic mecha-
nisms are involved, where mechanical processes  have the most important role in OA of 
weight-bearing joint and systemic processes in OA of non-weight-bearing joints. 
As discussed by Cicuttini et al. in a response to the study on the relative contribution of 
mechanical stress and systemic processes in OA of different joints described in chapter 2, 
the different risk factors may overlap in their effect on the joints although the mechanisms 
by which such risk factors specifically affect joints may differ (see appendix 1). Chapter 2 
suggests a major effect of systemic processes in OA of non-weight-bearing joints and a 
major effect of mechanical processes on OA of weight-bearing joints. In their response 
to this study, Cicuttini et al. mentioned previously shown associations between markers 
for metabolic processes (increased fat mass, glucose levels, inflammatory cytokines) and 
cartilage loss (described as early preclinical stage of OA) of the weight-bearing knee joint. 
In addition, they describe low grade synovitis and the adipokine adiponectin to be asso-
ciated with cartilage loss in knee OA.33 Although these associations suggest a systemic or 
local effect of metabolic processes in the early development of knee OA, biomechanical 
factors were not taken into account in these analyses. As described in chapter 2, it could 
be that systemic processes have a minor effect on knee OA but are overshadowed by the 
major effect of mechanical factors. 
However, all associations between different measures of obesity and OA described in 
this thesis were the result of cross-sectional analyses. Longitudinal data could confirm 
and further elucidate the role of both biomechanical and systemic mechanisms in the 
pathogenesis of OA. Follow-up data of the NEO study are currently obtained and will be 
of help. To further unravel the role of systemic processes in OA development, measures 
of the underlying mechanisms should be assessed over time. 
Also additional cross-sectional studies in other assumed underlying mediating processes, 
such as adipokines, hyperglycemia or diabetes mellitus and atherosclerosis are of inter-
est. Measurement of adipokines, such as leptin, adiponectin, resistin and visfatin, will 
provide more insight in the systemic role of adipose tissue in OA development. These 
are especially of interest in hand OA development, since in an earlier study we showed a 
negative association between adiponectin and radiographic progression of hand OA.34 
The role of atherosclerosis in OA development may be further investigated by relating 
measures of atherosclerosis such as cholesterol levels and the intima media thickness to 
OA development. Involvement of the glucose metabolism in OA development, suggested 
to act via insulin-like growth factor I resistance of chondrocytes, striated muscle changes 
due to insulin resistance, or via formation of advanced glycation end (AGE) products, 
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can be assessed by measuring glucose and insulin concentrations, insulin resistance and 
products of the glycation process. Within the NEO study we already assessed cross-sec-
tional associations of serum glucose and insulin concentrations and HbA1c (an early stage 
glycation product) with hand OA, showing only an association of fasting glucose con-
centrations and HbA1c with hand OA in men. No association was found with OA of the 
knees or with OA of both knees and hands. Insulin concentrations and insulin resistance 
were not associated with any type of OA.35 These cross-sectional data of the NEO study 
suggest that the glucose metabolism does not seem to play a major role in OA. The asso-
ciation of glucose and HbA1c as measure of the glycation process with hand OA was only 
observed in men and should be confirmed by other studies. However, it is interestingly 
that this association only to be observed in men is in line with chapter 3, where we re-
ported an association between the systemically active amount of visceral adipose tissue 
and hand OA also in men. More research should be performed, using sex-stratified anal-
yses, to further elucidate the role of glucose metabolism and other systemic processes 
especially in men.
This thesis suggests some potential targets for treatment of OA and for treatment or 
prevention of decreased HRQOL due to OA. Longitudinal research is warranted to further 
investigate these potential targets. Reducing inflammatory processes may be beneficial, 
either locally by preventing the development of Baker’s cysts and associated symptomat-
ic OA or systemically by inhibiting the systemic processes leading to OA development. 
Furthermore, interventions aimed at increasing or maintaining HRQOL in OA patients 
should be further explored since OA is not only a major cause of disability but also results 
in impaired HRQOL. Longitudinal studies should also explore the effect of increasing fat 
free mass and prevention or treatment of obesity and comorbidities on HRQOL in OA 
patients.
Part II. Identification of appropriate outcome measurements 
for hand OA research
Although the need for trials on disease-modifying treatment modalities for OA is high, 
performance of high-quality studies is difficult because of the use of many different and 
poor outcome measures, especially in hand OA. This hampers adequate assessment of 
the disease process and possible treatment effects. Part II of this thesis therefore focuses 
on the identification of appropriate outcome measures that can be applied in hand OA 
research. In the framework of the Outcome Measures in Rheumatology (OMERACT) Hand 
OA working group, which aims to develop a core set of outcome measures for research 
on hand OA,36 we performed two systematic reviews to assess available instruments for 
measurement of the domains pain, physical function, patient global assessment and im-
aging in hand OA in order to enable recommendations for use in clinical trials. 
Assessment of pain, physical function or patient global assessment in hand OA
In chapter 7, we evaluated the use of instruments measuring pain, physical function or 
patient global assessment in studies on hand OA, as well as the metric properties of these 
instruments. Metric properties were assessed with the OMERACT filter, including discrim-
ination (reliability, sensitivity to change), feasibility and validity. In 66 included studies, 
9
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various questionnaires and performance-/assessor-based instruments were applied for 
evaluation of pain, physical function or patient global assessment. No major differenc-
es regarding metric properties were observed between the instruments although the 
amount of supporting evidence varied. The most frequently evaluated questionnaires 
were the Australian/Canadian Hand OA Index (AUSCAN) pain subscale and visual ana-
logue scale (VAS) pain for pain assessment and the AUSCAN function subscale and Func-
tional Index for Hand OA (FIHOA) for assessment of physical function. Excellent reliability 
was shown for the AUSCAN and FIHOA and good sensitivity to change for all mentioned 
instruments; additionally the FIHOA had good feasibility. Good construct validity was 
suggested for all mentioned questionnaires. The most commonly applied performance-/
assessor-based instrument were grip and pinch strength for assessment of physical func-
tion, in addition to assessment of pain by palpation. For these measures good sensitivity 
to change and construct validity were established. The AUSCAN, FIHOA, VAS pain, grip 
and pinch strength and pain on palpation were most frequently tested and provided 
most supporting evidence for good metric properties.
Radiographic assessment of hand OA
In chapter 8 we focused on imaging, evaluating the use of conventional radiography in 
studies on hand OA and assessing the metric properties of the different available radio-
graphic scoring methods, again using the OMERACT filter. In the 48 included studies, 13 
different scoring methods had been used for evaluation of radiographic hand OA. The 
number of examined joints differed extensively and the obtained scores were analyzed 
in various ways. The reliability of the assessed radiographic scoring methods was good 
for all evaluated scoring methods, for both cross-sectional and longitudinal radiographic 
scoring. The responsiveness to change was similar for all evaluated scoring methods. 
There were no major differences in feasibility between the evaluated scoring methods, 
although the evidence was limited. There was limited knowledge about the validity of 
radiographic OA findings compared with clinical nodules and deformities, whereas there 
was better evidence for an association of radiographic findings with symptoms and hand 
function.
Although no major differences regarding metric properties of the scoring methods were 
observed, the amount of supporting evidence differed for the evaluated methods. Most 
evidence across all evaluated domains was available for the Kellgren-Lawrence (KL) and 
Osteoarthritis Research Society International (OARSI) scoring methods. For the Verbrug-
gen-Veys anatomical phase score, supporting evidence was observed across all evalu-
ated domains except for validity. For the Kallman scoring method, supporting evidence 
was observed across all domains except for sensitivity to change. Although global scor-
ing methods may be more reliable than the scoring of individual radiographic features, 
individual features may be more suitable for evaluation of specific study objectives. To 
enhance the comparability of studies in hand OA, consensus has to be reached on the 
preferred scoring methods, the examined joints, the presentation of radiographic out-




The results of both literature reviews were presented and discussed during the OMER-
ACT12 meeting (see appendix 2).37 In the discussion on instruments measuring pain, there 
was agreement to use the VAS or numeric rating scale as a preliminary instrument for 
self-reported pain. It was noted that further information is needed on a number of items: 
whether overall hand pain or single joint pain should be assessed, which joints should be 
assessed, how the questions should be asked and which anchors should be used. In the 
discussion on instruments assessing physical function, there was concern about the use 
of the FIHOA due to some too sex role-specific items, cultural differences and items with 
low secular relevance. The alternative, i.e., the AUSCAN, had the disadvantage of limited 
access due to mandatory payment for use. Therefore, it was voted to use the FIHOA for 
assessment of the physical function domain until more research has been performed for 
a more contemporary instrument. It was agreed to use grip and pinch strength as pre-
liminary instruments for hand strength and the count of tender joints upon palpation as 
a preliminary instrument for assessment of joint activity.
In the discussion on radiographic scoring methods consensus was reached on applying 
the most widely used and currently best validated measures, since there are only limited 
data for some of the other available scoring methods. It was agreed to use either the KL, 
OARSI, Verbruggen-Veys anatomical phases or the Kallman scoring method as prelimi-
nary instruments for assessment of structural damage.
Discussion and future perspectives
The systematic reviews in part II of this thesis increase the knowledge of available instru-
ments for measurement of the domains pain, physical function, patient global assess-
ment and imaging in hand OA. Since we aimed at providing a thorough overview of the 
current literature we included all studies providing information on available instruments 
and any of their metric properties reliability, sensitivity to change, feasibility and validity, 
independent of the study aim. Because of the large heterogeneity across studies regard-
ing their purpose (primarily aiming at evaluation of instruments or applying instruments 
for other primary aims) and study design, the methodological quality of the included 
studies was not assessed. For further assessment of the instruments measuring the men-
tioned domains in hand OA the quality of the studies evaluating the instruments should 
be taken into account.   
In addition, the OMERACT Hand OA working group made a research agenda describing 
items for further research. Regarding measurement of the domain pain, VAS or numeric 
rating scale questions should be developed and validated. Furthermore, a new measure 
for intermittent and constant hand OA pain should be developed and the subdomain 
tender joints should be investigated. In addition, the value of patient-performed joint 
count versus physician-performed joint count should be investigated. Regarding meas-
urement of physical function, instruments that are commonly used by hand therapists 
such as the Disability of the Arm, Shoulder and Hand and Michigan Hand Outcomes 
Questionnaire should be more thoroughly evaluated for use in hand OA. For measure-
ment of patient global assessment, quality interviews should be performed. For further 
assessment of the domain imaging, the metric properties of ultrasound and MR imaging 
should be investigated, as well as the value of computed tomography scans in hand OA.
After further assessment of the different available instruments, consensus can be reached 
9
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on which instruments should be used for measurement of the different core domains in 
different settings (clinical trials with specific aims or clinical practice). Consensus on stand-
ardized instruments for measurement of OA will enhance performance of high-quality 
trials and development of disease-modifying treatments for OA. 
Although further assessment of instruments measuring the domains pain, physical func-
tion, patient global assessment and imaging in hand OA is necessary, the results of the 
two systematic reviews included in this thesis already contributed to an update of the 
recommendations for the conduct and design of clinical trials in hand OA, described 
by a Task Force set-up by the OARSI.38 The purpose of this Task Force is to provide evi-
dence-based guidance on the design, execution and analysis of clinical trials in hand OA 
where published evidence is available, supplemented by expert opinion where evidence 
is lacking. This guidance will enhance the quality and comparability of future studies in 
OA.
In addition to the identification of appropriate instruments for standardized measure-
ment of outcomes, improvement of the classification criteria for hand OA will also en-
hance the performance of high-quality studies. Within the current widely used ACR clas-
sification criteria for hand OA all hand phenotypes are lumped together, which could 
result in heterogeneous study populations since different subtypes of hand OA are not 
distinguished by these criteria. Development of classification criteria addressing different 
subtypes of hand OA such as interphalangeal or thumb base OA will be of help in identi-
fying these different entities and enhance high-quality research in hand OA.
The combination of enhancement of high-quality research in OA and further elucidation 
of the mechanisms underlying the disease process could ultimately lead to development 
of disease-modifying treatment modalities for OA instead of the current limitation to 
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Artrose is de meest voorkomende musculoskeletale aandoening en een belangrijke oor-
zaak van pijn, stijfheid en functiebeperking van de gewrichten. Het is een multicausale aan-
doening waarbij alle gewrichtsweefsels worden aangedaan; behalve degeneratieve veran-
deringen van kraakbeen en subchondraal bot treedt ook inflammatie van het synoviale 
weefsel op. De pathogenese van artrose is grotendeels onbekend, wel zijn verschillende 
risicofactoren bekend die bijdragen aan de ontwikkeling van artrose. Zowel systemische 
als lokale biomechanische factoren lijken hierbij een rol te spelen. Bekende risicofactoren 
zijn bijvoorbeeld leeftijd, vrouwelijk geslacht en overgewicht. 
Hoewel het klinisch effect van artrose groot is, zijn behandelmogelijkheden beperkt tot 
verlichting van symptomen. Het tekort aan behandelingen die aangrijpen op het ziekte-
proces zelf komt niet alleen door gebrek aan kennis over de pathogenese van artrose maar 
ook door de afwezigheid van goede studies naar de behandeling van artrose. Om betere 
behandelmogelijkheden te ontwikkelen is meer begrip nodig van de mechanismen die 
leiden tot artrose, en bovendien is meer kennis nodig van uitkomstmaten die toegepast 
kunnen worden in onderzoek naar artrose om de effecten van behandeling adequaat te 
kunnen meten. 
Dit proefschrift bestaat derhalve uit twee delen. Het eerste deel beschrijft studies die ge-
richt waren op het begrijpen van de mechanismen onderliggend aan de relatie tussen 
artrose en bekende risicofactoren zoals overgewicht. Het tweede deel van dit proefschrift 
richt zich op het identificeren van geschikte uitkomstmaten voor toepassing in onderzoek 
naar artrose.
Deel I. Mechanismen onderliggend aan de relatie tussen risi-
cofactoren en artrose
Deel I van dit proefschrift richt zich op de mechanismen die ten grondslag liggen aan de 
relatie tussen artrose en bekende risicofactoren; hierbij wordt in het bijzonder ingegaan 
op de associatie tussen overgewicht en artrose. Omdat overgewicht een risicofactor is 
voor artrose in zowel gewichtsdragende als niet-gewichtsdragende gewrichten lijken in 
deze relatie zowel mechanische overbelasting als overgewicht-geassocieerde systemische 
factoren een rol te spelen. Voor dit deel van het proefschrift werd gebruik gemaakt van 
gegevens uit de Nederlandse Epidemiologie van Obesitas (NEO) studie. De NEO studie is 
een onderzoek in de algemene bevolking dat werd opgezet om de mechanismen van obe-
sitas-gerelateerde aandoeningen zoals artrose te ontrafelen. De studiepopulatie bestaat 
uit 6,673 individuen uit de Leidse regio tussen de 45 en 65 jaar oud van wie een meer-
derheid overgewicht of vetzucht had. Alle deelnemers vulden uitgebreide vragenlijsten in 
en ondergingen een lichamelijk onderzoek, inclusief gewrichtsonderzoek van de hand- 
en kniegewrichten. Bij 1,285 deelnemers werd daarnaast nog een ‘magnetic resonance 




Obesitas en artrose in gewichtsdragende en niet-gewichtsdragende gewrichten
In hoofdstuk 2 hebben we de relatieve bijdrage van mechanische belasting en systemi-
sche processen in artrose in gewichtsdragende (knie) en niet-gewichtsdragende (hand) 
gewrichten onderzocht. Hierbij hebben we gebruik gemaakt van gegevens uit de NEO 
studie en cross-sectionele analyses verricht. Als surrogaat voor mechanische belasting 
werden gewicht en vetvrije massa gebruikt, en voor systemische processen het metabool 
syndroom. Vetmassa was hierbij zowel een maat voor mechanische belasting als voor sys-
temische processen door te corrigeren voor respectievelijk het metabool syndroom of 
voor gewicht. In knieartrose bleken de surrogaatmaten voor mechanische belasting de 
belangrijkste risicofactoren terwijl surrogaatmaten voor systemische processen de belang-
rijkste risicofactoren bleken in handartrose. Ook hebben we de relatie tussen risicofactoren 
en artrose in zowel de hand als knie bestudeerd. Hoewel de hypothese voorafgaand aan 
ons onderzoek was dat bij artrose in meer dan één gewricht systemische processen het 
belangrijkst zouden zijn, bleek de aanwezigheid van artrose in zowel de knie als hand 
juist geassocieerd te zijn met surrogaatmaten voor mechanische belasting, net als bij de 
aanwezigheid van artrose in alleen de knie. Dit suggereert dat het tegelijk voorkomen 
van artrose in de knie en hand twee verschillende typen artrose representeert in plaatst 
van veroorzaakt te worden door een gedeeld onderliggend systemisch mechanisme. De 
associatie tussen mechanische belasting en knieartrose lijkt de associatie tussen het me-
tabool syndroom en handartrose te maskeren bij het gelijktijdig voorkomen van hand- en 
knieartrose. 
De associatie tussen het metabool syndroom en handartrose kan worden verklaard door 
een effect van systemische inflammatie. Vetweefsel is een bron van pro- en anti-inflam-
matoire cytokines. Deze cytokines kunnen gerelateerd zijn aan het metabool syndroom en 
lijken ook effect te hebben op gewrichtsweefsels. In hoofdstuk 3 werd de relatie tussen 
adipositas en artrose onderzocht door de associatie tussen vetweefsel en de abdominale 
verdeling hiervan met artrose in de niet-gewichtsdragende handen te analyseren. In ver-
band met de antropomorfe verschillen tussen mannen en vrouwen werden deze apart 
van elkaar geanalyseerd. Vetpercentage, vetmassa en de middel-heup-ratio waren geas-
socieerd met handartrose in zowel mannen als vrouwen. Daarnaast was in mannen de 
hoeveelheid visceraal vetweefsel geassocieerd met handartrose, in tegenstelling tot de 
hoeveelheid subcutaan vetweefsel. Dit suggereert dat zowel de hoeveelheid vet als de 
verdeling hiervan van belang zijn in de pathogenese van handartrose. Vooral visceraal vet 
lijkt een rol te spelen, wat verklaard kan worden doordat de uitscheiding van cytokines 
die gewrichtsweefsels kunnen beïnvloeden met name lijkt te gebeuren door visceraal vet. 
Om het inzicht in de rol van overgewicht in het ontstaan van knieartrose te vergroten, 
onderzochten we in hoofdstuk 4 de associatie van vetmassa en skeletspiermassa met 
knieartrose. Vetmassa, vetpercentage en spierskeletmassa waren positief geassocieerd 
met de aanwezigheid van knieartrose, terwijl spierskelet als percentage van het totale li-
chaamsgewicht negatief geassocieerd was met knieartrose. Vooral een hoge vetmassa ge-
combineerd met een lage spierskeletmassa bleek ongunstig. In obese individuen neemt de 
hoeveelheid spierskelet toe door de verhoogde belasting van het gewicht. Deze toename 
in spierskeletmassa is echter minder dan de totale gewichtstoename (voornamelijk vet-
massa), resulterend in een verlaagd spierskeletpercentage in individuen met overgewicht. 
Dit verklaart de omgekeerde associaties met artrose tussen spierskelet als absolute massa 




mannen en vrouwen verricht, en hierbij bleek de spierskeletmassa het sterkst gerelateerd 
te zijn aan knieartrose in mannen terwijl vetmassa het belangrijkst bleek in knieartrose 
in vrouwen. Dit suggereert een vooral biomechanische etiologie van artrose in mannen 
terwijl artrose in vrouwen bovenal door systemische processen gedreven lijkt te worden. 
Echter een hoge spierskeletmassa relatief aan een lage vetmassa was in beide seksen gun-
stig, interventies die zich richten op verbetering van de spierskeletmassa in combinatie 
met gewichtsreductie kunnen daarom geschikt zijn als preventie en behandeling van knie-
artrose in zowel mannen als vrouwen.
Structurele afwijkingen en symptomatische artrose
Artrose kan op verschillende manieren gedefinieerd worden, zowel op basis van symp-
tomen en afwijkingen bij lichamelijk onderzoek (klinische artrose) als op basis van struc-
tuurafwijkingen zichtbaar op MRI (structurele artrose). De in hoofdstuk 4 beschreven as-
sociaties van vetmassa en spierskeletmassa met knieartrose werden zowel met klinische 
artrose als met structurele artrose gevonden. Wel viel een grote discrepantie op tussen 
deze twee definities van knieartrose; slechts een derde van de individuen met klinische 
of structurele artrose had beide. Hoewel artrose gekenmerkt wordt door degeneratie-
ve veranderingen in het gewricht zijn niet al deze structurele afwijkingen specifiek voor 
artrose, want ook in individuen zonder artrose worden degeneratieve veranderingen in 
het gewricht gezien. Om de processen die tot symptomatische artrose leiden beter te 
begrijpen, hebben we in hoofdstuk 5 onderzocht welke structurele afwijkingen op spe-
cifieke locaties in het kniegewricht het best kunnen onderscheiden tussen het wel en niet 
hebben van symptomatische artrose in dezelfde knie, rekening houdend met het tegelijk 
voorkomen van meer dan één structurele afwijking. Zowel in individuen met als zonder 
symptomatische knieartrose waren vaak structurele afwijkingen zichtbaar op MRI, zowel 
in het tibiofemorale als in het patellofemorale compartiment van het kniegewricht. Van al 
deze structurele afwijkingen bleek de aanwezigheid van een Bakerse cyste het best te on-
derscheiden tussen het wel of niet aanwezig zijn van symptomatische artrose in dezelfde 
knie. Verder bleken effusie en structurele afwijkingen als osteofyten en beenmerglaesies 
de aanwezigheid van symptomatische artrose ook goed te kunnen onderscheiden, met 
name structurele afwijkingen aan de mediale zijde van het tibiofemorale compartiment. 
Gezien eerder onderzoek gesuggereerd heeft dat Bakerse cysten veroorzaakt worden door 
ontsteking zal behandeling van knieartrose zich misschien moeten richten op preventie 
van ontwikkeling van Bakerse cysten door het behandelen van ontsteking.
Artrose en risicofactoren in relatie tot gezondheidsgerelateerde kwaliteit van leven
Artrose levert de op een na grootste bijdrage aan functionele beperking van alle muscu-
loskeletale aandoeningen en heeft een negatieve invloed op de gezondheidsgerelateerde 
kwaliteit van leven. Een aantal van de bekende risicofactoren voor artrose zijn niet alleen 
geassocieerd met de ontwikkeling van artrose maar ook met een verminderde gezond-
heidsgerelateerde kwaliteit van leven. De aanwezigheid van artrose tegelijk met een van 
deze risicofactoren resulteert mogelijk in versterking van beide negatieve associaties met 
de gezondheidsgerelateerde kwaliteit van leven. Om inzicht te krijgen in mogelijke aan-
grijppunten voor verbetering of preventie van vermindering van de gezondheidsgerela-
teerde kwaliteit van leven in patiënten met knieartrose hebben we in hoofdstuk 6 het ef-
fect van knieartrose en van de te beïnvloeden of te voorkomen risicofactoren overgewicht, 
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lage vetvrije massa (als surrogaat voor spiermassa) en comorbiditeiten geëvalueerd. Daar-
naast werd de interactie tussen knieartrose en deze risicofactoren in relatie tot de gezond-
heidsgerelateerde kwaliteit van leven onderzocht. Zowel knieartrose als de risicofactoren 
overgewicht, lage vetvrije massa en comorbiditeiten waren geassocieerd met een klinisch 
relevante vermindering van de gezondheidsgerelateerde kwaliteit van leven. Daarbij gaf 
gelijktijdige aanwezigheid van knieartrose en lage vetvrije massa in mannen een additio-
nele vermindering van de gezondheidsgerelateerde kwaliteit van leven. Dit suggereert dat 
toename van de vetvrije massa (verbetering van spiermassa) de gezondheidsgerelateerde 
kwaliteit van leven in patiënten met knieartrose kan verbeteren. Daarnaast kunnen inter-
venties die zich richten op overgewicht en preventie of behandeling van comorbiditeiten 
ook van belang zijn om de gezondheidsgerelateerde kwaliteit van leven in patiënten met 
knieartrose te behouden of verbeteren.
Deel II. Identificatie van geschikte uitkomstmaten voor onder-
zoek naar handartrose
Hoewel de behoefte aan onderzoek naar behandelmogelijkheden die aangrijpen op het 
ziekteproces van artrose groot is, is het uitvoeren van studies van goede kwaliteit hier-
naar moeilijk door de vele verschillende en soms matig geëvalueerde uitkomstmaten die 
beschikbaar zijn, met name in handartrose. Dit belemmert de adequate evaluatie van het 
ziekteproces en effecten van potentiële behandelingen. Deel II van dit proefschrift richt 
zich daarom op het identificeren van geschikte uitkomstmaten voor toepassing in onder-
zoek naar handartrose. In het kader van de ‘Outcome Measures in Rheumatology’ (OMER-
ACT) handartrose werkgroep, die als doel heeft om een kernset van uitkomstmaten voor 
onderzoek naar handartrose te ontwikkelen, hebben we twee systematische reviews ver-
richt. Deze systematische reviews evalueren de beschikbare instrumenten voor het meten 
van de domeinen pijn, fysieke functie, patient global assessment (algeheel welbevinden), 
en beeldvorming in handartrose om aanbevelingen te kunnen doen voor het gebruik van 
deze instrumenten in klinisch onderzoek.
Pijn, fysiek functioneren en patient global assessment in handartrose
In hoofdstuk 7 hebben we het gebruik van instrumenten voor het meten van pijn, fysiek 
functioneren en patient global assessment in onderzoek naar handartrose geëvalueerd, 
alsmede de metrische eigenschappen van deze instrumenten. De metrische eigenschap-
pen werden geëvalueerd volgens het OMERACT filter, namelijk discriminatie (betrouw-
baarheid en gevoeligheid voor verandering), uitvoerbaarheid en validiteit. Met behulp van 
een systematische zoekstrategie identificeerden we 66 publicaties over onderzoek waarin 
verschillende vragenlijsten en testen werden toegepast om pijn, fysiek functioneren en 
patient global assessment te meten. Er werden geen grote verschillen in metrische eigen-
schappen tussen de instrumenten geobserveerd, echter de hoeveelheid ondersteunend 
bewijs verschilde wel sterk tussen de instrumenten. De meest frequent geëvalueerde vra-
genlijsten waren de ‘Australian/Canadian Hand Osteoarthritis Index’ (AUSCAN) pijn sub-
schaal en de visueel analoge schaal (VAS) pijn voor het meten van pijn, en de AUSCAN 
functie subschaal en ‘Functional Index for Hand Osteoarthritis’ (FIHOA) voor het meten 




AUSCAN als de FIHOA. De uitvoerbaarheid van de FIHOA was goed. Goede gevoeligheid 
voor verandering en validiteit werden gesuggereerd voor alle beschreven instrumenten. 
De meest toegepaste testen waren de grijp- en knijpkracht voor het meten van fysiek func-
tioneren en het meten van pijn door middel van palpatie. Voor deze beide testen werden 
goede gevoeligheid voor verandering en validiteit aangetoond. 
Radiografische evaluatie van handartrose
Hoofdstuk 8 richt zich op beeldvorming, hierin hebben we het gebruik van conventio-
nele röntgenfoto’s in studies naar handartrose en de metrische eigenschappen van de 
beschikbare scoremethoden voor evaluatie van deze röntgenfoto’s geëvalueerd, opnieuw 
gebruikmakend van het OMERACT filter. We identificeerden door een systematische zoek-
strategie 48 publicaties waarin 13 verschillende scoremethoden waren gebruikt voor de 
radiografische evaluatie van handartrose. Het aantal onderzochte gewrichten verschilde 
opvallend tussen de studies en de verkregen scores werden op verschillende manieren 
geanalyseerd. Hoewel er geen grote verschillen waren met betrekking tot de metrische 
eigenschappen van de scoremethoden, verschilde de hoeveelheid ondersteunend bewijs 
voor de gebruikte scoremethoden. Het meeste bewijs voor alle geëvalueerde domeinen 
was beschikbaar voor de ‘Kellgren-Lawrence’ en ‘Osteoarthritis Research Society Interna-
tional’ scoremethoden. Voor de ‘Verbruggen-Veys anatomical phase score’ werd onder-
steunend bewijs gevonden voor alle geëvalueerde domeinen behalve voor validiteit. Voor 
de ‘Kallman’ scoremethode werd ondersteunend bewijs gevonden voor alle domeinen 
behalve voor de gevoeligheid voor verandering. Om de vergelijkbaarheid van studies naar 
handartrose te verbeteren moet consensus worden bereikt over de te gebruiken score-
methoden, de te evalueren gewrichten, de analysemethode van de scores en de definitie 
van handartrose. In de keus zal rekening moeten worden gehouden met het doel van de 
studies.
Toekomstperspectieven  
Overgewicht wordt als een van de belangrijkste risicofactoren voor het ontstaan van artro-
se gezien, maar door welke mechanismen is nog grotendeels onbekend. De bevindingen 
beschreven in deel I van dit proefschrift vergroten ons begrip van deze mechanismen. 
Verder wordt beschreven welke structurele afwijkingen in het kniegewricht de aanwezig-
heid van symptomatische artrose het best karakteriseren. Tot slot hebben we de bijdrage 
van een aantal modificeerbare risicofactoren vastgesteld in de gezondheidsgerelateerde 
kwaliteit van leven in patiënten met knieartrose. Al deze bevindingen geven aangrijppun-
ten voor het verbeteren van de behandeling van artrose, zowel gericht op de symptomen 
als op het ziekteproces zelf. Een kanttekening hierbij is dat de associaties beschreven in 
dit proefschrift allemaal cross-sectioneel zijn. Longitudinaal onderzoek door de tijd kan 
deze associaties bevestigen en de precieze pathogenese van artrose verder ophelderen. 
Follow-up gegevens van de NEO studie worden op dit moment verzameld en kunnen 
hierbij van nut zijn. 
Deel II van dit proefschrift vergroot de kennis van beschikbare instrumenten voor het me-
ten van de domeinen pijn, fysiek functioneren, patient global assessment en beeldvorming 
in handartrose. De resultaten van de beide overzichtsartikelen in dit deel werden gepre-
senteerd en bediscussieerd tijdens de OMERACT12 meeting. Daarbij werd consensus be-
reikt over het toepassen van de instrumenten waarvoor op dit moment het meeste onder-
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steunende bewijs beschikbaar is. Voor de hiaten in de kennis van een aantal instrumenten 
werd een onderzoeksagenda opgesteld waarin items voor nader onderzoek beschreven 
werden. Na verdere evaluatie van de beschikbare instrumenten kan consensus worden be-
reikt over de toepassing van specifieke instrumenten voor het meten van de verschillende 
domeinen, dit zal de uitvoering van studies van hoge kwaliteit bevorderen. 
De combinatie van bevordering van onderzoek van hoge kwaliteit en het verder ophel-
deren van de pathogenese van artrose kunnen uiteindelijk leiden tot het ontwikkelen van 
behandelmogelijkheden die aangrijpen op het ziekteproces in plaats van de huidige be-
perking tot verlichting van symptomen van artrose.
10
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APPENDIX 1
Comment in Nature Reviews Rheumatology on ‘The relative contribution of mechanical 
stress and systemic processes in different types of osteoarthritis: the NEO study (Annals 
of the Rheumatic Diseases 2015;74(10):1842-7)’
Is osteoarthritis a mechanical or systemic disease? 
F.M. Cicuttini and A.E. Wluka 




Osteoarthritis (OA) is a heterogeneous group of diseases with different pathogenesis 
in different joints. What effect do metabolic factors, inflammation and obesity have on 
OA in non-loadbearing structures? A new study reports that, in the absence of knee OA, 
systemic processes are important in the pathogenesis of hand OA. 
A new paper by Visser et al.1 examines the question of whether osteoarthritis (OA) is pre-
dominantly a biomechanical or systemic disease, and whether these mechanisms differ in 
hand and knee OA. They concluded that, although mechanical factors are probably more 
important in knee OA whether or not it coexists with hand OA, systemic processes, such 
as inflammation, aberrant metabolic regulation and obesity, control the pathogenesis of 
hand OA. How should these results be interpreted in the context of other evidence in the 
field? 
The first thing to consider is that an increasing body of evidence shows that OA is joint 
failure – an outcome with myriad causes. It is now apparent that, in order to explore risk 
factors for OA, a joint-specific approach, such as that used by Visser et al.,1 is needed. Al-
though different risk factors, such as obesity and physical activity, overlap in their effect 
on joints, the mechanisms by which such risk factors specifically affect joints might differ. 
What do we know about the role of different biomechanical and systemic factors in knee 
OA? With the advent of sensitive, noninvasive imaging modalities such as MRI, it is now 
possible to visualize knee OA on a spectrum from a normal joint through to one with clin-
ically and radiographically evident OA (Figure 1). By the time the first knee joint changes 
are detected by radiography, more than 10% of cartilage is already lost.2 In addition, to 
better understand the role of a risk factor, its effect on structural change needs to be 
examined at different stages of the disease because the susceptibility of the joint to the 
risk factor in question might vary according to the severity of the pathological changes. 
A large body of evidence based on highly sensitive MRI now shows that reduced knee 
cartilage volume is associated with metabolic factors, including increased fat mass and 
serum glucose levels. These MRI data correlate with radiographic evidence of OA and can 
predict increased knee pain and the risk of joint replacement.3 Knee cartilage volume is 
also negatively associated with the concentration of circulating inflammatory cytokines, 
such as IL-6 and TNF,4 as well as C-reactive protein (CRP), a systemic marker of inflamma-
tion.5 Consistent with these findings, low-grade synovitis is common in patients with OA 
and is associated with cartilage loss.6 Evidence also indicates that the adipokine leptin is 
an important mediator of the effect obesity has on knee cartilage.7 Taken together, these 
data suggest that metabolism-related inflammatory factors substantially affect early 
stages of the pathogenesis of knee OA. 
By contrast, Visser et al.1 concluded that mechanical stress rather than systemic factors 
are important in knee OA. This conclusion was based on a cross-sectional examination 
of 6,673 participants aged 45 to 65 years, including 5,002 participants who were selected 
for BMI ≥27 kg/m2, thereby providing a study group enriched for overweight individuals, 
and 1,671 participants selected as a reference from the general population. The definition 
of OA was based on the ACR clinical criteria, so no imaging was performed. Surrogates 
for mechanical stress (weight, fat-free mass, fat mass [adjusted for metabolic factors]) 
and systemic processes (metabolic syndrome, fat mass [adjusted for weight]) were used 
to examine the effect of mechanical stress and systemic processes, respectively, on OA. 
Knee OA was associated with weight and fat-free mass, adjusted for metabolic factors, 
with an OR of 1.49 (95% CI 1.32 to 1.68) and 2.05 (95% CI 1.60 to 2.62), respectively, but 
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was not associated with fat mass. As this study was cross-sectional, it has the potential 
problem of ‘reverse causation’: patients with knee pain might have gained weight or their 
body composition might have changed as a consequence of clinical knee OA. Studies 
examining asymptomatic individuals have correlated fat mass and markers of metabo-
lism related-inflammation with structural changes to joints.7 Nevertheless, these findings, 
in patients with clinical OA, are consistent with other data showing that biomechanical 
factors predominate in established OA; for example, minor degrees of knee malalign-
ment have a more substantial pathogenic role in later rather than earlier stages of the 
disease.8 With cartilage loss already present by the time OA is identified by clinical and 
radiographic analysis, it is not surprising to find that the local biomechanical environment 
in the knee has also changed and is the main factor contributing to disease progression. 
In contrast to the mechanical pathogenesis of knee OA, the data from Visser et al.1 sup-
port a prominent role for metabolic factors in the aetiology of hand OA; hand OA was 
associated with the metabolic syndrome, adjusted for weight, with an OR of 1.46 (95% CI 
1.06 to 2.02). For decades, obesity has been recognized as a risk factor for hand OA.9 Giv-
en that we do not walk on our hands, this risk factor is circumstantial evidence against a 
mechanical pathogenesis for OA. The study by Visser et al.1 further supports this concept; 
however, the 3rd National Health and Nutrition Examination Survey found no relationship 
between serum concentrations of leptin and the presence of clinical hand OA,10 suggest-
ing an alternative systemic pathway of OA pathogenesis. That is not to say that the results 
from Visser et al.1 are definitive that systemic factors drive hand OA, or that they exclude 
the role of biomechanics; only muscle mass was examined as a surrogate for a mechanical 
effect of hand OA. One could argue that total-body muscle mass might not be a good 
surrogate measure of mechanical factors relevant to hand OA. Thus, further work in this 
area is needed.
What can we conclude? OA is not a single disease, but a heterogeneous condition, result-
ing from a variety of different exposures. These new data from Visser et al.1 and others 
suggest that the pathogenesis of OA needs to be examined on a joint-by-joint basis. 
To not do so is likely to impede our understanding of the pathogenesis of OA and the 
identification of novel drug targets for prevention and treatment. The emerging data 
suggest that, although mechanical factors might have a larger role in established or late 
OA, systemic factors have a substantial effect on the knee joint structure in preclinical 
OA (Figure 1). Although mechanical factors are also involved in hand OA, the case for a 
systemic mechanism in the pathogenesis of this condition seems clearer. Thus, in regards 
to the question of whether OA is a mechanical or systemic disease, perhaps the correct 




Figure 1. The spectrum of knee OA. OA can be considered as being on a spectrum from a healthy joint to preclin-
ical disease and the beginning of cartilage damage (which is now detectable by MRI), through to radiographically 
evident OA and end-stage joint replacement. Systemic metabolic and inflammatory factors predominate in the 
early stages of knee OA, whereas mechanical factors seem to be more important in the later stages. 
OA, osteoarthritis.
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ABSTRACT
Objective 
During OMERACT 12, a workshop was held with the aim to endorse a core set of domains 
for 3 settings: clinical trials of symptom and structure modification and observational 
studies. Additional goals were to endorse a core set of contextual factors for these set-
tings, and to define preliminary instruments for each core domain. Finally, an agenda for 
future research in hand osteoarthritis (OA) was to be proposed. 
Methods 
Literature reviews of preliminary instruments for each core domain of the proposed core 
set for hand OA in the settings described above. Literature review of radiographic scoring 
methods and modern imaging in hand OA were also performed. Proposed contextual 
factors for a core set were identified through 2 Delphi exercises with participation of hand 
OA experts, patient partners, and OMERACT participants. 
Results 
Results from Delphi exercises and systematic literature reviews were presented and dis-
cussed. It was agreed that a preliminary core domain set for the setting clinical trials 
of symptom modification should contain at least “pain, physical function, patient glob-
al assessment, joint activity and hand strength.” The settings clinical trial of structure 
modification and observational studies would in addition include structural damage. 
Preliminary instruments for the proposed domains were agreed on. A list of prioritized 
contextual factors was defined and endorsed for further research. A research agenda was 
proposed for domain instrument validation according to the OMERACT Filter 2.0. 
Conclusion 
Preliminary core sets for clinical trials of symptom and structure modification and obser-
vational studies in hand osteoarthritis, including preliminary instruments and contextual 




Osteoarthritis (OA) is a highly prevalent musculoskeletal disorder involving all compo-
nents of the joint.1 All joints may be involved, but the hand is a predilection site. The 
phenotype hand OA warrants special attention, because hand OA is in itself polyarticular, 
making it complex to study. Moreover, hand OA is frequently accompanied by OA in 
other joint sites, such as the knees or hips.2 Hand OA is not one phenotype, but com-
prises several subsets, such as nodal hand OA, thumb base OA, and erosive hand OA,3,4 
which are associated with different risk factors, requiring different treatment strategies. 
Currently, insight in underlying pathophysiologic mechanisms of hand OA is limited and 
insufficient treatment options exist.5 Therefore, high-quality observational cohorts and 
clinical trials are warranted, requiring optimal sets of outcome measures for adequate 
assessment of hand OA. 
In 2010 the Outcome Measures in Rheumatology (OMERACT) hand OA working group 
was assembled, comprising health professionals, researchers, and patient research part-
ners (PRP), with interest and experience in hand OA, aiming at defining a set of core 
domains using the OMERACT framework.6 Previously, four core domains (pain, function, 
patient global assessment, and imaging) for knee, hip, and hand OA trials of ≥1 year 
duration were defined for phase III clinical trials following the OMERACT III consensus 
conference.7 An Osteoarthritis Research Society International taskforce added the fol-
lowing domains: mobility, deformity, inflammation, performance, stiffness, and esthetic 
damage.8 However, the above-mentioned set of core domains has several shortcomings: 
only the clinical trial setting was addressed, patients were not involved in the process, and 
the core sets lacked incorporation of hand OA–specific aspects.9,10 
First, the OMERACT hand OA group performed a Delphi exercise among hand OA group 
members and OMERACT participants to identify a set of core domains.6 Potential do-
mains were identified from a qualitative study with 10 focus groups among 56 patients 
with hand OA from five European countries.11 This was done separately for four settings: 
clinical trials of symptom modification and structure modification, observational studies, 
and clinical record keeping. Results of the Delphi exercises were discussed in a special 
interest group (SIG) during OMERACT 11 and resulted in a proposed set of core domains.6 
Further, it was agreed during the SIG to apply the new OMERACT Filter 2.0 in the devel-
opment process.12 Further discussions were held at annual meetings of the American 
College of Rheumatology (ACR) in 2012 and 2013. 
As a next step we proposed a workshop during OMERACT 12 with the following objec-
tives: (1) to endorse a core domain set for three settings, clinical trials of symptom modi-
fication, of structural modification, and of observational studies, (2) to endorse a core set 
of contextual factors for the same settings, (3) to define a preliminary set of instruments 
for each core domain, and (4) to propose a research agenda for domain instrument vali-
dation according to the OMERACT Filter 2.0. 
502331-L-bw-Visser
212   
MATERIALS AND METHODS 
Delphi Exercise 
Prior to the OMERACT 12 meeting, we performed a Delphi exercise to reach consensus 
about the contextual factors that should be considered as mandatory in hand OA studies. 
In Delphi round 1 an initial list of 36 potential contextual factors was circulated to experts 
in hand OA, PRP, and OMERACT participants. The list was derived from hand OA experts, 
hand OA patient focus groups, OMERACT participants, and an International Classification 
of Functioning review.13 Potential contextual factors, i.e., variables that are not outcomes 
of the study but need to be recognized (and measured) to understand the study results,12 
included demographics, OA-specific factors, physical health, mental health, physical fit-
ness, and others. Participants were asked to divide 100 points among the contextual 
factors they considered important; participants were explicitly encouraged to include 
additional factors. Domains with high agreement (average >6 points) were kept, whereas 
domains with low agreement (average <1 point) were excluded. Factors with moderate 
agreement and suggested factors were voted on in Delphi round 2. 
Literature Reviews of Instruments to Assess Hand OA Outcomes 
A systematic search of the medical literature up to January 2014 was performed to iden-
tify instruments measuring pain, physical function, patient global assessment, joint ac-
tivity, and hand strength and to summarize their metric properties, i.e., discrimination 
(reliability, sensitivity to change), feasibility, and validity. Inclusion criteria required for 
studies to evaluate these aspects differed per item (Visser et al, manuscript submitted).14 
Another systematic review of the medical literature up to November 2013 was performed 
to evaluate the use of radiography in hand OA and to assess the reliability, sensitivity to 
change, validity, and feasibility of the different available radiographic scoring methods.15 
OMERACT 12 Hand OA Workshop 
A plenary session was held during which presentations were given: (1) On results of the 
Delphi exercises concerning core domains and later discussions (MK); (2) on the Delphi 
exercises concerning contextual factors (PB); (3) on systematic literature searches con-
cerning instruments to assess pain, function, patient global, hand strength, and tender 
joints (AWV); (4) on searches to assess structural damage by radiography (AWV); and (5) 
on searches to assess joint activity or disease activity at joint level and structural damage 
using modern imaging techniques (IKH). 
Subsequently, 4 breakout sessions took place to discuss (1) core domains in outcome 
measures, (2) contextual factors, (3) instruments to assess patient reported outcomes 
and performance measures, and (4) imaging instruments. Summaries of the breakout 
sessions were reported back during a plenary session. During this final plenary session, 




Endorsement of Domains for a Core Domain Set for 3 Settings 
Based on results of the Delphi exercise and discussions during OMERACT 11, the pro-
posed core domains included pain, physical function, patient global assessment, joint 
activity, health-related quality of life (HRQOL), reduced strength, pain medication, struc-
tural damage, and reduced mobility.6 The proposed core domain set was widely dis-
cussed during a breakout session attended by 11 physicians, 2 PRP, 1 representative from 
industry, 2 researchers, and 2 research fellows. 
Discussions touched upon similarities and differences between “reduced strength” and 
“physical function,” and the term “hand strength” was proposed instead of “reduced 
strength.” HRQOL was included as a core domain. However, HRQOL contains differ-
ent domains, and instruments are not available. Therefore, HRQOL was included as a 
non-mandatory domain until disease-specific instruments are available. After discussion, 
the proposed domain “pain medication” was incorporated as a potential contextual fac-
tor. After the breakout session, it was proposed that in the setting of clinical trials of 
symptom modification, a preliminary set of core domains should at least contain pain, 
physical function, patient global assessment, HRQOL (although not mandatory as long 
as no disease-specific instruments are available), joint activity, and hand strength. In the 
final plenary, 47 (89%) of the voting participants agreed; 11% did not agree; and none 
responded “don’t know.” 
Figure 1. Preliminary set of endorsed core domains for hand osteoarthritis studies. Inner circle: Domains for all set-
tings, i.e., clinical trials of symptom modification, clinical trials of structure modification, and observational studies. 
Outer circle: Domains for some settings, i.e., clinical trials of structure modification and observational studies. 
*Domains not mandatory as long as no disease-specific instruments are available. 
HR, health-related. 
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For the setting of clinical trials of structure modification, the breakout group proposed 
to define subdomains as radiographic damage, esthetic damage, bony damage, and de-
formity. Further, “reduced mobility” was discussed: whether it is distinct from or similar to 
physical function, as well as the current lack of an appropriate instrument; “hand mobili-
ty” was suggested as a more appropriate term. Finally, it was agreed by 41 voting partici-
pants (76%) that a preliminary set of core domains for clinical trials of structure modifica-
tion contain at least the domains endorsed for clinical trials of symptom modification and 
structural damage and mobility; 13% did not agree and 11% did not know. Thirty-eight 
(72%) agreed that the preliminary set of endorsed core domains for the assessment of 
hand OA in observational studies is similar to that for structure modification; 11% did not 
agree and 17% did not know (Figure 1). 
Definition of a Preliminary Set of Instruments for Each Core Domain 
Patient-reported outcomes and performance tests
In the systematic literature review, 66 studies concerning hand OA were included, in 
which various questionnaires, perform - ance-based instruments, and assessor-based 
instruments were applied. No major differences regarding metric properties were ob-
served between the instruments, although the amount of supporting evidence varied. 
The most frequently evaluated questionnaires were the Australian Canadian Hand OA 
Index (AUSCAN) pain subscale16 and visual analog scale (VAS) or numerical rating scale 
(NRS) for pain assessment, and the AUSCAN function subscale and Functional Index of 
Hand OA (FIHOA)17 for physical function assessment. Excellent reliability was shown for 
the AUSCAN and FIHOA and good sensitivity to change for all mentioned instruments; 
additionally, the FIHOA had good feasibility. No validation by comparing to a gold stand-
ard has been performed; however, good construct validity was suggested for all instru-
ments. Grip and pinch strength to assess hand strength and palpation of tender joints 
to assess joint activity18 were commonly applied. For these measures, good sensitivity to 
change and construct validity were established. Supporting evidence (Table 1) was pre-
sented and discussed in a breakout session, attended by 2 PRP, 1 representative from the 
pharmaceutical industry, 2 occupational therapists, 1 statistician, 1 epidemiologist, and 
several rheumatologists. 
There was general agreement to use the VAS or NRS to assess pain. A single question was 
generally preferred over multiple pain questions. Further information is needed whether 
overall hand pain or joint pain specifically should be assessed, which joints should be 
assessed, how questions should be asked, and which anchors should be used. During 
voting, 49 participants (88%) agreed on either the VAS or NRS as a preliminary instrument 
for the self-reported pain domain; 4% did not agree; and 9% did not know. There was 
concern about the use of the FIHOA to assess physical function because of sex role-spe-
cific items (men use screwdrivers and women sew), cultural issues (e.g., handshake), and 
some items with low secular relevance, e.g., writing for a long period of time versus typ-
ing on computer. The alternative AUSCAN instrument had the disadvantage of limited 
access due to a mandatory fee. Therefore, it was voted by 31 participants (61%; 18% did 
not agree; 22% did not know) to use the FIHOA for the physical function domain for the 
time being. Research is warranted for a more contemporary instrument. To measure the 
hand strength domain, 43 participants (81%) agreed on use of grip/pinch strength as a 
preliminary instrument; 13% did not agree; and 6% did not know. Although it was agreed 
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that more studies are needed, 43 participants (75%) agreed on use of the tender joint 
count on palpation as a preliminary instrument to assess joint activity; 11% did not agree, 
and 14% did not know. 
Radiographic scoring methods 
The domain structural damage includes the subdomain radiographic damage. The sys-
tematic literature review revealed 13 different scoring methods that evaluated radio-
graphic hand OA; some scores were more extensively studied than others.15 Data on 
reliability, validity, sensitivity to change, and feasibility were available. There were major 
differences between studies in the number of examined joints and the way scores were 
analyzed. The reliability of the assessed radiographic scoring methods was good for all 
evaluated scoring methods, although longitudinal performance was tested only for some 
methods. The validity of radiographic OA findings compared to that of clinical findings 
such as nodules and deformities was limited, but the association of radiographic findings 
with symptoms and hand function was better. The sensitivity to change was comparable 
for all evaluated scoring methods, as well as the smallest detectable change. Few studies 
explored the feasibility of the radiographic scoring methods. Apart from time required 
for scoring (longer for individual features than for composite scores), no major differ-
ences between the evaluated scoring methods was shown. The metric properties are 
summarized in Table 2 for the most extensive studied scores. 
The systematic review served as starting point in the breakout session (attended by 2 
radiologists and 13 rheumatologists) discussing imaging instruments. The group sup-
ported that radiographs provide information on structural damage measures. There was 
consensus on including the most widely used and currently best-validated measures in 
a core set for structural damage. During voting it was agreed by 46 participants (87%) to 
use the Kellgren-Lawrence method, the OARSI atlas, the Verbruggen-Veys method, or the 
Kallman method as preliminary instruments for the structural damage domain; 6% did 
not agree; and 8% did not know. 
Table 1. Supporting evidence from at least 3 studies for the most frequently applied instruments for evaluation of 
pain, physical function or patient global assessment. From Visser et al. J Rheumatol (manuscript submitted).14
Reliability Sensitivity to change Feasibility Validity
Questionnaires
AUSCAN + + - # +
FIHOA + + +** +
VAS pain + +
Performance-/assessor-based instruments
Grip strength +* + +
Pinch strength +* + +
Tenderness/pain on palpation +* + +*
+ established evidence
* supporting evidence in only 2 studies
** supporting evidence in only 1 study
# not available in public domain
AUSCAN, Australian/Canadian Hand Osteoarthritis Index; FIHOA, Functional Index for Hand Ostearthritis; VAS, 
visual analogue scale.
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Modern imaging methods
Updated literature overviews19 of ultrasonography (US) and magnetic resonance imag-
ing (MRI) scoring systems and metric properties were presented; the data were limit-
ed. US enables a dynamic image of joints and allows visualization of osteophytes, but 
also marginal erosions and synovitis. US studies of patients with hand OA have reported 
high prevalence of greyscale synovitis, while power Doppler activity is less frequent. One 
preliminary US scoring system has been developed for hand OA including assessment 
of synovitis (greyscale hypertrophy/effusion and power Doppler) and osteophytes on 
semiquantitative scales.20 An US atlas for assessment of osteophytes was developed with 
excellent intra- and inter-reader reliability.21 Preliminary studies have shown that validity 
and sensitivity in comparison with radiography of US seems good; however, more data 
are needed.22 
MRI provides a multiplanar image of all joint components; it is the only imaging modality 
enabling the visualization of bone marrow lesions (BML). Synovitis, based on gadolini-
um enhancement, is frequent in patients with hand OA; the frequency of BML varies. A 
preliminary MRI scoring system, which includes assessment of osteophytes, joint space 
narrowing, erosions, cysts, malalignment, synovitis, flexor tenosynovitis, BML, collateral 
ligament pathology and BML at insertion sites, has shown good reliability.23 Lately, this 
scoring system was revised by OMERACT.24 Knowledge about validity is limited. 
In the breakout group, modern imaging techniques were discussed. The group noted that 
US and MRI provide information about inflammation and structural damage, with the 
benefit of multiplanar visualization and highlighting of the complex multitissue pathol-
ogy in OA. It was felt that experience from rheumatoid arthritis could be transferred, al-
though caution should be taken, especially, when evaluating very small joints. The group 
noted that knowledge is needed concerning metric properties of these modern imaging 
modalities. This notion was supported during voting: 98% of voting participants agreed 
to have US and MRI on the research agenda. 
Table 2. Supporting evidence for most frequently applied radiographic scoring methods. Modified from Visser et 
al. Osteoarthritis Cartilage 2014;22:1710-2315; with permission.
Reliability Sensitivity to change Feasibility Validity
Composite score
KL17 + + + +
Individual features
Anatomical phases18 + + +
OARSI19 + + + +
Kallman20 + + +
+ established evidence
KL, Kellgren-Lawrence; OARSI, Osteoarthritis Research Society International.
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Endorsement of a preliminary core set of contextual factors for 3 settings. 
The Delphi round 1 and 2 had 54 and 21 respondents, respectively. Age and sex as con-
textual factors reached high agreement across all settings in round 1, whereas hand OA 
subsets reached high agreement solely for the setting of symptom modification trials. 
Ethnicity, alcohol consumption, previous surgery for OA in locations other than hands, 
energy functions, control of voluntary movements, and effects of weather were excluded 
from further voting owing to low agreement. In round 2, body mass index (BMI), hand OA 
symptom duration, and hand OA subsets reached high agreement for all settings. Treat-
ment for OA, comorbidities, OA in other specified joint sites, and fulfillment of the ACR 
Hand OA criteria reached high agreement for some settings and moderate agreement 
for others (Table 3). 







Age  9.3* 9.3* 9.4*
Sex 8.3* 8.2* 8.3*
Body mass index 7.7 9.2 8.4
Handedness 5.6 5.6 5.5
Postmenopausal state 4.2 3.8 3.4
Socioeconomic status 3.1 2.4 3.8
Smoking 3.3 2.5 2.7
Current occupation 4.7 5.0 4.2
Work absenteeism/pension due to OA 2.0 1.8 1.8
Hand OA subsets 6.1* 16.5 8.3
Symptom duration  8.9 8.6 7.9
Disease duration 5.1 5.0 4.1
Secondary OA 0.7 2.0 1.9
Previous trauma of the hands 1.6 2.3 1.9
OA in other specified joint sites 6.5 5.2 6.7
Treatment for OA 8.3 6.5 5.8
Previous specified surgery for hand 
OA 
3.1 3.5 2.7
Use of orthotics for hand OA 3.3 2.4 2.1
Previous surgery for OA other location 0.3 1.5 1.1
Family history of hand OA 2.2 2.8 3.8
Hand exercise 2.0 2.8 1.8
Comorbidities 6.8 4.9 5.2
Impairment of body functions due to 
comorbidities 
2.5 NA NA
Treatment for comorbidities 1.2 NA NA
Sleep functions 1.2 0.2 0.7
Emotional functions 2.0 0.2 0.5
Coping and illness perceptions 3.2 0.7 2.8
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Results of the Delphi exercise were discussed in a breakout session, among 6 rheumatol-
ogists, 1 occupational therapist, and 1 PRP. The group discussed generic issues regarding 
contextual factors and hand OA–specific issues. On a general level, there is a methodo-
logical need for validation of contextual factors. It was felt that a “core” contextual fac-
tor requires rigorous evidence that this factor influences the result of disease/drug on 
core outcome. However, there is no current consensus on the level of evidence required. 
Overall, the group held the opinion that the Delphi exercise was complex, with a large 
list of candidate contextual factors. The 100-point approach of the Delphi exercise and 
the choice of cutoff were debated. Although the results from the Delphi exercise were 
thought to be more informative than decisive, the breakout group agreed that the factors 
with high agreement from the Delphi exercise represent candidate contextual factors; i.e., 
age, sex, BMI, hand OA subsets, hand OA symptom duration, treatment for OA, OA in oth-
er specified joint sites, fulfillment of the ACR hand OA criteria, and comorbidities. The vast 
majority of voting participants [50 (93%)] agreed to continue research on the prioritized 
candidate contextual factors. Breakout group discussions and later voting supported the 
suggestion of 1 common set of contextual factors in hand OA across different settings [41 
voting participants (75%) agreed; 9 (16%) did not agree; 5 (9%) did not know]. 
DISCUSSION 
Discussions and voting during the consensus meeting at OMERACT 12 resulted in a pre-
liminary set of core domains and subdomains, from which the majority was similar for 3 
settings. The (sub)domains were distributed over the core area life impact and patho-
physiological manifestations, according to the OMERACT filter 2.0, as depicted in Table 
4. Preliminary instruments were identified for some (sub)domains. But for several others, 
research is needed to define disease-specific instruments. The results are summarized in 
Table 5. Candidate contextual factors have been identified, but need further investiga-








Activities/hobbies requiring intensive 
use of the hands 
2.7 3.5 1.7
Lower extremity exercise 0.2 0.3 0.2
Mental status 0.9 NA 0.6
Fulfilling ACR hand OA criteria 6.2 NA 4.1
Nutritional habits NA 0.8 0.3
Degree of catastrophizing 1.7 NA NA
Frustration NA 0.2 NA
Use of stress management techniques NA NA 0.5
Activity limitation NA NA 1.6
 * Candidate contextual factors with high agreement from Delphi round. Dark grey shading: high agreement 
(average score >6); light grey shading: moderate agreement (average score between 1 and 6); no shading: low 
agreement (average score <1). 
ACR, American College of Rheumatology; NA, not applicable; OA, osteoarthritis. 
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Table 4. Preliminary core outcomes measurement set according to the OMERACT Filter 2.0.
Death Life impact Pathophysiological Manifestations
Adverse event • Pain • Pain
• Physical function • Physical function
• Patiënt global assessment • Patiënt global assessment
• Hand strength • Joint activity (tender joints, 
soft swollen joints*)
• HRQOL* • Hand strength
• Structural damage (radio-
graphic damage, aesthetic 







• Fulfillment ACR hand OA 
criteria
• Hand OA subsets
• Symptom duration
• OA at other joint sites
• Concomitant treatment for OA
• Comorbidities
 * Domains not mandatory as long as no disease-specific instruments are available. 
ACR, American College of Rheumatology; BMI, body mass index; HRQOL, health-related quality of life; OA, osteo-
arthritis.
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Table 5. Preliminary set of core (sub) domains with preliminary instruments. 
Domains Subdomains Instruments Settings
Clinical Trials of Symptom 
Modification
Clinical Trials of Structure Modifi-
cation and Observational Studies
Pain Pain VAS/NRS Pain VAS/NRS
Physical function FIHOA FIHOA
Patient global assessment Research Research
Joint activity Tender joints Tender joint count Tender joint count
Soft swollen joints Research Research
Hand strength Grip/pinch strength Grip/pinch strength
HRQOL* Research Research
Structural damage Radiographic 
damage
Kellgren Lawrence or Verbrug-





 * Domains not mandatory as long as no disease-specific instruments are available. 
VAS/NRS: visual analog scale/numerical rating scale; FIHOA: Functional Index for Hand Osteoarthritis; OARSI: Oste-
oarthritis Research Society International. 
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Table 6. Future research for domain instrument validation according to the OMERACT Filter 2.0. 
• A definition for each contextual factor in hand OA should be formulated
• Performance of a literature review to assess the level of evidence for the different candidate contextual 
factors
• Identification or development of potential instruments to assess contextual factors, where applicable
• Disease-specific instruments have to be developed for the (sub)domains HRQOL, aesthetic damage, bony 
damage, deformity, and hand mobility
• Development and testing of VAS/NRS questions to measure the domain pain
• Development of a new measure for hand pain in analogy to knee and hip pain (Intermittent and Constant 
OA Pain for the hand)
• Evaluation of instruments that are commonly used by hand therapists, such as the DASH, PRWHE, and 
Michigan Hand Outcome Questionnaire, for use in hand OA.
• Investigation what hand OA contributes to grip strength or pinch strength relative to other conditions that 
affect hand strength or function
• Performance of qualitative interviews: how to measure patient global assessment
• Investigation of the subdomain tender joints
• Further evaluation of the instrument to assess tender joints (Doyle index), with respect to validation in 
OA — e.g., what is the added value of joint count to other domains, like pain. How many joints and which 
ones should be incorporated in the tender joint count? How should the tender joint count be performed? 
Is there a floor effect?
• To develop instruments to assess soft swollen joints and bony damage 
• Investigation of the value of patient-performed joint count (e.g., self-complete homunculus) versus physi-
cian-performed joint count
• Investigation of the metric properties of US and MRI 
• Investigation of the value of CT
 CT, computerized tomography; DASH, Disabilities of the Arm Shoulder and Hand; HRQOL, health-related quality 
of life; MRI, magnetic resonance imaging; OA, osteoarthritis; PRWHE, Patient-rated Wrist Hand Evaluation; US, 
ultrasound; VAS/NRS, visual analog scale/numerical rating scale.
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